https://www.pharmasalmanac.com/articles/garmin-health-and-cardiogram-announce-integration-of-cardiogram-heart-health-app-and-garmin-wearables 2018-08-27 09:15:00.852+00 https://www.pharmasalmanac.com/articles/cerenovus-receives-european-regulatory-approval-for-bravo-flow-diverter-to-treat-intracranial-aneurysms 2018-08-24 18:28:06.619+00 https://www.pharmasalmanac.com/articles/bioaxone-biosciences-receives-notice-of-allowance-on-patent-for-treatment-of-cerebral-cavernous-malformations-and-cerebral-aneurysms-with-rho-kinase-inhibitors 2018-08-24 09:15:13.185+00 https://www.pharmasalmanac.com/articles/context-therapeutics-signs-strategic-research-collaborations 2018-08-24 09:15:13.085+00 https://www.pharmasalmanac.com/articles/cook-medical-introduces-a-new-length-of-zilver-ptx 2018-08-24 09:15:13.012+00 https://www.pharmasalmanac.com/articles/quadax-introduces-prior-authorization-management-service-to-streamline-the-authorization-process-for-labs 2018-08-23 09:15:07.331+00 https://www.pharmasalmanac.com/articles/affordable-regenerative-stem-cell-therapy-is-now-offered-through-zen-care-physical-medicine-in-irvine-at-an-extraordinary-value 2018-08-23 09:15:04.266+00 https://www.pharmasalmanac.com/articles/first-generic-version-of-epipen-receives-fda-approval 2018-08-22 22:32:38.247+00 https://www.pharmasalmanac.com/articles/fast-approval-for-roche-drug-alecensa-in-china 2018-08-22 22:21:39.365+00 https://www.pharmasalmanac.com/articles/brexit-issues-could-impact-flu-shot-deliveries-to-the-uk 2018-08-22 22:15:57.512+00 https://www.pharmasalmanac.com/articles/spr-therapeutics-single-and-dual-lead-peripheral-nerve-stimulation-devices-pass-fda 2018-08-22 22:08:41.69+00 https://www.pharmasalmanac.com/articles/meeting-the-changing-demands-for-sterile-fill-finish-operations 2018-08-22 20:23:50.699+00 https://www.pharmasalmanac.com/articles/milestone-pharmaceuticals-randomized-clinical-trials 2018-08-22 09:15:01.675+00 https://www.pharmasalmanac.com/articles/first-participant-enrolled-in-biondvaxs-universal-flu-vaccine-pivotal-phase-3-clinical-trial 2018-08-22 09:15:00.756+00 https://www.pharmasalmanac.com/articles/legislation-introduced-to-require-reporting-of-biosimilar-agreements 2018-08-21 21:53:42.645+00 https://www.pharmasalmanac.com/articles/brainsways-transcranial-magnetic-stimulation-system-gets-fda-clearance 2018-08-21 21:49:02.962+00 https://www.pharmasalmanac.com/articles/building-a-biologics-business-from-the-ground-up 2018-08-21 20:30:04.881+00 https://www.pharmasalmanac.com/articles/marken-offers-first-hybrid-service-from-brazil-to-usa 2018-08-21 20:09:45.442+00 https://www.pharmasalmanac.com/articles/alector-receives-orphan-drug-designation-from-the-u.s.-fda-for-al001-for-the-treatment-of-frontotemporal-dementia 2018-08-21 09:15:03.499+00 https://www.pharmasalmanac.com/articles/oncopep-announces-a-phase-1b-clinical-trial-of-its-multi-peptide-cancer-vaccine-pvx-410-in-combination-with-citarinostat-for-smoldering-multiple-myeloma 2018-08-21 09:15:02.892+00 https://www.pharmasalmanac.com/articles/ambys-medicines-and-takeda-announce-partnership-to-pioneer-first-in-class-therapies-for-the-treatment-of-serious-liver-diseases 2018-08-21 09:15:00.995+00 https://www.pharmasalmanac.com/articles/civatech-oncology-inc.-offers-new-technology-to-fight-lung-cancer 2018-08-21 09:15:00.401+00 https://www.pharmasalmanac.com/articles/new-york-state-grants-approval-of-igenexs-newly-developed-lyme-immunoblot-tests 2018-08-20 09:15:13.594+00 https://www.pharmasalmanac.com/articles/first-and-only-fully-implanted-esteem-hearing-device-receives-fda-approval-for-mr-conditional-labeling-at-both-1.5-and-3.0-tesla 2018-08-20 09:15:12.513+00 https://www.pharmasalmanac.com/articles/ambys-medicines-launches-with-140-million-to-pioneer-regenerative-medicine-therapies-for-serious-liver-diseases 2018-08-20 09:15:11.517+00 https://www.pharmasalmanac.com/articles/biocompare-launches-antibody-therapeutic-discovery-and-development-content-hub 2018-08-17 09:15:05.17+00 https://www.pharmasalmanac.com/articles/california-cryobank-and-cord-blood-registry-combine-to-create-a-leading-life-sciences-platform 2018-08-17 09:15:05.147+00 https://www.pharmasalmanac.com/articles/grifols-achieves-key-milestone-with-fda-approval-of-the-new-consolidated-manufacturing-facility-cmf-for-production-of-recombinant-proteins 2018-08-16 16:18:21.202+00 https://www.pharmasalmanac.com/articles/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-exclusive-license-agreement 2018-08-16 09:15:08.045+00 https://www.pharmasalmanac.com/articles/sanifit-announces-completion-of-enrollment-in-calipso 2018-08-16 09:15:07.988+00 https://www.pharmasalmanac.com/articles/prometic-receives-rare-pediatric-disease-designation-from-u.s.-fda-for-small-molecule-drug-candidate-pbi-4050 2018-08-16 09:15:07.087+00 https://www.pharmasalmanac.com/articles/array-biopharma-receives-fda-breakthrough-therapy-designation-for-braftovi-in-combination-with-mektovi-and-cetuximab-for-brafv600e-mutant-metastatic-colorectal-cancer 2018-08-16 09:15:06.125+00 https://www.pharmasalmanac.com/articles/pilot-study-indicates-qualia-mind-improving-reasoning-episodic-memory-verbal-ability-and-concentration 2018-08-16 09:15:06.02+00 https://www.pharmasalmanac.com/articles/eiger-biopharmaceuticals-announces-first-patient-enrolled-in-phase-2-lift-study 2018-08-15 09:15:03.569+00 https://www.pharmasalmanac.com/articles/pliant-therapeutics-receives-fda-orphan-drug-designation-for-lead-program-pln-74809-in-idiopathic-pulmonary-fibrosis 2018-08-15 09:15:02.59+00 https://www.pharmasalmanac.com/articles/quethera-acquired-by-astellas-pharma 2018-08-14 16:36:54.498+00 https://www.pharmasalmanac.com/articles/groundbreaking-for-amgen-in-rhode-island 2018-08-14 16:32:45.323+00 https://www.pharmasalmanac.com/articles/xolair-gets-breakthrough-therapy-designation-from-us-fda-for-treatment-of-food-allergies 2018-08-14 16:28:08.063+00 https://www.pharmasalmanac.com/articles/perrigo-to-divest-its-prescription-drug-business 2018-08-14 16:24:57.372+00 https://www.pharmasalmanac.com/articles/artios-pharma-receives-84-million-in-series-b-funding 2018-08-14 16:22:40.804+00 https://www.pharmasalmanac.com/articles/china-to-accelerate-review-of-48-foreign-drugs 2018-08-14 16:19:37.521+00 https://www.pharmasalmanac.com/articles/alteogen-gets-fda-approval-for-orphan-drug-designation-with-an-antibody-drug-conjugate-for-gastric-cancer 2018-08-14 09:15:03.152+00 https://www.pharmasalmanac.com/articles/regeneron-and-bluebird-bio-announce-collaboration-to-discover-develop-and-commercialize-new-cell-therapies-for-cancer 2018-08-14 09:15:01.646+00 https://www.pharmasalmanac.com/articles/final-results-from-the-protagonist-propel-study-support-further-clinical-development-of-ptg-100-for-the-treatment-of-ulcerative-colitis 2018-08-14 09:15:00.865+00 https://www.pharmasalmanac.com/articles/britannia-pharmaceuticals-ltd-phase-3-toledo-study-shows-apomorphine-infusion-provides-effective-relief-of-persistent-motor-fluctuations-in-parkinsons-disease 2018-08-13 09:15:05.166+00 https://www.pharmasalmanac.com/articles/harpoon-therapeutics-treats-first-patient-with-hpn424-in-phase-1-clinical-trial-of-metastatic-castration-resistant-prostate-cancer-mcrpc-patients 2018-08-13 09:15:04.168+00 https://www.pharmasalmanac.com/articles/regenacy-pharmaceuticals-announces-collaboration-with-the-charcot-marie-tooth-association-cmta-to-advance-ricolinostat-for-the-treatment-of-hereditary-neuropathy 2018-08-13 09:15:03.187+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-the-uk-cystic-fibrosis-gene-therapy-consortium-imperial-innovations-and-oxford-biomedica-announce-new-partnership 2018-08-13 09:15:03.165+00 https://www.pharmasalmanac.com/articles/trovagene-receives-positive-opinion-for-orphan-drug-designation-in-the-european-union-for-pcm-075-trovagenes-investigational-cancer-drug 2018-08-10 15:55:04.444+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-reports-positive-top-line-four-week-data-from-phase-2-trial-of-td-9855-for-the-treatment-of-symptomatic-neurogenic-orthostatic-hypotension 2018-08-10 15:51:16.273+00 https://www.pharmasalmanac.com/articles/sensus-healthcare-receives-fda-501k-clearance-to-market-next-generation-srt-100-superficial-radiation-therapy-for-treating-non-melanoma-skin-cancer-and-keloids 2018-08-10 09:15:08.406+00 https://www.pharmasalmanac.com/articles/regenerx-licensee-gtreebnt-enters-into-joint-venture-to-globally-develop-rgn-137-for-treatment-of-epidermolysis-bullosa 2018-08-10 09:15:08.389+00 https://www.pharmasalmanac.com/articles/hologic-announces-fda-clearance-of-the-panther-fusion-gbs-assay 2018-08-10 09:15:07.406+00 https://www.pharmasalmanac.com/articles/mimedx-announces-publication-of-phase-2b-clinical-trial-efficacy-data-for-micronized-dhacm-in-the-treatment-of-plantar-fasciitis-in-foot-ankle-international 2018-08-10 09:15:07.402+00 https://www.pharmasalmanac.com/articles/regenera-pharma-enrolls-first-patient-in-us-phase-3-study-of-rph201-in-naion-advances-phase-2-study-in-alzheimers-disease-in-canada 2018-08-10 09:15:07.392+00 https://www.pharmasalmanac.com/articles/forces-driving-growth-in-the-u.s.-surgical-microscopes-market 2018-08-09 20:13:58.585+00 https://www.pharmasalmanac.com/articles/intertek-groups-expands-offerings-with-the-acquisition-of-alchemy-systems 2018-08-09 17:27:27.336+00 https://www.pharmasalmanac.com/articles/secant-group-announces-collaboration-between-orgenesis-and-atvio-biotech 2018-08-09 09:15:09.237+00 https://www.pharmasalmanac.com/articles/xcovery-announces-first-cohort-of-patients-dosed-in-a-phase-1/2-clinical-trial-of-vorolanib 2018-08-09 09:15:08.201+00 https://www.pharmasalmanac.com/articles/qiagen-creates-collaboration-with-japans-largest-clinical-laboratory-testing-company-srl-to-accelerate-launch-of-companion-diagnostics 2018-08-09 09:15:08.199+00 https://www.pharmasalmanac.com/articles/new-method-developed-for-stereoselective-synthesis-of-biologic-drug-substances 2018-08-08 18:26:07.81+00 https://www.pharmasalmanac.com/articles/big-pharma-companies-taking-new-drugs-to-china-first 2018-08-08 18:18:22.071+00 https://www.pharmasalmanac.com/articles/from-internal-lab-to-external-service-provider 2018-08-08 18:12:27.936+00 https://www.pharmasalmanac.com/articles/the-als-association-partners-with-gns-healthcare-to-apply-ai-to-accelerate-answer-als-research 2018-08-08 09:15:02.365+00 https://www.pharmasalmanac.com/articles/laekna-acquires-exclusive-worldwide-rights-to-two-clinical-stage-oncology-assets 2018-08-08 09:15:02.274+00 https://www.pharmasalmanac.com/articles/sangamo-announces-preliminary-data-from-champions-study-evaluating-sb-913 2018-08-08 09:15:01.686+00 https://www.pharmasalmanac.com/articles/biolinerx-initiates-phase-1/2a-clinical-study-for-agi-134-a-novel-immunotherapy-for-treatment-of-solid-tumors 2018-08-08 09:15:00.876+00 https://www.pharmasalmanac.com/articles/hologic-to-acquire-faxitron-bioptics-leader-in-digital-specimen-radiography-for-approximately-85-million 2018-08-08 09:15:00.817+00 https://www.pharmasalmanac.com/articles/exosomes-explored-as-new-option-in-drug-delivery 2018-08-07 19:48:41.083+00 https://www.pharmasalmanac.com/articles/new-collaboration-targets-drug-development-using-the-gut-microbiome 2018-08-07 19:27:18.174+00 https://www.pharmasalmanac.com/articles/fresenius-kabi-introduces-four-presentations-of-heparin-sodium-in-freeflexcontainers 2018-08-07 09:15:11.664+00 https://www.pharmasalmanac.com/articles/xeljanz-tofacitinib-citrate-receives-marketing-authorization-in-the-european-union-for-moderately-to-severely-active-ulcerative-colitis 2018-08-07 09:15:11.251+00 https://www.pharmasalmanac.com/articles/qiagen-and-hamilton-launch-new-collaboration-to-improve-pre-analytical-sample-processing-for-quantiferon-tb-gold-plus 2018-08-07 09:15:11.221+00 https://www.pharmasalmanac.com/articles/pfizer-receives-european-approval-for-oncology-biosimilar-trazimera-trastuzumab 2018-08-06 09:15:13.927+00 https://www.pharmasalmanac.com/articles/blockchain-based-pilot-for-exchange-of-clinical-data-announced-by-grapevine-world-in-collaboration-with-the-university-of-southampton-and-tiani-spirit 2018-08-06 09:15:12.922+00 https://www.pharmasalmanac.com/articles/roches-cobas-hpv-test-receives-fda-approval-for-first-line-cervical-cancer-screening-using-surepath-preservative-fluid 2018-08-06 09:15:12.901+00 https://www.pharmasalmanac.com/articles/fda-makes-more-quality-moves 2018-08-03 13:43:13.294+00 https://www.pharmasalmanac.com/articles/wuxi-stas-jinshan-site-passes-fourth-u.s.-fda-inspection 2018-08-03 09:15:10.717+00 https://www.pharmasalmanac.com/articles/nektar-therapeutics-announces-new-drug-application-for-nktr-181-accepted-for-review-by-fda 2018-08-03 09:15:10.274+00 https://www.pharmasalmanac.com/articles/arcus-biosciences-announces-initiation-of-phase-1-trial-for-ab154-its-anti-tigit-antibody 2018-08-03 09:15:09.761+00 https://www.pharmasalmanac.com/articles/thermedical-announces-fda-investigational-device-exemption-approval-to-begin-us-clinical-study-of-durablate-catheter-for-treatment-of-ventricular-tachycardia 2018-08-03 09:15:09.735+00 https://www.pharmasalmanac.com/articles/pierre-fabre-receives-positive-chmp-opinion-for-braftovi-encorafenib-mektovi-binimetinib-in-adult-patients-with-advanced-braf-mutant-melanoma 2018-08-02 09:15:04.596+00 https://www.pharmasalmanac.com/articles/janssen-receives-positive-chmp-opinion-for-darzalex-daratumumab-as-frontline-treatment-for-newly-diagnosed-patients-with-multiple-myeloma 2018-08-02 09:15:04.187+00 https://www.pharmasalmanac.com/articles/abzena-signs-protein-engineering-agreement-with-nyu-langone-health 2018-08-02 09:15:03.608+00 https://www.pharmasalmanac.com/articles/new-weekly-dose-of-tafenoquine-gets-favorable-vote-from-fda-advisory-committee 2018-07-31 18:01:54.661+00 https://www.pharmasalmanac.com/articles/new-understanding-of-muscle-repair-cells-may-lead-to-treatments-for-neurological-diseases 2018-07-31 18:00:43.208+00 https://www.pharmasalmanac.com/articles/promising-phase-2-results-for-eye-implant-from-genentech 2018-07-31 17:59:47.696+00 https://www.pharmasalmanac.com/articles/fda-analysis-shows-reduced-competition-for-first-in-class-drugs 2018-07-31 17:57:21.227+00 https://www.pharmasalmanac.com/articles/are-rebates-contributing-to-higher-drug-prices 2018-07-31 17:56:18.046+00 https://www.pharmasalmanac.com/articles/marken-offers-unique-clinical-logistics-services-in-russia 2018-07-31 15:38:19.915+00 https://www.pharmasalmanac.com/articles/marken-opens-clinical-trial-logistics-hub-in-melbourne-australia 2018-07-31 15:37:46.296+00 https://www.pharmasalmanac.com/articles/abl-bio-and-i-mab-biopharma-announce-global-collaboration-on-innovative-bispecific-antibodies 2018-07-30 20:28:01.519+00 https://www.pharmasalmanac.com/articles/cerapedics-announces-first-patients-enrolled-in-ide-clinical-trial-of-p-15l-bone-graft-for-transforaminal-lumbar-interbody-fusion-surgery 2018-07-30 20:27:20.773+00 https://www.pharmasalmanac.com/articles/mylan-and-fujifilm-kyowa-kirin-biologics-announce-positive-chmp-opinion-for-hulio-biosimilar-adalimumab 2018-07-30 18:33:08.771+00 https://www.pharmasalmanac.com/articles/building-a-robust-supply-chain-with-dependable-quality-primary-suppliers 2018-07-26 20:27:25.444+00 https://www.pharmasalmanac.com/articles/phase-3-study-of-subcutaneous-pertuzumab-and-trastuzumab-initiated-using-halozymes-enhanze-technology 2018-07-26 19:29:17.352+00 https://www.pharmasalmanac.com/articles/foresee-pharmaceuticals-announces-results-from-a-phase-1-clinical-study 2018-07-26 19:28:26.678+00 https://www.pharmasalmanac.com/articles/insightec-receives-fda-approval-to-initiate-clinical-study-of-mr-guided-focused-ultrasound-to-treat-patients-with-alzheimers-disease 2018-07-26 19:27:27.46+00 https://www.pharmasalmanac.com/articles/bio-thera-solutions-initiates-phase-i-clinical-trial-for-bat-1806-a-proposed-biosimilar-of-actemra-tocilizumab 2018-07-26 19:25:01.091+00 https://www.pharmasalmanac.com/articles/asuragen-expands-amplidex-technology-and-product-line-with-launch-of-pcr/ce-smn1-kit 2018-07-26 19:23:37.896+00 https://www.pharmasalmanac.com/articles/siemens-healthineers-transforms-care-delivery-with-innovative-new-tests-for-diagnosing-heart-attacks-faster 2018-07-25 17:52:10.218+00 https://www.pharmasalmanac.com/articles/tolero-pharmaceuticals-announces-first-patient-dosed-with-investigational-agent-tp-0184-in-phase-1-study-of-patients-with-advanced-solid-tumors 2018-07-25 17:51:30.845+00 https://www.pharmasalmanac.com/articles/takeda-announces-phase-3-trial-of-alunbrig-brigatinib-met-primary-endpoint-demonstrating-superiority-in-progression-free-survival-versus-crizotinib 2018-07-25 17:50:09.626+00 https://www.pharmasalmanac.com/articles/pfizer-to-build-cutting-edge-sterile-injectable-facility-in-michigan-investing-nearly-half-a-billion-dollars-in-u.s.-manufacturing-creating-more-than-450-jobs 2018-07-25 17:48:55.789+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-announced-successful-completion-of-the-first-cgmp-run-in-mfg3 2018-07-25 17:47:35.07+00 https://www.pharmasalmanac.com/articles/novartis-goes-to-court-over-gilenya-generics 2018-07-24 22:15:15.733+00 https://www.pharmasalmanac.com/articles/kite-makes-move-on-gadeta 2018-07-24 22:10:51.82+00 https://www.pharmasalmanac.com/articles/fda-to-import-drugs-from-other-countries 2018-07-24 21:51:51.538+00 https://www.pharmasalmanac.com/articles/endoscopy-publishes-the-dayb-phase-iii-trial-for-plenvuner1006-the-first-one-litre-peg-bowel-preparationi 2018-07-24 20:42:35.895+00 https://www.pharmasalmanac.com/articles/gilead-announces-new-data-on-the-impact-of-truvada-for-pre-exposure-prophylaxis-prep-on-the-number-of-hiv-diagnoses-in-the-united-states 2018-07-24 20:41:16.241+00 https://www.pharmasalmanac.com/articles/celgene-announces-phase-iii-augment-study-of-revlimid-in-combination-with-rituximab-r2 2018-07-24 20:04:29.541+00 https://www.pharmasalmanac.com/articles/novartis-will-spend-up-to-more-than-1-billion-on-an-eczema-candidate 2018-07-24 18:35:06.044+00 https://www.pharmasalmanac.com/articles/ifm-gets-funding-to-support-work-on-nlrp3-inhibitors 2018-07-24 18:32:43.147+00 https://www.pharmasalmanac.com/articles/shire-exec-selected-to-run-servier-pharmaceuticals-u.s 2018-07-24 18:26:26.876+00 https://www.pharmasalmanac.com/articles/abbvie-receives-u.s.-fda-approval-of-orilissa-elagolix-for-the-management-of-moderate-to-severe-pain-associated-with-endometriosis 2018-07-24 15:26:54.766+00 https://www.pharmasalmanac.com/articles/dps-group-and-tria-celebrate-opening-of-state-of-the-art-cgmp-mrna-clinical-manufacturing-facility-for-moderna-therapeutics 2018-07-24 14:39:18.4+00 https://www.pharmasalmanac.com/articles/brammer-bio-manufacturing-personalized 2018-07-24 13:44:05.761+00 https://www.pharmasalmanac.com/articles/st.-baldricks-foundation-announces-19.1-million-in-grants-to-fund-lifesaving-childhood-cancer-research 2018-07-20 15:17:46.162+00 https://www.pharmasalmanac.com/articles/researchers-are-one-step-closer-to-developing-eye-drops-to-treat-age-related-macular-degeneration-amd 2018-07-19 20:04:58.135+00 https://www.pharmasalmanac.com/articles/vyriad-announces-collaboration-with-merck-kgaa-darmstadt-germany-and-pfizer 2018-07-18 16:21:23.09+00 https://www.pharmasalmanac.com/articles/hbi-solutions-tool-predicts-who-is-likely-to-abuse-opioids-using-medical-and-social-data 2018-07-18 16:16:14.115+00 https://www.pharmasalmanac.com/articles/cook-regentec-announces-first-u.s.-clinical-use-of-advance-cs-coronary-sinus-infusion-catheter-to-deliver-a-therapeutic-in-heart-failure-patients 2018-07-18 16:11:39.995+00 https://www.pharmasalmanac.com/articles/painreform-gets-fda-approval-for-phase-iii-post-operative-pain-relief-study 2018-07-18 16:08:13.804+00 https://www.pharmasalmanac.com/articles/appeals-board-rules-in-favor-of-novartis-and-its-multiple-sclerosis-drug-gilenya 2018-07-18 15:52:07.91+00 https://www.pharmasalmanac.com/articles/safety-concerns-raised-about-valsartan-from-china 2018-07-18 15:46:21.085+00 https://www.pharmasalmanac.com/articles/xtandi-gets-fda-second-cancer-therapy-approval 2018-07-18 15:42:55.131+00 https://www.pharmasalmanac.com/articles/china-turning-to-indian-drug-manufacturers-in-response-to-trade-war-with-us 2018-07-18 15:35:34.834+00 https://www.pharmasalmanac.com/articles/locus-biosciences-acquires-epibiomes-high-throughput-discovery-platform-to-enhance-its-global-leadership-in-crispr-engineered-phage-therapeutics 2018-07-18 14:28:49.843+00 https://www.pharmasalmanac.com/articles/biosurgery-market-worth-15.58-billion-usd-by-2023 2018-07-17 21:45:54.495+00 https://www.pharmasalmanac.com/articles/pulmatrix-announces-positive-top-line-preliminary-results-from-part-3-of-the-3-part-phase-1/1b-clinical-trial-of-pulmazole 2018-07-17 21:42:04.707+00 https://www.pharmasalmanac.com/articles/idtechex-research-long-term-in-vivo-performance-of-tissue-engineered-heart-valves 2018-07-17 21:39:02.161+00 https://www.pharmasalmanac.com/articles/fda-committee-gives-nod-to-new-treatment-for-plasmodium-vivax-malaria 2018-07-17 18:16:01.735+00 https://www.pharmasalmanac.com/articles/new-antibiotic-to-be-tested-against-potential-bioweapons 2018-07-17 18:12:46+00 https://www.pharmasalmanac.com/articles/leiters-and-avanos-medical-announce-preferred-provider-agreement 2018-07-16 21:31:32.741+00 https://www.pharmasalmanac.com/articles/court-ruling-in-favor-of-aquestive-therapeutics-enjoining-dr.-reddys-laboratories-from-launching-its-generic-suboxone-product 2018-07-16 21:27:49.057+00 https://www.pharmasalmanac.com/articles/peptron-announces-published-data-showing-a-new-sustained-release-exendin-4-formulation-prevents-neurodegeneration-in-a-parkinsons-disease-model 2018-07-16 21:17:20.404+00 https://www.pharmasalmanac.com/articles/upsher-smith-launches-vigabatrin-for-oral-solution-under-the-brand-name-vigadrone 2018-07-16 21:08:49.321+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approves-xtandi-enzalutamide-for-the-treatment-of-men-with-non-metastatic-castration-resistant-prostate-cancer-crpc 2018-07-13 20:26:35.01+00 https://www.pharmasalmanac.com/articles/bausch-health-companies-inc.-completes-name-change 2018-07-13 20:21:43.785+00 https://www.pharmasalmanac.com/articles/roche-pct-assay-cleared-for-expanded-use-important-tool-in-antibiotic-resistance-crisis 2018-07-13 20:14:26.892+00 https://www.pharmasalmanac.com/articles/digital-ad-spending-by-pharma-is-growing-slowly 2018-07-13 15:40:20.598+00 https://www.pharmasalmanac.com/articles/womens-health-company-to-expand 2018-07-13 15:25:25.114+00 https://www.pharmasalmanac.com/articles/abbott-receives-fda-approval-for-next-generation-mitraclip-device-to-treat-people-with-leaky-heart-valves 2018-07-12 20:12:16.295+00 https://www.pharmasalmanac.com/articles/diabetes-research-institute-launches-new-clinical-trial-to-explore-effects-of-omega-3-fatty-acids-and-vitamin-d-in-type-1-diabetes 2018-07-12 20:04:17.757+00 https://www.pharmasalmanac.com/articles/abbvie-announces-submission-of-supplemental-new-drug-application-to-us-fda-for-venetoclax 2018-07-12 19:58:34.925+00 https://www.pharmasalmanac.com/articles/eating-well-might-improve-cancer-treatments 2018-07-12 18:59:14.042+00 https://www.pharmasalmanac.com/articles/organ-on-a-chip-company-raises-36-million 2018-07-12 18:54:35.128+00 https://www.pharmasalmanac.com/articles/medimmune-and-4d-molecular-therapeutics-collaborate-to-design-develop-and-commercialize-aav-gene-therapy-for-chronic-lung-disease 2018-07-11 18:23:53.056+00 https://www.pharmasalmanac.com/articles/biocryst-provides-update-on-strategy-pipeline-and-outlook 2018-07-11 18:14:32.343+00 https://www.pharmasalmanac.com/articles/ensembleiq-acquires-media-brands-from-lebhar-friedman 2018-07-10 21:52:05.147+00 https://www.pharmasalmanac.com/articles/reddress-receives-fda-510k-clearance-for-rd1-system 2018-07-10 21:48:36.141+00 https://www.pharmasalmanac.com/articles/bioarctic-receives-regulatory-approval-in-finland-for-a-clinical-study-in-patients-with-complete-spinal-cord-injury 2018-07-10 21:45:42.743+00 https://www.pharmasalmanac.com/articles/bosch-packaging-business-up-for-sale 2018-07-10 15:06:50.631+00 https://www.pharmasalmanac.com/articles/gottlieb-discusses-results-of-online-opioid-summit 2018-07-10 15:04:07.216+00 https://www.pharmasalmanac.com/articles/alcon-set-out-on-its-own 2018-07-10 14:59:58.56+00 https://www.pharmasalmanac.com/articles/japan-approves-two-new-astrazeneca-cancer-meds 2018-07-10 14:24:44.448+00 https://www.pharmasalmanac.com/articles/bd-acquires-tva-medical-to-advance-leadership-in-solutions-for-chronic-kidney-disease 2018-07-09 18:53:06.704+00 https://www.pharmasalmanac.com/articles/mylan-adds-to-central-nervous-system-portfolio-with-launch-of-generic-exelon-patch 2018-07-09 18:33:46.039+00 https://www.pharmasalmanac.com/articles/companion-medical-announces-fda-clearance-for-the-inpen-system-for-android 2018-07-09 17:48:19.63+00 https://www.pharmasalmanac.com/articles/bosch-plans-to-sell-its-packaging-business 2018-07-06 21:16:54.466+00 https://www.pharmasalmanac.com/articles/evonetix-awarded-innovate-uk-funding-for-1.3-million-gene-synthesis-project 2018-07-06 21:03:37.988+00 https://www.pharmasalmanac.com/articles/recipharm-announces-global-serialisation-collaboration 2018-07-06 19:10:42.737+00 https://www.pharmasalmanac.com/articles/phase-iii-impassion130-study-showed-roches-tecentriq-plus-abraxane-significantly-reduced-the-risk-of-disease-worsening-for-metastatic-triple-negative-breast-cancer 2018-07-06 19:04:49.132+00 https://www.pharmasalmanac.com/articles/abzena-and-telix-sign-strategic-manufacturing-and-bioconjugation-agreement 2018-07-05 17:42:57.69+00 https://www.pharmasalmanac.com/articles/sanofi-to-further-accelerate-its-scientific-presence-with-the-opening-of-a-global-rd-operations-hub-in-chengdu-china 2018-07-05 17:37:57.981+00 https://www.pharmasalmanac.com/articles/-the-wave-of-cannabis-legalization-is-impending-abroad 2018-07-05 17:23:55.9+00 https://www.pharmasalmanac.com/articles/google-amazon-facebook-and-apple-propel-the-life-sciences-industry-with-strategic-partnerships 2018-07-05 17:17:04.926+00 https://www.pharmasalmanac.com/articles/the-global-biosimulation-market-size-is-expected-to-reach-usd-3.77-billion-by-2024 2018-07-05 15:13:04.734+00 https://www.pharmasalmanac.com/articles/catalent-signs-agreement-to-acquire-juniper-pharmaceuticals-inc 2018-07-05 11:00:12.883+00 https://www.pharmasalmanac.com/articles/leveraging-hot-melt-extrusion-for-solubility-and-continuous-manufacturing 2018-07-02 17:56:38.216+00 https://www.pharmasalmanac.com/articles/i-mab-successfully-raised-usd-220-million-in-series-c-funding 2018-06-29 20:53:06.444+00 https://www.pharmasalmanac.com/articles/novartis-announces-intention-to-seek-shareholder-approval-for-100-spinoff-of-alcon-eye-care-devices-business-initiates-share-buyback-of-up-to-usd-5-bn 2018-06-29 20:21:05.255+00 https://www.pharmasalmanac.com/articles/chinarx-author-rosemary-gibson-to-speak-at-rx-360-conference 2018-06-29 18:19:03.43+00 https://www.pharmasalmanac.com/articles/nice-insight-launches-2017-study-season 2018-06-29 16:23:53.409+00 https://www.pharmasalmanac.com/articles/new-post-raw-material-supply-many-issues-to-manage 2018-06-29 16:23:05.063+00 https://www.pharmasalmanac.com/articles/q2-tn-single-use-equipment-proving-useful-managing-bio-manufacturing-costs 2018-06-29 16:23:04.885+00 https://www.pharmasalmanac.com/articles/novartis-and-amgen-highlight-findings-from-a-large-global-patient-survey-on-migranes 2018-06-29 11:00:15.264+00 https://www.pharmasalmanac.com/articles/science-exchange-adds-allergan-evp-chief-rd-officer-david-nicholson-to-its-board-of-directors 2018-06-27 21:07:45.48+00 https://www.pharmasalmanac.com/articles/amgen-announces-top-line-results-from-phase-3-study-of-abp-710-biosimilar-candidate-to-infliximab 2018-06-27 21:03:01.77+00 https://www.pharmasalmanac.com/articles/ligand-receives-47-million-from-wuxi-biologics-for-expansion-of-worldwide-omniab-platform-license-agreement 2018-06-27 20:55:29.473+00 https://www.pharmasalmanac.com/articles/arrowhead-receives-positive-ema-opinion-on-orphan-designation-for-aro-aat-for-treatment-of-congenital-alpha-1-antitrypsin-deficiency 2018-06-27 20:51:16.384+00 https://www.pharmasalmanac.com/articles/precision-biosciences-raises-110m-to-advance-arcus-genome-editing-programs 2018-06-26 16:15:10.762+00 https://www.pharmasalmanac.com/articles/3d-bioprinting-market-size-worth-2.6-billion-by-2024-cagr-18.4-grand-view-research-inc 2018-06-26 15:58:38.459+00 https://www.pharmasalmanac.com/articles/italian-pharmaceutical-manufacturer-and-cmo-ibi-lorenzini-selects-tracelink-to-comply-with-global-serialization-regulations 2018-06-26 15:45:24.767+00 https://www.pharmasalmanac.com/articles/trump-administration-proposes-hhs-restructuring-including-major-changes-at-fda 2018-06-26 14:20:49.444+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-lilly-announce-positive-top-line-phase-iii-data-results-for-empagliflozin-as-adjunct-to-insulin-in-type-1-diabetes 2018-06-26 14:08:16.213+00 https://www.pharmasalmanac.com/articles/array-biopharma-announces-a-62-observed-overall-survival-at-one-year-from-the-phase-3-beacon-crc-safety-lead-in 2018-06-26 14:07:34.119+00 https://www.pharmasalmanac.com/articles/a-risk-analysis-approach-to-producing-environmentally-sensitive-parenterals 2018-06-26 13:53:56.414+00 https://www.pharmasalmanac.com/articles/oramed-enrolls-first-patient-in-its-glucose-clamp-study-for-oral-insulin 2018-06-25 18:23:33.435+00 https://www.pharmasalmanac.com/articles/processa-pharmaceuticals-receives-orphan-designation-status-for-pcs499-in-necrobiosis-lipoidica-from-the-food-and-drug-administration-fda 2018-06-22 20:06:43.994+00 https://www.pharmasalmanac.com/articles/lilly-completes-acquisition-of-armo-biosciences 2018-06-22 19:55:38.112+00 https://www.pharmasalmanac.com/articles/johnson-johnson-innovation-opens-jlabs-nyc-in-collaboration-with-new-york-state-and-the-new-york-genome-center 2018-06-21 21:20:03.189+00 https://www.pharmasalmanac.com/articles/building-healthcare-brands-through-recognizable-capsules 2018-06-21 15:08:35.811+00 https://www.pharmasalmanac.com/articles/progress-on-new-antiviral-drugs-at-chimerix 2018-06-21 14:30:39.349+00 https://www.pharmasalmanac.com/articles/successful-ipo-for-verrica-pharmaceuticals 2018-06-21 14:22:43.734+00 https://www.pharmasalmanac.com/articles/cellectic-car-t-therapy-contains-safety-switch-and-more 2018-06-21 14:15:25.768+00 https://www.pharmasalmanac.com/articles/new-diagnostic-tool-for-heart-disease-based-on-crispr-technology 2018-06-21 14:11:07.09+00 https://www.pharmasalmanac.com/articles/a-key-to-the-cage-opening-the-living-membrane-gate 2018-06-21 14:02:46.34+00 https://www.pharmasalmanac.com/articles/meeting-biopharma-contract-manufacturing-needs-with-a-flexible-global-network 2018-06-21 13:56:44.76+00 https://www.pharmasalmanac.com/articles/fda-grants-qidp-designation-to-acurxs-lead-antibiotic-product-candidate-acx-362e-for-clostridium-difficile-infection 2018-06-21 11:00:03.788+00 https://www.pharmasalmanac.com/articles/vantage-solutions-guides-reed-lane-through-smooth-serialization-projects 2018-06-20 21:15:17.779+00 https://www.pharmasalmanac.com/articles/pharmaceutical-robots-market-global-industry-analysis-size-share-growth-trends-and-forecast-2018-2026 2018-06-20 21:08:30.272+00 https://www.pharmasalmanac.com/articles/distek-inc.-releases-small-volume-conversion-kit-for-symphony-7100-bathless-dissolution-tester 2018-06-20 16:35:21.484+00 https://www.pharmasalmanac.com/articles/reducing-time-to-market-with-targeted-regulatory-affairs-support 2018-06-20 14:31:30.641+00 https://www.pharmasalmanac.com/articles/could-a-bispecific-antibody-be-a-functional-cure-for-aids 2018-06-19 17:14:03.225+00 https://www.pharmasalmanac.com/articles/china-grants-first-approval-for-pd-1/l1-checkpoint-inhibitor 2018-06-19 17:11:18.839+00 https://www.pharmasalmanac.com/articles/single-blood-drop-analysis-technologies-and-global-market 2018-06-18 19:34:32.24+00 https://www.pharmasalmanac.com/articles/recipharm-expands-inhalation-capabilities-with-gbp-45-million-acquisition-of-sanofi-cmo-business-located-in-uk 2018-06-15 19:19:38.096+00 https://www.pharmasalmanac.com/articles/sage-announces-pivotal-phase-3-trial-status-for-sage-217-in-major-depressive-disorder-and-postpartum-depression-based-on-fda-breakthrough-therapy-meeting 2018-06-15 19:13:19.505+00 https://www.pharmasalmanac.com/articles/new-data-for-nktr-181-a-first-in-class-investigational-opioid-to-treat-chronic-low-back-pain-in-adult-patients-new-to-opioid-therapy 2018-06-15 18:54:07.331+00 https://www.pharmasalmanac.com/articles/wuxi-sta-first-cdmo-to-support-the-approval-of-an-innovative-drug-in-china-through-the-mah-pilot 2018-06-15 18:49:05.805+00 https://www.pharmasalmanac.com/articles/french-pharma-company-ipsen-moves-us-headquarters-from-new-jersey-to-boston 2018-06-15 17:00:08.582+00 https://www.pharmasalmanac.com/articles/will-rapid-genome-sequencing-become-a-standard-practice-for-acutely-ill-infants 2018-06-15 16:53:45.748+00 https://www.pharmasalmanac.com/articles/stridebio-closes-15.7-million-series-a-financing-to-advance-transformational-aav-platform 2018-06-15 11:00:08.019+00 https://www.pharmasalmanac.com/articles/fda-advisory-committee-votes-in-favor-of-cardinal-healths-incraft-aaa-stent-graft-system-for-the-endovascular-treatment-of-infrarenal-abdominal-aortic-aneurysms 2018-06-14 20:16:22.189+00 https://www.pharmasalmanac.com/articles/wests-selfdose-patient-controlled-injector-wins-silver-medical-design-excellence-award 2018-06-14 18:50:11.521+00 https://www.pharmasalmanac.com/articles/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders 2018-06-14 18:43:26.353+00 https://www.pharmasalmanac.com/articles/alcamis-extended-workbench-supports-commercial-supply-of-flexion-therapeuticss-zilrettatriamcinolone-acetonide-extended-release-injectable-suspension 2018-06-14 18:07:36.315+00 https://www.pharmasalmanac.com/articles/international-cannabis-legalization-to-spur-global-medical-and-recreational-sales 2018-06-14 17:47:34.391+00 https://www.pharmasalmanac.com/articles/hormone-therapy-appears-to-be-the-best-bet-for-treating-early-breast-cancer 2018-06-14 17:00:03.064+00 https://www.pharmasalmanac.com/articles/pfizer-expands-investment-in-biotech-through-pfizer-ventures 2018-06-14 16:55:14.651+00 https://www.pharmasalmanac.com/articles/allergan-announces-positive-topline-phase-3-clinical-data-for-bimatoprost-sr-sustained-release-implant- 2018-06-14 16:45:11.43+00 https://www.pharmasalmanac.com/articles/fda-approves-venclexta/rituxan-combination-treatment-for-leukemia 2018-06-12 18:35:43.85+00 https://www.pharmasalmanac.com/articles/preliminary-data-suggests-denki-pain-blockers-dont-have-abuse-potential 2018-06-12 18:29:54.583+00 https://www.pharmasalmanac.com/articles/fujifilm-expands-ris-revenue-cycle-solutions-with-availity-partnership 2018-06-12 18:25:21.103+00 https://www.pharmasalmanac.com/articles/marken-moves-chicago-operations-to-new-full-service-location 2018-06-12 16:31:26.044+00 https://www.pharmasalmanac.com/articles/biobanking-market-forecasts-2018-2028-visiongain-report 2018-06-11 18:31:12.704+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-leads-strategic-investment-in-insilico-medicine-to-accelerate-drug-discovery-using-next-generation-artificial-intelligence 2018-06-11 18:16:55.971+00 https://www.pharmasalmanac.com/articles/global-bioprinting-market-to-reach-4.70-billion-by-2025-reports-bis-research 2018-06-11 11:00:06.663+00 https://www.pharmasalmanac.com/articles/new-data-demonstrate-artemis-therapeutics-artemisone-may-be-an-effective-inhibitor-of-human-cmv-replication 2018-06-08 18:36:34.201+00 https://www.pharmasalmanac.com/articles/astellas-names-nahrin-marino-to-vice-president-head-of-ethics-compliance-americas 2018-06-08 18:35:57.444+00 https://www.pharmasalmanac.com/articles/another-mab-biosimilar-on-the-horizon-in-europe 2018-06-05 18:14:21.914+00 https://www.pharmasalmanac.com/articles/funding-round-will-boost-efforts-to-develop-antibiotic-for-alzheimers-disease 2018-06-05 18:11:04.318+00 https://www.pharmasalmanac.com/articles/fda-announces-policies-to-facilitate-development-of-generic-drugs 2018-06-05 18:07:02.672+00 https://www.pharmasalmanac.com/articles/partnerships-between-bayer-and-doe-formed-to-produce-radioactive-pharma-intermediate 2018-06-05 18:03:40.282+00 https://www.pharmasalmanac.com/articles/blueprint-medicines-targets-asian-market 2018-06-05 17:57:01.932+00 https://www.pharmasalmanac.com/articles/loxo-oncology-reports-positive-results-for-second-targeted-cancer-therapy 2018-06-05 17:51:59.601+00 https://www.pharmasalmanac.com/articles/five-tips-to-ensure-faster-equipment-procurement-and-installation 2018-06-04 19:06:15.8+00 https://www.pharmasalmanac.com/articles/lanxess-introduces-new-stabilizers-to-reliably-protect-plastics-from-hydrolysis 2018-06-04 14:18:08.328+00 https://www.pharmasalmanac.com/articles/amgen-and-md-anderson-announce-collaboration-to-accelerate-early-stage-treatments-for-cancer 2018-06-04 14:17:40.154+00 https://www.pharmasalmanac.com/articles/tenax-therapeutics-announces-study-design-for-phase-2-trial-of-levosimendan-in-ph-hfpef-patients 2018-06-04 14:15:34.169+00 https://www.pharmasalmanac.com/articles/labcorp-and-unilabs-collaborate-to-expand-global-reach-of-precision-medicine-capabilities-to-serve-patients-physicians-and-pharma 2018-06-04 14:14:04.418+00 https://www.pharmasalmanac.com/articles/exelixis-announces-further-expansion-to-clinical-research-protocol-for-phase-1b-cosmic-021-trial-of-cabozantinib-in-combination-with-anti-pd-l1-immunotherapy 2018-06-04 14:13:24.229+00 https://www.pharmasalmanac.com/articles/bayer-and-md-anderson-cancer-center-collaborate-to-strengthen-oncology-translational-research-and-clinical-development 2018-06-04 14:11:50.824+00 https://www.pharmasalmanac.com/articles/alcami-to-become-industry-leading-platform-cdmo-following-acquisition-by-madison-dearborn-partners 2018-06-04 14:11:19.555+00 https://www.pharmasalmanac.com/articles/chronic-migraine-prevention-trial-shows-positive-results-for-cefaly-prevent-medical-device 2018-06-04 14:10:25.059+00 https://www.pharmasalmanac.com/articles/advance-in-colon-cancer-detection-avantis-medical-systems-partners-with-pentax-medical 2018-06-04 14:08:35.43+00 https://www.pharmasalmanac.com/articles/xoran-and-fiagon-collaborate-in-the-neuro-and-spine-markets 2018-06-04 14:07:59.282+00 https://www.pharmasalmanac.com/articles/genea-biocells-announces-fda-orphan-drug-designation-for-gbc0905-for-the-treatment-of-facioscapulohumeral-muscular-dystrophy-fshd 2018-06-04 14:07:25.201+00 https://www.pharmasalmanac.com/articles/evotec-forms-academic-bridge-lab591-with-arix-bioscience-and-fred-hutchinson-cancer-research-center 2018-06-04 13:47:10.547+00 https://www.pharmasalmanac.com/articles/therapeuticsmd-announces-fda-approval-of-tx-004hr-imvexxy-estradiol-vaginal-inserts-the-lowest-dose-vaginal-estrogen-product-approved-for-treatment 2018-06-04 11:00:07.7+00 https://www.pharmasalmanac.com/articles/state-of-the-art-biologics-manufacturing-in-an-unexpected-location 2018-06-01 18:19:04.834+00 https://www.pharmasalmanac.com/articles/right-to-try-now-legal-across-state-lines 2018-06-01 17:46:08.551+00 https://www.pharmasalmanac.com/articles/pfizer-announces-u.s.-fda-approves-xeljanz-tofacitinib-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis 2018-06-01 15:21:03.534+00 https://www.pharmasalmanac.com/articles/cloud-pharmaceuticals-forms-drug-design-collaboration-with-gsk 2018-06-01 15:18:57.014+00 https://www.pharmasalmanac.com/articles/researchers-find-link-between-tuberculosis-and-parkinsons-disease 2018-05-31 19:54:26.367+00 https://www.pharmasalmanac.com/articles/more-positive-phase-3-results-for-roches-tecentriq 2018-05-31 19:45:14.069+00 https://www.pharmasalmanac.com/articles/investing-in-chinese-pharma-companies-proves-profitable 2018-05-31 19:37:50.516+00 https://www.pharmasalmanac.com/articles/gsk-applies-in-japan-for-approval-of-a-once-daily-single-inhaler-triple-therapy-for-copd 2018-05-31 19:22:42.33+00 https://www.pharmasalmanac.com/articles/rentschler-fill-solutions-and-ultragenyx-start-fill-finish-collaboration-for-the-us-commercial-supply-of-drug-product-mepsevii 2018-05-31 15:44:19.776+00 https://www.pharmasalmanac.com/articles/nwbio-announces-scientific-publication-of-interim-survival-data-from-phase-3-trial-of-dcvax-l-for-glioblastoma-brain-cancer 2018-05-31 15:43:34.953+00 https://www.pharmasalmanac.com/articles/sage-therapeutics-announces-fda-acceptance-of-nda-filing-and-grant-of-priority-review-for-brexanolone-iv-in-the-treatment-of-postpartum-depression 2018-05-31 15:40:44.216+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-tsinghua-university-innovation-center-for-immune-therapy-sign-mou-and-announce-strategic-partnership 2018-05-31 15:37:58.171+00 https://www.pharmasalmanac.com/articles/exelixis-announces-u.s.-fda-accepts-supplemental-new-drug-application-for-cabometyx-cabozantinib-in-previously-treated-advanced-hepatocellular-carcinoma 2018-05-31 15:37:10.812+00 https://www.pharmasalmanac.com/articles/evotec-and-celgene-expand-ipsc-collaboration-to-include-additional-cell-lines 2018-05-31 15:30:02.639+00 https://www.pharmasalmanac.com/articles/corporate-social-responsibility-as-a-driver-for-improved-sustainability 2018-05-29 22:40:31.746+00 https://www.pharmasalmanac.com/articles/strengthening-the-outsource-service-offering-through-integration 2018-05-29 22:38:58.55+00 https://www.pharmasalmanac.com/articles/using-a-risk-based-approach-to-manufacturing-in-a-multi-product-facility 2018-05-29 22:29:30.652+00 https://www.pharmasalmanac.com/articles/taking-middle-market-cros-and-cdmos-to-the-next-level 2018-05-29 22:21:35.241+00 https://www.pharmasalmanac.com/articles/finishing-touches-the-future-of-fill-finish-and-pharma-packaging 2018-05-29 21:25:33.203+00 https://www.pharmasalmanac.com/articles/thinking-a-generation-ahead-biologics-based-therapy 2018-05-29 21:24:02.471+00 https://www.pharmasalmanac.com/articles/supporting-patient-centric-clinical-trials-from-point-of-origin-through-the-last-mile 2018-05-29 20:59:23.647+00 https://www.pharmasalmanac.com/articles/addressing-development-challenges-for-complex-biologic-drugcandidates 2018-05-29 20:55:54.145+00 https://www.pharmasalmanac.com/articles/flexible-mobile-modular-high-containment-viral-vector-center-of-excellence 2018-05-29 20:55:05.511+00 https://www.pharmasalmanac.com/articles/modern-osd-facility-design-considerations-for-operational-efficiency-and-regulatory-compliance 2018-05-29 20:48:37.286+00 https://www.pharmasalmanac.com/articles/maximizing-roi-through-equipment-liquidation 2018-05-29 20:42:41.542+00 https://www.pharmasalmanac.com/articles/scientific-expertise-facilitates-oral-peptide-product-development-and-manufacturing 2018-05-29 20:40:58.711+00 https://www.pharmasalmanac.com/articles/biopharma-cdmo-success-requires-technical-leadership-and-problem-solving-capabilities 2018-05-29 20:39:14.677+00 https://www.pharmasalmanac.com/articles/doping-famous-cases-substances-and-values-in-sports 2018-05-29 20:36:54.561+00 https://www.pharmasalmanac.com/articles/valneva-receives-fast-track-designation-for-lyme-disease-vaccine 2018-05-29 19:39:28.408+00 https://www.pharmasalmanac.com/articles/teva-hopes-to-launch-new-migraine-drug-immediately-after-pdufa-date 2018-05-29 19:35:46.571+00 https://www.pharmasalmanac.com/articles/transforming-the-pharmaceutical-industry-pipeline-with-in-silico-approaches 2018-05-29 19:07:40.118+00 https://www.pharmasalmanac.com/articles/atox-bio-announces-enrollment-of-first-patient-in-phase-2-study-of-acute-kidney-injury-aki 2018-05-29 18:33:41.031+00 https://www.pharmasalmanac.com/articles/olix-pharmaceuticals-receives-clinical-trial-authorization-in-the-uk-to-initiate-phase-i-study-with-olx10010-an-anti-scar-rnai-therapeutics 2018-05-29 18:32:22.545+00 https://www.pharmasalmanac.com/articles/phase-iii-impower130-study-showed-genentechs-tecentriq-atezolizumab-plus-chemotherapy-carboplatin-and-abraxane-helped-against-lung-cancer 2018-05-29 18:30:42.971+00 https://www.pharmasalmanac.com/articles/cerenis-therapeutics-and-university-of-north-texas-health-science-center-announce-a-strategic-initiative-to-develop-new-hdl-based-pharmaceutical-products 2018-05-29 18:30:18.807+00 https://www.pharmasalmanac.com/articles/demand-for-butadiene-driven-by-the-asia-pacific-market 2018-05-29 18:24:23.592+00 https://www.pharmasalmanac.com/articles/fda-accepts-larotrectinib-new-drug-application-and-grants-priority-review 2018-05-29 18:08:16.238+00 https://www.pharmasalmanac.com/articles/beactica-signs-three-year-extension-agreement-with-sanofi 2018-05-29 17:59:12.19+00 https://www.pharmasalmanac.com/articles/changes-in-the-biopharma-industry-from-minor-to-major-evolution 2018-05-29 17:58:22.502+00 https://www.pharmasalmanac.com/articles/pfizers-xalkori-crizotinib-receives-fda-breakthrough-therapy-designation-in-two-new-indications 2018-05-29 17:51:37.805+00 https://www.pharmasalmanac.com/articles/adaptive-biotechnologies-announces-a-collaboration-with-sanofi 2018-05-29 17:49:37.865+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-to-invest-s80-million-to-establish-a-biologics-manufacturing-facility-in-singapore 2018-05-29 17:49:03.307+00 https://www.pharmasalmanac.com/articles/inside-mergers-acquisitions 2018-05-29 17:48:16.265+00 https://www.pharmasalmanac.com/articles/achieving-controlled-nucleation-during-aseptic-lyophilization 2018-05-29 16:20:05.765+00 https://www.pharmasalmanac.com/articles/worldwide-clinical-trials-receives-2018-cro-leadership-awards-for-outstanding-capabilities-compatibility-expertise-quality-and-reliability 2018-05-29 14:40:46.29+00 https://www.pharmasalmanac.com/articles/splash-pharmaceuticals-announces-dose-escalation-in-phase-i-clinical-trial-in-platinum-resistant-ovarian-cancer-patients 2018-05-25 16:00:18.983+00 https://www.pharmasalmanac.com/articles/oncternal-announces-clinical-supply-arrangement-to-evaluate-the-combination-of-cirmtuzumab-and-ibrutinib-in-b-cell-malignancies 2018-05-25 15:55:40.823+00 https://www.pharmasalmanac.com/articles/swift-biosciences-and-genomenon-announce-partnership-to-accelerate-biomarker-selection-for-targeted-ngs-panels 2018-05-25 15:44:21.924+00 https://www.pharmasalmanac.com/articles/imbruvica-ibrutinib-plus-gazyva-obinutuzumab-phase-3-illuminate-trial-for-first-line-therapy-of-chronic-lymphocytic-leukemia-cll-patients-met-primary-endpoint 2018-05-25 14:23:30.003+00 https://www.pharmasalmanac.com/articles/foundation-medicine-establishes-immuno-oncology-companion-diagnostics-collaboration-with-merck 2018-05-25 14:22:51.183+00 https://www.pharmasalmanac.com/articles/samsung-biologics-receives-an-additional-fda-approval-for-its-world-largest-plants-production 2018-05-25 14:22:05.489+00 https://www.pharmasalmanac.com/articles/amgen-enters-groundbreaking-collaboration-to-improve-symptom-management-during-cancer-treatment 2018-05-25 14:21:33.423+00 https://www.pharmasalmanac.com/articles/fujifilm-announces-the-expansion-of-its-fill-finish-services 2018-05-25 14:19:06.87+00 https://www.pharmasalmanac.com/articles/a-study-analyzing-observational-data-shows-real-world-effectiveness-of-prevnar-13-in-adults-age-65 2018-05-25 14:18:10.449+00 https://www.pharmasalmanac.com/articles/berkeley-lights-and-tpg-biologics-enter-into-a-strategic-collaboration-for-cell-line-development 2018-05-25 14:17:14.928+00 https://www.pharmasalmanac.com/articles/new-treatment-for-management-of-opioid-withdrawal-symptoms-approved-by-fda 2018-05-24 16:33:51.78+00 https://www.pharmasalmanac.com/articles/rna-modifying-proteins-may-provide-new-drug-targets 2018-05-24 16:31:10.881+00 https://www.pharmasalmanac.com/articles/strong-growth-of-cro-market-expected-to-continue 2018-05-24 14:54:11.458+00 https://www.pharmasalmanac.com/articles/bacteria-in-the-stomach-found-to-play-a-role-in-multiple-sclerosis 2018-05-24 14:43:05.307+00 https://www.pharmasalmanac.com/articles/fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes 2018-05-23 16:37:48.494+00 https://www.pharmasalmanac.com/articles/new-single-pill-hiv-treatment-approved-in-europe 2018-05-22 17:53:44.342+00 https://www.pharmasalmanac.com/articles/fda-approves-new-migraine-treatment 2018-05-22 17:50:07.45+00 https://www.pharmasalmanac.com/articles/rxi-pharmaceuticals-announces-positive-results-from-phase-2-trial-with-samcyprone-for-the-treatment-of-common-warts 2018-05-21 17:03:31.073+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-bioasis-announce-initial-strategic-collaboration 2018-05-21 16:30:04.7+00 https://www.pharmasalmanac.com/articles/paragon-bioservices-recognized-as-life-science-company-of-the-year-by-maryland-tech-council 2018-05-21 16:27:12.989+00 https://www.pharmasalmanac.com/articles/histoindex-and-cymabay-therapeutics-team-up-to-advance-nash-drug-development 2018-05-18 16:33:22.193+00 https://www.pharmasalmanac.com/articles/glenmark-pharmaceuticals-announces-oral-presentation-of-new-data-on-gbr-830-an-investigational-anti-ox40-monoclonal-antibody 2018-05-18 16:32:41.705+00 https://www.pharmasalmanac.com/articles/aegea-biotechnologies-announces-the-issuance-of-key-patents-related-to-its-core-next-generation-nucleic-acid-clinical-diagnostic-technologies 2018-05-18 16:29:32.083+00 https://www.pharmasalmanac.com/articles/novartis-and-amgen-announce-fda-approval-of-aimovig-erenumab-aooe-a-novel-treatment-developed-specifically-for-migraine-prevention 2018-05-18 16:27:30.551+00 https://www.pharmasalmanac.com/articles/sanofi-accelerating-future-breakthroughs-through-clinical-trials-part-2-of-3 2018-05-18 16:24:09.177+00 https://www.pharmasalmanac.com/articles/cancer-immunotherapies-reach-patients-more-quickly-than-other-drugs 2018-05-18 15:48:10.697+00 https://www.pharmasalmanac.com/articles/researchers-develop-diagnostic-for-rare-cancer-generated-glycoproteins 2018-05-18 15:43:58.601+00 https://www.pharmasalmanac.com/articles/editas-founders-start-new-gene-editing-company 2018-05-17 16:40:27.864+00 https://www.pharmasalmanac.com/articles/medigene-bluebird-bio-collaboration-on-tcr-immunotherapy-extended 2018-05-17 16:33:27.616+00 https://www.pharmasalmanac.com/articles/genenews-announces-collaboration-with-aim-laboratories-to-expand-test-utilization 2018-05-17 15:36:49.114+00 https://www.pharmasalmanac.com/articles/lyrica-pregabalin-oral-solution-cv-phase-3-trial-in-pediatric-epilepsy-meets-primary-endpoint 2018-05-17 15:35:32.048+00 https://www.pharmasalmanac.com/articles/pierre-fabre-and-array-biopharma-announce-columbus-phase-3-study-overall-survival-results-in-braf-mutant-melanoma-will-be-presented-at-2018-asco-annual-meeting 2018-05-17 15:34:34.366+00 https://www.pharmasalmanac.com/articles/u.s.-food-and-drug-administration-approves-expanded-indication-for-truvada 2018-05-17 14:56:31.922+00 https://www.pharmasalmanac.com/articles/pfizers-biosimilar-retacrit-epoetin-alfa-epbx-approved-by-u.s.-fda 2018-05-17 14:53:47.652+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-to-build-an-integrated-biologics-development-clinical-and-commercial-manufacturing-center-in-shijiazhuang 2018-05-17 14:52:46.44+00 https://www.pharmasalmanac.com/articles/with-expertise-comes-security 2018-05-17 13:46:55.488+00 https://www.pharmasalmanac.com/articles/x4-pharmaceuticals-presents-clinical-data-demonstrating-combinability-of-x4p-001-io-and-opdivo-nivolumab-in-patients-with-clear-cell-renal-cell-carcinoma 2018-05-16 20:14:30.137+00 https://www.pharmasalmanac.com/articles/kaneka-has-invested-in-ab-biotics-sa-a-spanish-biotech-company-and-concluded-a-license-agreement-for-production-and-sales-of-its-probiotics-products 2018-05-16 20:13:56.77+00 https://www.pharmasalmanac.com/articles/kite-announces-new-worldwide-facilities-and-expanded-collaboration-with-national-cancer-institute-to-support-cell-therapy-pipeline 2018-05-16 20:13:25.151+00 https://www.pharmasalmanac.com/articles/research-ready-program-expands-and-diversifies-clinical-trial-patient-populations 2018-05-16 20:12:53.399+00 https://www.pharmasalmanac.com/articles/fda-approves-subcutaneous-formulation-of-actemra-for-use-in-active-polyarticular-juvenile-idiopathic-arthritis-pjia-a-rare-form-of-juvenile-arthritis 2018-05-16 20:12:27.761+00 https://www.pharmasalmanac.com/articles/saama-technologies-and-icon-commercialization-and-outcomes-partner-to-unlock-the-value-of-real-world-evidence-rwe 2018-05-16 20:11:59.63+00 https://www.pharmasalmanac.com/articles/novartis-announces-fda-approval-of-gilenya-as-the-first-disease-modifying-therapy-for-pediatric-relapsing-multiple-sclerosis 2018-05-16 11:00:08.006+00 https://www.pharmasalmanac.com/articles/marken-announces-expansion-of-cryogenic-services 2018-05-15 15:59:57.562+00 https://www.pharmasalmanac.com/articles/roches-tecentriq-atezolizumab-receives-priority-review 2018-05-15 15:30:45.592+00 https://www.pharmasalmanac.com/articles/eli-lilly-makes-two-acquisitions-in-the-oncology-space 2018-05-15 15:14:38.808+00 https://www.pharmasalmanac.com/articles/agc-biologics-enters-into-commercial-supply-agreement-with-macrogenics 2018-05-15 11:30:06.028+00 https://www.pharmasalmanac.com/articles/fda-approves-additional-claim-for-roche-cobas-zika-test 2018-05-14 18:30:27.774+00 https://www.pharmasalmanac.com/articles/grifols-expands-its-blood-typing-solutions-portfolio-in-the-united-states-with-antisera-reagents 2018-05-14 17:55:23.97+00 https://www.pharmasalmanac.com/articles/recently-presented-preclinical-data-show-potential-for-adxs-neo-as-anti-cancer-immunotherapy-agent 2018-05-11 21:18:24.751+00 https://www.pharmasalmanac.com/articles/philips-emory-healthcare-and-royal-perth-hospital-in-australia-partner-to-launch-remote-intensive-care-monitoring-program 2018-05-11 21:17:18.389+00 https://www.pharmasalmanac.com/articles/cancer-treatment-developed-at-ben-gurion-university-shows-ability-to-reprogram-cancer-cells-to-pre-cancerous-state 2018-05-11 21:15:15.519+00 https://www.pharmasalmanac.com/articles/neuclone-announces-preclinical-results-for-stelara-ustekinumab-biosimilar-candidate 2018-05-10 21:02:07.639+00 https://www.pharmasalmanac.com/articles/forma-therapeutics-and-the-university-of-oxford-announce-multi-year-collaboration-to-advance-the-development-of-deubiquitinating-enzyme-dub-inhibitors 2018-05-10 21:00:21.984+00 https://www.pharmasalmanac.com/articles/polaris-signs-collaboration-agreement-with-md-anderson-cancer-center-to-join-its-immunotherapy-platform-for-clinical-trials-and-preclinical-research 2018-05-10 20:59:14.904+00 https://www.pharmasalmanac.com/articles/lilly-announces-agreement-to-acquire-armo-biosciences 2018-05-10 20:58:19.742+00 https://www.pharmasalmanac.com/articles/genentech-provides-update-on-phase-iii-study-of-tecentriq-atezolizumab-and-cotellic-cobimetinib- 2018-05-10 20:56:04.314+00 https://www.pharmasalmanac.com/articles/evotec-and-carna-biosciences-collaborate-on-indigo-platform 2018-05-10 20:17:12.4+00 https://www.pharmasalmanac.com/articles/proteon-therapeutics-and-lonza-extend-manufacturing-agreement-for-commercial-supply 2018-05-10 20:15:49.28+00 https://www.pharmasalmanac.com/articles/ea-health-and-photon-announce-strategic-partnership 2018-05-10 20:08:55.894+00 https://www.pharmasalmanac.com/articles/new-wuxi-sta-solid-dose-api-plant-gets-okay-from-us-fda 2018-05-10 18:58:31.035+00 https://www.pharmasalmanac.com/articles/crispr-gene-editing-technology-could-eliminate-the-need-for-hemophilia-b-sufferers-to-receive-ongoing-injections 2018-05-10 18:14:32.646+00 https://www.pharmasalmanac.com/articles/globaldata-predicts-strong-sales-for-humira-biosimilars-in-europe 2018-05-10 18:11:15.377+00 https://www.pharmasalmanac.com/articles/takeda-acquires-shire-for-62-billion 2018-05-10 18:03:32.573+00 https://www.pharmasalmanac.com/articles/xtalpi-inc.-announces-strategic-research-collaboration-with-pfizer-inc.-to-develop-artificial-intelligence-powered-molecular-modeling-technology-for-drug-discovery 2018-05-09 22:45:46.331+00 https://www.pharmasalmanac.com/articles/phase-iii-study-evaluating-the-efficacy-and-safety-of-lonsurf-in-patients-with-metastatic-gastric-cancer-meets-primary-endpoint 2018-05-09 22:44:10.935+00 https://www.pharmasalmanac.com/articles/worldwide-clinical-trials-and-datavant-take-steps-toward-transforming-clinical-trial-success-in-neurodegenerative-diseases 2018-05-09 22:40:44.356+00 https://www.pharmasalmanac.com/articles/biomax-informatics-software-licensed-by-global-pharma-company-boehringer-ingelheim-to-build-a-target-discovery-knowledge-platform 2018-05-09 22:38:48.647+00 https://www.pharmasalmanac.com/articles/alcami-st.-louis-facility-to-be-honored-by-missouri-house-of-representatives-and-city-of-st.-louis 2018-05-09 11:40:03.186+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-announces-listing-of-initial-public-offering-of-common-stock-on-shanghai-stock-exchange 2018-05-08 16:40:02.601+00 https://www.pharmasalmanac.com/articles/novasep-invests-10m-in-senefill-its-new-facility-for-commercial-aseptic-fill-finish-operations 2018-05-08 11:40:08.352+00 https://www.pharmasalmanac.com/articles/alkermes-launches-award-program-to-support-and-advance-central-nervous-system-disorders-research 2018-05-04 22:12:10.15+00 https://www.pharmasalmanac.com/articles/sanofi-named-to-diversityincs-top-50-companies-for-diversity 2018-05-04 22:05:53.543+00 https://www.pharmasalmanac.com/articles/trintellix-prescribing-information-now-includes-new-data-showing-improvement-in-processing-speed 2018-05-04 21:54:49.3+00 https://www.pharmasalmanac.com/articles/wuxi-vision-pro-ltd.-has-completed-b-round-financing-of-rmb-80-million-from-qiming-venture-etc.-to-accelerate-domestic-era-in-the-treatment-of-cataracts-in-china 2018-05-04 19:18:02.671+00 https://www.pharmasalmanac.com/articles/agc-biologics-enters-into-commercial-manufacturing-agreement-with-horizon-pharma-plc 2018-05-04 19:17:03.54+00 https://www.pharmasalmanac.com/articles/roche-expands-partnership-with-4d-molecular-therapeutics-to-treat-night-blindness 2018-05-04 17:59:29.991+00 https://www.pharmasalmanac.com/articles/study-shows-ast-005-is-safe-and-tolerable-in-patients-at-higher-doses-than-previously-studied 2018-05-04 17:58:06.312+00 https://www.pharmasalmanac.com/articles/gilead-sciences-and-verily-life-sciences-llc-enter-collaboration-hope-to-better-understand-inflammatory-diseases 2018-05-04 17:52:09.135+00 https://www.pharmasalmanac.com/articles/bausch-lomb-ultra-contact-lenses-receive-fda-approval-for-extended-wear-indication 2018-05-03 19:13:24.654+00 https://www.pharmasalmanac.com/articles/abbvie-submits-marketing-authorization-application-to-the-european-medicines-agency-for-investigational-treatment-risankizumab-for-moderate-to-severe-plaque-psoriasis 2018-05-01 21:40:32.734+00 https://www.pharmasalmanac.com/articles/spectrum-pharmaceuticals-enters-into-a-next-generation-sequencing-companion-diagnostic-partnership-with-thermo-fisher-scientific 2018-05-01 21:36:55.245+00 https://www.pharmasalmanac.com/articles/labcorp-announces-collaboration-with-the-recovery-platform-to-assist-physicians-treating-patients-with-opioid-dependency 2018-05-01 21:35:35.131+00 https://www.pharmasalmanac.com/articles/new-study-finds-probiotic-treatment-can-reduce-rehospitalization-for-individuals-with-mania 2018-05-01 21:34:06.475+00 https://www.pharmasalmanac.com/articles/marken-announces-expanded-hybrid-services-in-latin-america 2018-05-01 18:43:36.643+00 https://www.pharmasalmanac.com/articles/icagen-receives-award-from-the-cystic-fibrosis-foundation-to-discover-transformative-therapies-to-treat-cystic-fibrosis 2018-05-01 18:38:12.774+00 https://www.pharmasalmanac.com/articles/4dmt-and-roche-expand-ophthalmology-partnership-to-develop-and-commercialize-multiple-aav-gene-therapy-products 2018-04-30 23:02:29.827+00 https://www.pharmasalmanac.com/articles/real-world-study-shows-invokana-canagliflozin-300mg-demonstrates-better-blood-glucose-control-than-farxiga-dapagliflozin-10mg-in-patients-with-type-2-diabetes 2018-04-30 22:58:29.296+00 https://www.pharmasalmanac.com/articles/thermo-fisher-and-leica-collaborate-to-develop-integrated-cryotomography-workflow-solution 2018-04-30 22:57:00.471+00 https://www.pharmasalmanac.com/articles/abbvie-presents-new-investigational-data-for-elagolix-at-the-2018-american-college-of-obstetricians-and-gynecologists-acog-annual-meeting 2018-04-30 22:55:00.537+00 https://www.pharmasalmanac.com/articles/alkermes-completes-patient-enrollment-in-pivotal-weight-study-of-alks-3831-for-schizophrenia 2018-04-30 22:52:27.293+00 https://www.pharmasalmanac.com/articles/insysbio-llc-announces-extension-of-collaboration-with-gsk-on-quantitative-systems-pharmacology-modeling-in-asthma 2018-04-30 22:48:18.182+00 https://www.pharmasalmanac.com/articles/catabasis-pharmaceuticals-presents-new-edasalonexent-data-showing-significantly-slowed-duchenne-muscular-dystrophy-disease-progression 2018-04-27 22:23:35.742+00 https://www.pharmasalmanac.com/articles/discgenics-announces-first-patient-treated-in-u.s.-clinical-trial-of-idct-for-degenerative-disc-disease 2018-04-27 22:19:17.995+00 https://www.pharmasalmanac.com/articles/biocad-interleukin-17-inhibitor-shows-high-efficacy-after-one-year-of-therapy-in-psoriasis-patients 2018-04-27 22:16:17.871+00 https://www.pharmasalmanac.com/articles/collaboration-intends-to-improve-multidisciplinary-teaching-and-research-in-biotech 2018-04-26 15:53:17.083+00 https://www.pharmasalmanac.com/articles/good-news-for-cancer-survivors 2018-04-26 15:50:29.801+00 https://www.pharmasalmanac.com/articles/development-of-blood-tests-for-early-cancer-detection-may-be-possible 2018-04-26 15:45:38.283+00 https://www.pharmasalmanac.com/articles/encouraging-preclinical-data-for-anticancer-drugs-reported-by-verseon 2018-04-26 15:40:29.048+00 https://www.pharmasalmanac.com/articles/sta-pharmaceutical-co.-to-manufacture-phoenix-molecular-designs-anticancer-candidate 2018-04-26 15:35:22.538+00 https://www.pharmasalmanac.com/articles/new-approach-by-novo-nordisk-ties-pricing-to-patient-behavior 2018-04-26 15:31:21.547+00 https://www.pharmasalmanac.com/articles/novartis-launches-focalview-app-providing-opportunity-for-patients-to-participate-in-ophthalmology-clinical-trials-from-home 2018-04-25 21:54:21.788+00 https://www.pharmasalmanac.com/articles/abbvies-upadacitinib-meets-primary-and-key-efficacy-endpoints-in-phase-2b/3-rheumatoid-arthritis-study-in-japanese-patients 2018-04-25 21:47:33.163+00 https://www.pharmasalmanac.com/articles/lsne-announces-acquisition-of-psc-biotechs-parenteral-manufacturing-facility 2018-04-25 21:40:01.084+00 https://www.pharmasalmanac.com/articles/grand-river-aseptic-manufacturing-inc.-expands-pharmaceutical-manufacturing-capacity-with-major-equipment-purchase 2018-04-25 21:33:18.525+00 https://www.pharmasalmanac.com/articles/biocardia-receives-new-potency-assay-patent-providing-further-protection-to-autologous-cell-therapy-programs-in-heart-failure-and-refractory-angina 2018-04-25 21:32:26.553+00 https://www.pharmasalmanac.com/articles/asembia-expands-collaboration-with-pfizer-oncology 2018-04-25 21:30:32.937+00 https://www.pharmasalmanac.com/articles/u.s.-food-and-drug-administration-accepts-supplemental-biologics-license-application-for-opdivo-nivolumab 2018-04-24 11:45:07.578+00 https://www.pharmasalmanac.com/articles/innovation-pharmaceuticals-signs-drug-supply-contract-with-evonik-to-bulk-produce-commercial-grade-brilacidin 2018-04-23 21:26:00.022+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-50-million-investment-to-enhance-biologics-capabilities 2018-04-23 21:20:01.529+00 https://www.pharmasalmanac.com/articles/new-ocrevus-ocrelizumab-data-at-aan-demonstrate-significant-reductions-in-disease-activity-and-disability-progression-in-relapsing-multiple-sclerosis 2018-04-23 19:29:57.019+00 https://www.pharmasalmanac.com/articles/xellia-pharmaceuticals-appoints-craig-boyd-as-president-xellia-us-as-it-expands-its-commercial-organization 2018-04-23 19:28:22.039+00 https://www.pharmasalmanac.com/articles/pg-acquires-the-consumer-health-business-of-merck-kgaa-darmstadt-germany 2018-04-19 23:20:22.292+00 https://www.pharmasalmanac.com/articles/us-fda-approves-tagrisso-osimertinib-as-1st-line-treatment-for-egfr-mutated-non-small-cell-lung-cance 2018-04-19 23:18:55.25+00 https://www.pharmasalmanac.com/articles/vaccibody-moving-forward-with-cancer-neoantigen-vaccine-trial 2018-04-19 22:54:26.893+00 https://www.pharmasalmanac.com/articles/jll-and-water-street-announce-acquisition-to-expand-global-life-sciences-commercialization-services-platform 2018-04-19 22:50:24.626+00 https://www.pharmasalmanac.com/articles/fda-provides-full-approval-to-praxbind-specific-reversal-agent-for-pradaxa 2018-04-19 22:08:37.923+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-wins-cmo-leadership-award-from-life-science-leader-magazine 2018-04-19 21:59:35.13+00 https://www.pharmasalmanac.com/articles/ai-guided-cancer-therapy-platform-from-sri-international-identifies-novel-molecular-targets-for-aggressive-form-of-breast-cancer 2018-04-19 21:56:22.366+00 https://www.pharmasalmanac.com/articles/grifols-donates-over-25-million-international-units-of-blood-clotting-factor-in-2017 2018-04-19 21:47:35.058+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-expands-site-in-the-u.s.-for-drug-development-testing-services 2018-04-19 17:21:37.66+00 https://www.pharmasalmanac.com/articles/roche-receives-fda-clearance-for-cobas-ct/ng-for-cobas-6800/8800-systems 2018-04-18 11:30:10.421+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-to-expand-partnership-with-pathoquest 2018-04-17 16:19:34.644+00 https://www.pharmasalmanac.com/articles/immunotherapy-prior-to-surgery-shows-promise-in-fight-against-lung-cancer 2018-04-17 16:06:20.816+00 https://www.pharmasalmanac.com/articles/pfizer-and-allogene-therapeutics-form-alliance-further-developing-car-t-therapy 2018-04-17 15:55:11.951+00 https://www.pharmasalmanac.com/articles/robotic-microscope-used-for-brain-surgery 2018-04-17 15:47:51.48+00 https://www.pharmasalmanac.com/articles/marken-announces-plans-to-add-nursing-services-to-home-based-trials 2018-04-17 15:40:06.337+00 https://www.pharmasalmanac.com/articles/new-lung-cancer-treatment-awarded-priority-review-by-fda 2018-04-17 15:38:55.448+00 https://www.pharmasalmanac.com/articles/united-neuroscience-ltd.-and-boston-university-lee-goldstein-laboratory-enter-collaboration-targeting-treatment-and-prevention-of-chronic-traumatic-encephalopathy-cte 2018-04-17 15:34:03.551+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-and-illumina-announce-strategic-collaboration-to-develop-and-commercialize-companion-diagnostics 2018-04-16 22:37:57.054+00 https://www.pharmasalmanac.com/articles/opdivo-nivolumab-first-pd-1-inhibitor-to-demonstrate-superior-survival-benefit-compared-with-chemotherapy 2018-04-16 22:36:31.579+00 https://www.pharmasalmanac.com/articles/syros-announces-new-preclinical-data-on-sy-1365-showing-potent-anti-tumor-activity-in-multiple-models-of-heavily-pretreated-ovarian-cancer 2018-04-16 22:32:31.806+00 https://www.pharmasalmanac.com/articles/city-of-hope-certified-to-provide-first-fda-approved-car-t-cell-therapy-for-pediatric-and-young-adult-patients 2018-04-16 22:31:32.809+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-launches-oncomine-childhood-cancer-research-assay-and-establishes-international-childhood-oncology-network 2018-04-16 22:08:19.535+00 https://www.pharmasalmanac.com/articles/shire-announces-sale-of-oncology-business-to-servier-for-2.4-billion 2018-04-16 19:35:49.384+00 https://www.pharmasalmanac.com/articles/fresenius-kabi-announces-new-approval-and-immediate-availability-of-daptomycin-for-injection 2018-04-16 19:17:08.124+00 https://www.pharmasalmanac.com/articles/sysmex-inostics-expands-oncobeam-liquid-biopsy-testing-in-the-u.s.-to-assist-clinicians-and-patients 2018-04-16 19:15:33.206+00 https://www.pharmasalmanac.com/articles/allergan-announces-launch-of-the-truetear-intranasal-neurostimulation-device-during-2018-ascrs-asoa-annual-meeting 2018-04-16 19:12:37.803+00 https://www.pharmasalmanac.com/articles/evotec-forms-collaboration-with-petra-pharma-on-indigo-platform 2018-04-16 11:45:10.226+00 https://www.pharmasalmanac.com/articles/new-breast-cancer-drug-accepted-for-review-by-ema 2018-04-12 14:27:57.07+00 https://www.pharmasalmanac.com/articles/eli-lilly-gets-good-news-for-cyramza 2018-04-12 14:23:11.84+00 https://www.pharmasalmanac.com/articles/gsk-to-take-over-full-ownership-of-consumer-healthcare-jv-with-novartis 2018-04-12 14:12:12.059+00 https://www.pharmasalmanac.com/articles/compugen-medimmune-to-collaborate-on-bi-and-multi-specific-antibodies 2018-04-12 14:08:21.36+00 https://www.pharmasalmanac.com/articles/casdin-capital-to-become-shareholder-in-biolife-solutions 2018-04-12 11:40:10.846+00 https://www.pharmasalmanac.com/articles/perrigo-launches-novel-omeprazole-orally-disintegrating-tablet-to-treat-frequent-heartburn 2018-04-11 22:28:01.549+00 https://www.pharmasalmanac.com/articles/novartis-drug-afinitor-disperz-receives-fda-approval-to-treat-tsc-associated-partial-onset-seizures 2018-04-11 22:26:31.188+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-its-first-cloud-enabled-biological-safety-cabinet 2018-04-11 22:19:00.597+00 https://www.pharmasalmanac.com/articles/swiss-advanced-vision-launches-active-intraocular-lens-concept-with-real-time-autofocus-for-cataract-surgery 2018-04-11 22:16:03.491+00 https://www.pharmasalmanac.com/articles/kadmon-receives-fda-guidance-on-pivotal-clinical-trial-design-for-kd025-in-chronic-graft-versus-host-disease 2018-04-11 22:14:38.402+00 https://www.pharmasalmanac.com/articles/illumina-and-loxo-oncology-to-partner-on-developing-next-generation-sequencing-based-pan-cancer-companion-diagnostics 2018-04-11 22:13:26.613+00 https://www.pharmasalmanac.com/articles/fimecs-inc-concludes-licensing-agreement-with-takeda-to-develop-novel-immuno-oncology-therapies 2018-04-11 22:11:38.245+00 https://www.pharmasalmanac.com/articles/allogene-therapeutics-completes-agreement-for-pfizers-allogeneic-car-t-immuno-oncology-portfolio 2018-04-11 22:01:50.156+00 https://www.pharmasalmanac.com/articles/transcriptional-wiring-of-cancer-genes-can-be-resolved-using-lexogens-slamseq-and-quantseq-technologies-to-facilitate-drug-discovery 2018-04-11 11:50:00.683+00 https://www.pharmasalmanac.com/articles/immunoprecise-acquires-modiquest-research-bv 2018-04-11 11:45:06.446+00 https://www.pharmasalmanac.com/articles/applied-dna-signs-definitive-agreements-with-colorcon-for-molecular-tagging-in-the-pharmaceutical-and-nutraceutical-markets-0 2018-04-11 11:40:09.38+00 https://www.pharmasalmanac.com/articles/frontage-acquires-concord-biosciences-adding-preclinical-agrochemical-and-toxicology-services-to-the-existing-product-development-portfolio 2018-04-11 11:30:08.243+00 https://www.pharmasalmanac.com/articles/applied-dna-signs-definitive-agreements-with-colorcon-for-molecular-tagging-in-the-pharmaceutical-and-nutraceutical-markets 2018-04-11 00:20:45.208+00 https://www.pharmasalmanac.com/articles/first-patient-treated-in-pivotal-phase-3-trial-to-evaluate-otl38-in-the-detection-of-ovarian-cancer 2018-04-06 20:03:48.197+00 https://www.pharmasalmanac.com/articles/ucb-strengthens-research-capabilities-with-acquisition-of-element-genomics-a-duke-university-biotech-spin-off 2018-04-06 20:02:33.132+00 https://www.pharmasalmanac.com/articles/charlotte-radiology-and-welsh-carson-anderson-stowe-announce-the-formation-of-us-radiology-specialists-appoint-new-ceo 2018-04-06 19:22:30.265+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-ose-immunotherapeutics-announce-global-immuno-oncology-partnership 2018-04-06 19:20:06.804+00 https://www.pharmasalmanac.com/articles/pharos-diagnostics-expands-diagnostic-testing-menu-to-include-routine-testing-and-valley-fever-cocci 2018-04-06 19:15:39.119+00 https://www.pharmasalmanac.com/articles/terns-pharmaceuticals-acquires-global-exclusive-rights-to-develop-and-commercialize-three-nash-assets-from-lilly 2018-04-06 19:14:44.422+00 https://www.pharmasalmanac.com/articles/iontas-and-igem-therapeutics-collaborate-to-identify-novel-ige-antibodies-for-cancer-targets 2018-04-06 19:13:42.11+00 https://www.pharmasalmanac.com/articles/daiichi-sankyo-and-darwinhealth-enter-exclusive-research-collaboration-for-novel-cancer-target-initiative 2018-04-06 19:12:39.6+00 https://www.pharmasalmanac.com/articles/lilly-and-sigilon-therapeutics-announce-strategic-collaboration-to-develop-encapsulated-cell-therapies-for-the-treatment-of-type-1-diabetes 2018-04-06 19:10:38.876+00 https://www.pharmasalmanac.com/articles/kymera-therapeutics-announces-discovery-collaboration-with-gsk-to-advance-new-treatment-modality 2018-04-05 22:45:40.296+00 https://www.pharmasalmanac.com/articles/european-commission-approves-expanded-indication-for-amgens-xgeva-denosumab-for-the-prevention-of-skeletal-related-events-in-patients-with-multiple-myeloma 2018-04-05 22:41:00.207+00 https://www.pharmasalmanac.com/articles/dr.-reddys-laboratories-and-its-u.s.-subsidiary-promius-pharma-announce-the-filing-of-an-nda-for-its-migraine-candidate 2018-04-04 19:20:34.27+00 https://www.pharmasalmanac.com/articles/allergan-and-richter-announce-positive-topline-results-from-third-of-three-pivotal-trials-of-cariprazine-in-bipolar-i-depression 2018-04-04 19:18:02.39+00 https://www.pharmasalmanac.com/articles/hgs-acquires-axispoint-health 2018-04-04 19:14:08.453+00 https://www.pharmasalmanac.com/articles/agc-biologics-increases-footprint-in-bothell-wa 2018-04-04 19:12:39.277+00 https://www.pharmasalmanac.com/articles/successful-solid-dose-equipment-training 2018-04-04 19:03:29.587+00 https://www.pharmasalmanac.com/articles/sanofis-sotagliflozin-accepted-for-review-by-ema 2018-04-04 18:15:53.541+00 https://www.pharmasalmanac.com/articles/amgen-gets-expanded-approval-for-blincyto 2018-04-04 18:13:10.385+00 https://www.pharmasalmanac.com/articles/companies-join-forces-to-develop-novel-radio-conjugates 2018-04-04 18:06:57.156+00 https://www.pharmasalmanac.com/articles/macrolide-attracts-funding-and-executive-talent 2018-04-04 18:04:53.758+00 https://www.pharmasalmanac.com/articles/positive-results-for-pfizer-drug-tafamidis 2018-04-04 17:51:44.261+00 https://www.pharmasalmanac.com/articles/differentiating-generic-sodfs-with-hard-capsule-formulations 2018-04-03 18:50:55.334+00 https://www.pharmasalmanac.com/articles/medicinova-announces-phase-2-trial-of-mn-001-tipelukast-in-nash-/-nafld-will-be-terminated-early-based-on-significant-positive-results-from-interim-analysis 2018-04-03 00:59:14.146+00 https://www.pharmasalmanac.com/articles/first-patient-treated-on-mevions-next-generation-proton-therapy-system 2018-04-03 00:57:10.329+00 https://www.pharmasalmanac.com/articles/allergan-to-report-first-quarter-2018-earnings-and-host-conference-call-and-webcast 2018-04-03 00:50:43.129+00 https://www.pharmasalmanac.com/articles/spinal-resources-inc.-announces-first-implantation-with-swedge-pedicle-screw-system 2018-03-30 19:44:44.007+00 https://www.pharmasalmanac.com/articles/pfizer-announces-positive-topline-results-from-phase-3-attr-act-study-of-tafamidis-in-patients-with-transthyretin-cardiomyopathy 2018-03-30 19:38:54.303+00 https://www.pharmasalmanac.com/articles/abzenas-new-gmp-manufacturing-suite-expands-adc-chemistry-solutions-at-bristol-site 2018-03-30 14:19:04.043+00 https://www.pharmasalmanac.com/articles/partnership-to-develop-clostridial-based-medicines-moves-forward 2018-03-30 14:12:54.195+00 https://www.pharmasalmanac.com/articles/fujifilm-expands-into-bio-medical-business-with-acquisition 2018-03-30 13:47:57.497+00 https://www.pharmasalmanac.com/articles/final-results-from-landmark-dynagito-trial-published-in-the-lancet-respiratory-medicine 2018-03-29 18:59:45.945+00 https://www.pharmasalmanac.com/articles/omnicom-health-group-acquires-elseviers-pharma-communications-business-in-japan-rebrands-as-emc-k.k 2018-03-29 18:06:05.694+00 https://www.pharmasalmanac.com/articles/mylan-introduces-symfi-triple-combo-once-daily-hiv-treatment-in-the-u.s 2018-03-29 18:04:00.736+00 https://www.pharmasalmanac.com/articles/intertek-launches-inlight-advantage-to-accelerate-the-compliance-onboarding-process-at-every-level-of-the-supply-chain- 2018-03-29 17:57:24.53+00 https://www.pharmasalmanac.com/articles/new-stem-cell-therapy-approved-in-europe 2018-03-29 15:19:17.706+00 https://www.pharmasalmanac.com/articles/clinical-study-data-for-new-ms-drug-looks-promising 2018-03-29 15:13:12.883+00 https://www.pharmasalmanac.com/articles/jj-involved-in-probiotics-development-program 2018-03-29 15:00:36.148+00 https://www.pharmasalmanac.com/articles/transforming-a-cdmo-using-an-operational-excellence-approach 2018-03-29 14:26:10.435+00 https://www.pharmasalmanac.com/articles/brainstorm-cell-therapeutics-phase-3-trial-of-nurown-in-als-now-open-to-canadian-patients 2018-03-28 23:41:19.42+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-wins-in-six-categories-at-the-cmo-leadership-awards-2018 2018-03-27 21:55:22.143+00 https://www.pharmasalmanac.com/articles/clinical-trial-access-to-expand-following-receipt-of-additional-funding- 2018-03-27 18:44:46.76+00 https://www.pharmasalmanac.com/articles/citoxlab-acquires-solvo-biotechnology- 2018-03-27 18:40:30.539+00 https://www.pharmasalmanac.com/articles/samsung-unveils-new-innovative-ultrasound-system-at-aium-2018 2018-03-27 11:50:10.078+00 https://www.pharmasalmanac.com/articles/ipsen-receives-positive-chmp-opinion-for-cabometyx-cabozantinib-for-the-first-line-treatment-of-adults-with-intermediate-or-poor-risk-advanced-renal-cell-carcinoma 2018-03-27 11:45:02.841+00 https://www.pharmasalmanac.com/articles/phase-iii-data-in-the-lancet-show-novartis-siponimod-significantly-improved-outcomes-in-patients-with-secondary-progressive-ms 2018-03-26 22:01:53.455+00 https://www.pharmasalmanac.com/articles/novartis-drug-tasigna-approved-by-fda-to-treat-children-with-rare-form-of-leukemia 2018-03-26 21:41:12.94+00 https://www.pharmasalmanac.com/articles/pfizer-reports-top-line-results-from-a-study-of-chantix-/-champix-varenicline-in-adolescent-smokers 2018-03-26 21:36:22.977+00 https://www.pharmasalmanac.com/articles/pace-of-pharmaceutical-innovation-accelerates-as-record-number-of-new-blockbuster-drugs-forecast-to-hit-the-market-in-2018 2018-03-23 21:17:46.857+00 https://www.pharmasalmanac.com/articles/nohla-therapeutics-selects-advanced-therapies-business-unit-of-wuxi-apptec-to-manufacture-universal-donor-cell-therapies 2018-03-23 21:07:15.986+00 https://www.pharmasalmanac.com/articles/takeda-announces-publication-of-final-data-from-iclusig-ponatinib-pivotal-phase-2-pace-trial-in-blood 2018-03-23 21:06:12.243+00 https://www.pharmasalmanac.com/articles/more-good-news-for-novo-nordisks-semaglutide-and-weight-loss 2018-03-23 15:10:54.01+00 https://www.pharmasalmanac.com/articles/adaptimmunes-gsk-partnered-t-cells-trigger-responses-in-solid-tumor-patients 2018-03-23 13:53:46.461+00 https://www.pharmasalmanac.com/articles/lanxess-starts-production-line-for-specialty-compounds-in-germany 2018-03-23 13:49:05.932+00 https://www.pharmasalmanac.com/articles/anti-flu-drug-exploits-weakness-in-h3n2-strain 2018-03-23 13:41:00.116+00 https://www.pharmasalmanac.com/articles/tumor-derived-t-cells-demonstrate-potential-against-ovarian-cancer 2018-03-23 13:24:05.057+00 https://www.pharmasalmanac.com/articles/medical-marijuana-moves-to-the-big-time 2018-03-22 16:38:41.56+00 https://www.pharmasalmanac.com/articles/shingrix-vaccine-available-at-cvs 2018-03-22 16:26:15.686+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-acquires-integenx-provider-of-leading-rapid-dna-technology-for-human-identification 2018-03-21 22:24:48.928+00 https://www.pharmasalmanac.com/articles/u.s.-fda-grants-priority-review-for-a-supplemental-new-drug-application-snda-for-xtandi-enzalutamide-in-non-metastatic-castration-resistant-prostate-cancer-crpc 2018-03-21 22:24:25.553+00 https://www.pharmasalmanac.com/articles/grand-river-aseptic-manufacturing-inc.-announces-major-land-purchase-in-grand-rapids 2018-03-21 16:54:12.325+00 https://www.pharmasalmanac.com/articles/brammer-bio-expands-leadership-team-for-commercial-readiness 2018-03-20 23:01:52.079+00 https://www.pharmasalmanac.com/articles/abbotts-mitraclip-therapy-receives-national-reimbursement-in-japan-to-treat-patients-with-mitral-regurgitation 2018-03-20 22:42:30.685+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-reports-remarkable-2017-annual-results-revenue-up-63.7-to-a-record-high-of-rmb1618.8-million 2018-03-20 22:36:31.308+00 https://www.pharmasalmanac.com/articles/bioduro-collaboration-with-pfizer-inc.-leads-to-creation-of-a-shelf-stable-fluorosulfation-reagent 2018-03-20 22:29:21.838+00 https://www.pharmasalmanac.com/articles/ima-active-solid-dose-solutions-delivers-prexima-300-tablet-press-to-federal-equipment-company-for-upcoming-trainings-and-demonstrations-by-techceuticals-llc 2018-03-20 22:28:08.061+00 https://www.pharmasalmanac.com/articles/bavarian-nordic-expands-partnership-with-us-dod 2018-03-20 18:30:51.189+00 https://www.pharmasalmanac.com/articles/additional-funding-for-unitys-first-human-clinical-study 2018-03-20 18:27:01.506+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc 2018-03-19 21:59:43.933+00 https://www.pharmasalmanac.com/articles/sartorius-stedim-biotech-launches-new-ambr-250-high-throughput-bioreactor-system-for-perfusion-culture 2018-03-19 21:55:33.577+00 https://www.pharmasalmanac.com/articles/beth-brock-joins-crbs-kansas-city-office-as-pharmaceutical-process-engineer 2018-03-19 21:50:40.597+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-plans-to-build-state-of-the-art-pharma-services-facility-in-rheinfelden-baden-germany 2018-03-19 21:39:26.832+00 https://www.pharmasalmanac.com/articles/alcami-donation-to-outfit-trosa-medical-department 2018-03-19 11:30:08.353+00 https://www.pharmasalmanac.com/articles/insulin-market-expected-to-witness-enhanced-growth-due-to-increasing-numbers-of-pharmacological-firms-till-2022-million-insights 2018-03-16 20:30:02.28+00 https://www.pharmasalmanac.com/articles/protein-science-to-advance-through-leniobio-and-dow-agrosciences-license-agreement 2018-03-16 20:27:25.118+00 https://www.pharmasalmanac.com/articles/hitgen-and-basf-enter-dna-encoded-library-based-research-collaboration 2018-03-16 20:24:31.588+00 https://www.pharmasalmanac.com/articles/msd-launches-herceptin-biosimilar-in-uk 2018-03-16 18:35:46.669+00 https://www.pharmasalmanac.com/articles/wehealth-by-servier-and-deeplink-medical-sign-a-partnership-to-develop-a-new-e-health-solution 2018-03-16 16:53:52.671+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-showcases-new-solutions-for-accelerating-innovating-and-enhancing-productivity-in-the-fab-and-lab-at-semicon-china-2018 2018-03-16 11:35:03.835+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-to-supply-antibody-drugs-for-adagene-inc 2018-03-15 18:54:09.633+00 https://www.pharmasalmanac.com/articles/european-commission-expands-marketing-approval-for-gsks-relvar-ellipta 2018-03-15 18:51:22.916+00 https://www.pharmasalmanac.com/articles/parexel-and-cha-medical-group-partner-to-enhance-early-phase-clinical-research-in-korea 2018-03-15 11:35:11.685+00 https://www.pharmasalmanac.com/articles/siegfried-purchases-the-drug-product-manufacturing-facility-of-arena-pharmaceuticals-gmbh-in-zofingen 2018-03-14 22:40:49.819+00 https://www.pharmasalmanac.com/articles/xeris-pharmaceuticals-announces-a-formulation-development-collaboration-with-asahi-kasei-pharma 2018-03-14 22:30:28.815+00 https://www.pharmasalmanac.com/articles/abzena-strengthens-specialized-bioassay-offering-through-access-agreement-with-major-cell-line-depository 2018-03-14 22:25:28+00 https://www.pharmasalmanac.com/articles/sosei-regains-worldwide-rights-from-teva-to-develop-and-commercialize-novel-small-molecule-cgrp-antagonists-for-migraine-and-other-severe-headaches 2018-03-14 22:23:56.182+00 https://www.pharmasalmanac.com/articles/abbvie-announces-positive-topline-results-from-second-phase-3-study-evaluating-investigational-elagolix-in-women-with-uterine-fibroids 2018-03-14 22:08:25.334+00 https://www.pharmasalmanac.com/articles/biogen-to-acquire-from-pfizer-first-in-class-phase-2b-ready-asset-for-cognitive-impairment-associated-with-schizophrenia 2018-03-14 11:30:01.241+00 https://www.pharmasalmanac.com/articles/new-bi-vaccine-allows-very-early-vaccination-of-piglets-against-swine-flu 2018-03-13 22:58:01.757+00 https://www.pharmasalmanac.com/articles/smartphone-based-retinal-imaging-together-with-artificial-intelligence-powers-automated-sensitive-and-early-detection-of-retinopathy 2018-03-13 21:25:52.357+00 https://www.pharmasalmanac.com/articles/diurnal-selects-worldwide-clinical-trials-as-preferred-cro-provider 2018-03-13 21:14:02.171+00 https://www.pharmasalmanac.com/articles/supporting-parenteral-development-and-manufacturing-with-end-to-end-services 2018-03-13 15:42:58.966+00 https://www.pharmasalmanac.com/articles/oxford-biomedica-is-making-big-moves 2018-03-13 15:28:34.966+00 https://www.pharmasalmanac.com/articles/colorcon-up-and-running-in-puerto-rico 2018-03-13 15:21:58.828+00 https://www.pharmasalmanac.com/articles/fujifilm-debuts-aspire-bellus-ii-a-new-multimodality-mammography-workstation 2018-03-12 22:05:33.099+00 https://www.pharmasalmanac.com/articles/getting-to-the-finish-line 2018-03-12 15:41:31.527+00 https://www.pharmasalmanac.com/articles/death-to-cleanrooms-in-biopharmaceutical-manufacturing 2018-03-12 15:37:05.62+00 https://www.pharmasalmanac.com/articles/overcoming-formulation-challenges-with-liquid-fill-capsules 2018-03-12 15:34:38.794+00 https://www.pharmasalmanac.com/articles/creating-comprehensive-solutions-through-laboratory-testing- 2018-03-12 15:26:07.963+00 https://www.pharmasalmanac.com/articles/evotec-and-sanofi-in-exclusive-talks-to-create-an-evotec-led-infectious-disease-open-innovation-rd-platform 2018-03-09 23:23:31.029+00 https://www.pharmasalmanac.com/articles/novasep-supplies-complete-process-line-to-mefsco-corn-milling-facility 2018-03-09 23:23:04.817+00 https://www.pharmasalmanac.com/articles/eisai-co.-ltd.-and-merck-enter-global-strategic-oncology-collaboration-for-lenvima-lenvatinib-mesylate 2018-03-09 23:22:36.981+00 https://www.pharmasalmanac.com/articles/gsk-announces-positive-eu-approval-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma 2018-03-09 23:15:03.351+00 https://www.pharmasalmanac.com/articles/compugen-has-licensed-selexis-cell-line-based-protein-expression-platform-for-the-development-of-antibody-based-therapeutics 2018-03-09 23:07:50.819+00 https://www.pharmasalmanac.com/articles/next-generation-biologics-janssens-tremfya-eli-lillys-taltz-and-novartis-cosentyx-raising-the-bar-in-psoriasis-management 2018-03-09 23:01:21.98+00 https://www.pharmasalmanac.com/articles/thermo-scientific-krios-g3i-cryo-electron-microscope-announced-as-2018-edison-awards-finalist 2018-03-09 22:41:37.54+00 https://www.pharmasalmanac.com/articles/how-do-you-address-operational-excellence-as-an-institution 2018-03-09 22:17:21.179+00 https://www.pharmasalmanac.com/articles/whats-driving-ma-among-pharma-sponsors 2018-03-09 20:41:57.659+00 https://www.pharmasalmanac.com/articles/an-industry-stacked-mergers-acquisitions-in-discovery-manufacturing-and-fill/finish 2018-03-09 18:55:42.558+00 https://www.pharmasalmanac.com/articles/why-business-continuity-management-is-important-for-cdmos 2018-03-09 18:11:32.981+00 https://www.pharmasalmanac.com/articles/leveraging-lyophilization-development-expertise-for-clinical-manufacturing 2018-03-09 17:49:27.652+00 https://www.pharmasalmanac.com/articles/dsm-sinochem-pharmaceuticals-is-for-sale 2018-03-09 17:26:44.965+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-ireland-site-prepared-in-advance-to-meet-european-serialization-requirements 2018-03-09 17:23:21.487+00 https://www.pharmasalmanac.com/articles/lilly-reports-results-of-migraine-survey 2018-03-09 17:19:50.005+00 https://www.pharmasalmanac.com/articles/meet-chemo-cmo-preferred-partner-for-injectables-manufacturing 2018-03-09 16:38:41.133+00 https://www.pharmasalmanac.com/articles/focused-on-fermentation 2018-03-09 16:30:40.535+00 https://www.pharmasalmanac.com/articles/facilitating-implementation-and-customer-service-with-offline-serialization 2018-03-09 15:42:00.548+00 https://www.pharmasalmanac.com/articles/q2-fed-equip-investment-recovery-for-pharma-equipment 2018-03-08 22:21:57.671+00 https://www.pharmasalmanac.com/articles/novartis-in-collaboration-to-develop-software-applications 2018-03-08 19:23:12.47+00 https://www.pharmasalmanac.com/articles/celgene-vividion-therapeutics-collaborate-on-novel-protein-drugs 2018-03-08 19:17:29.114+00 https://www.pharmasalmanac.com/articles/orion-health-unveils-new-predictive-intelligence-using-machine-learning-to-help-save-billions-in-healthcare-costs 2018-03-08 12:50:02.457+00 https://www.pharmasalmanac.com/articles/segregation-in-the-design-of-gene-therapy-manufacturing-facilities 2018-03-07 22:59:10.765+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-receives-asias-cmo-of-2017-from-biopharma-industry-awards 2018-03-07 21:42:41.253+00 https://www.pharmasalmanac.com/articles/abbvie-receives-positive-recommendation-from-the-pan-canadian-oncology-drug-review-for-venclexta 2018-03-07 21:40:47.288+00 https://www.pharmasalmanac.com/articles/grand-river-aseptic-manufacturing-continues-to-expand-capabilities-with-new-state-of-the-art-colanar-syringe-filler 2018-03-07 21:22:15.443+00 https://www.pharmasalmanac.com/articles/agc-biologics-expands-capacity-at-berkeley-california-facility 2018-03-07 21:19:29.397+00 https://www.pharmasalmanac.com/articles/wuxi-nextcode-unveils-genomics-partnership-with-google-cloud 2018-03-07 21:18:34.896+00 https://www.pharmasalmanac.com/articles/meiragtx-receives-ema-prime-designation-for-achromatopsia-gene-therapy-candidate 2018-03-07 12:30:09.762+00 https://www.pharmasalmanac.com/articles/bioduro-new-strategies-required-to-meet-changing-needs-in-the-analytical-services-market 2018-03-06 17:24:15.546+00 https://www.pharmasalmanac.com/articles/gilead-announces-data-from-new-preclinical-study-evaluating-a-combination-of-an-investigational-tlr7-agonist-and-an-investigational-hiv-envelope 2018-03-06 12:45:03.668+00 https://www.pharmasalmanac.com/articles/bruker-gains-access-to-qcl-technology-with-irm2-acquisition 2018-03-05 22:42:41.777+00 https://www.pharmasalmanac.com/articles/boston-scientific-announces-acquisition-of-emcision-limited 2018-03-05 18:47:56.244+00 https://www.pharmasalmanac.com/articles/results-of-landmark-wearable-defibrillator-trial-to-be-presented-as-acc.18-late-breaker 2018-03-05 18:45:00.791+00 https://www.pharmasalmanac.com/articles/mylan-to-introduce-two-new-cost-saving-hiv-combination-treatments-in-the-u.s 2018-03-05 18:33:14.372+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-announces-positive-profit-alert 2018-03-05 17:45:01.904+00 https://www.pharmasalmanac.com/articles/bioduro-completes-acquisition-of-molecular-response-to-accelerate-translational-oncology-capabilities 2018-03-05 17:42:31.391+00 https://www.pharmasalmanac.com/articles/grifols-announces-new-agreement-with-henry-schein-to-distribute-normal-saline-solution-in-the-u.s 2018-03-05 17:40:38.01+00 https://www.pharmasalmanac.com/articles/celanese-manufacturing-facilities-recognized-for-achieving-energy-star-challenge-for-industry 2018-03-02 22:13:45.816+00 https://www.pharmasalmanac.com/articles/philips-launches-ai-platform-for-healthcare 2018-03-02 22:06:40.382+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-announces-new-online-tool 2018-03-02 18:11:21.836+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-laboratory-testing-division-becomes-dcat-member 2018-03-02 18:03:12.615+00 https://www.pharmasalmanac.com/articles/catalent-completes-4.6-million-expansion-at-singapore-clinical-supply-facility 2018-03-01 23:37:20.287+00 https://www.pharmasalmanac.com/articles/xencor-signs-four-commercial-license-agreements-with-selexis-sa-to-advance-its-pipeline-of-xmab-bispecific-antibody-drug-candidates 2018-03-01 23:36:11.719+00 https://www.pharmasalmanac.com/articles/thermo-fisher-supplies-analytical-instruments-to-world-anti-doping-agency-laboratory-in-south-korea 2018-03-01 23:32:47.308+00 https://www.pharmasalmanac.com/articles/cipher-pharmaceuticals-acquires-exclusive-canadian-rights-to-fda-approved-trulance-from-synergy-pharmaceuticals 2018-03-01 23:29:42.947+00 https://www.pharmasalmanac.com/articles/first-order-reported-for-new-samsung-plant 2018-03-01 19:58:35.139+00 https://www.pharmasalmanac.com/articles/abbott-and-surmodics-announce-agreement-for-next-generation-drug-coated-balloon 2018-03-01 12:55:10.752+00 https://www.pharmasalmanac.com/articles/brammer-bio-supports-rare-disease-day-2018 2018-02-28 22:04:40.693+00 https://www.pharmasalmanac.com/articles/capscanada-expands-k-capshpmc-capsules-manufacturing-capacity-for-second-time 2018-02-27 21:09:20.714+00 https://www.pharmasalmanac.com/articles/servier-reports-year-on-year-growth 2018-02-27 20:57:24.393+00 https://www.pharmasalmanac.com/articles/hepaxa-is-a-new-treatment-in-the-us-from-basf-for-patients-with-nafld 2018-02-27 20:50:59.91+00 https://www.pharmasalmanac.com/articles/gilead-sciences-announces-senior-management-change 2018-02-27 12:50:04.442+00 https://www.pharmasalmanac.com/articles/amgen-receives-positive-opinion-expanding-use-of-xgeva-denosumab-to-cover-prevention-of-skeletal-related-events-in-patients-with-multiple-myeloma-in-europe 2018-02-27 05:47:00.674+00 https://www.pharmasalmanac.com/articles/fda-acceptance-of-medicines360s-filing-for-supplemental-new-drug-application-for-liletta-levonorgestrel-releasing-intrauterine-system-52-mg 2018-02-27 05:38:55.763+00 https://www.pharmasalmanac.com/articles/kazia-receives-fda-orphan-designation-for-gdc-0084 2018-02-27 05:36:06.077+00 https://www.pharmasalmanac.com/articles/lanxess-expands-capacity-for-macrolex-dyes-at-its-leverkusen-site 2018-02-27 05:31:17.543+00 https://www.pharmasalmanac.com/articles/abarca-amgen-enter-outcomes-based-agreement-for-repatha-evolocumab 2018-02-27 05:29:20.327+00 https://www.pharmasalmanac.com/articles/astrazeneca-announces-renewed-recommendation-and-availability-of-flumist-quadrivalent-vaccine-in-the-us 2018-02-23 23:39:07.752+00 https://www.pharmasalmanac.com/articles/kite-a-gilead-company-and-sangamo-therapeutics-announce-collaboration-to-develop-next-generation-engineered-cell-therapies-for-the-treatment-of-cancer 2018-02-23 23:37:20.082+00 https://www.pharmasalmanac.com/articles/mylan-receives-tentative-approval-for-combination-hiv-treatment-dtg/ftc/taf-under-fdas-pepfar-program 2018-02-23 23:29:59.378+00 https://www.pharmasalmanac.com/articles/novartis-new-data-show-cosentyx-improved-quality-of-life-over-5-years-in-two-thirds-of-patients-with-moderate-to-severe-plaque-psoriasis 2018-02-23 12:35:03.559+00 https://www.pharmasalmanac.com/articles/gsk-presents-new-efficacy-data-for-fluarix-quadrivalent-influenza-vaccine-in-children-6-months-through-35-months-of-age 2018-02-23 12:30:09.242+00 https://www.pharmasalmanac.com/articles/johnson-johnson-medical-devices-companies-acquire-orthotaxy-to-develop-next-generation-robotic-assisted-surgery-platform-in-orthopaedics 2018-02-23 01:32:53.426+00 https://www.pharmasalmanac.com/articles/perrigo-appoints-ronald-l.-winowiecki-as-chief-financial-officer 2018-02-23 01:31:07.102+00 https://www.pharmasalmanac.com/articles/perrigo-confirms-patent-challenge-for-generic-version-of-finacea-foam-15 2018-02-23 01:29:11.805+00 https://www.pharmasalmanac.com/articles/kidney-disease-drug-licensed-to-astrazeneca 2018-02-22 15:17:07.87+00 https://www.pharmasalmanac.com/articles/roche-pays-1.9-billion-to-acquire-flatiron-health 2018-02-22 15:14:21.686+00 https://www.pharmasalmanac.com/articles/aimmunes-ar101-meets-phase-3-endpoints 2018-02-22 15:10:39.11+00 https://www.pharmasalmanac.com/articles/celanese-appoints-scott-richardson-as-chief-financial-officer 2018-02-21 22:42:31.13+00 https://www.pharmasalmanac.com/articles/catalent-announces-changes-to-its-board-of-directors 2018-02-21 22:27:28.676+00 https://www.pharmasalmanac.com/articles/abbvie-announces-new-phase-2-data-for-upadacitinib-showing-clinical-and-endoscopic-outcomes-in-crohns-disease-at-52-weeks 2018-02-21 22:24:58.965+00 https://www.pharmasalmanac.com/articles/abbvie-and-voyager-therapeutics-announce-global-strategic-collaboration-to-develop-potential-new-treatments-for-neurodegenerative-diseases 2018-02-21 22:18:18.044+00 https://www.pharmasalmanac.com/articles/novacap-acquires-interest-in-mailhot-industries 2018-02-20 20:50:42.527+00 https://www.pharmasalmanac.com/articles/evotec-and-mars-innovation-announce-first-funded-project-under-lab150-bridge 2018-02-20 20:49:34.009+00 https://www.pharmasalmanac.com/articles/abac-therapeutics-announces-16-million-series-a-to-develop-therapeutic-solutions-to-fight-antibiotic-resistant-bacteria 2018-02-20 20:47:41.683+00 https://www.pharmasalmanac.com/articles/device-plus-drug-approved-for-bladder-cancer-detection 2018-02-20 20:42:49.641+00 https://www.pharmasalmanac.com/articles/oxford-biomedica-completes-licensing-agreement-with-bioverativ-inc 2018-02-20 20:39:00.471+00 https://www.pharmasalmanac.com/articles/breakthrough-scar-treatment-in-clinical-trial 2018-02-20 20:34:40.586+00 https://www.pharmasalmanac.com/articles/marken-appoints-new-vice-president-global-quality-assurance 2018-02-20 20:24:26.87+00 https://www.pharmasalmanac.com/articles/gsk-submits-landmark-impact-data-to-european-medicines-agency-to-support-expanded-label-for-trelegy-ellipta 2018-02-19 12:50:08.804+00 https://www.pharmasalmanac.com/articles/biolife-solutions-executes-oem-agreement-with-milliporesigma 2018-02-16 12:40:05.033+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-and-nektar-therapeutics-announce-global-development-commercialization-collaboration-for-nektars-cd122-biased-agonist-nktr-214 2018-02-15 22:34:44.009+00 https://www.pharmasalmanac.com/articles/pfizer-receives-breakthrough-therapy-designation-from-fda-for-pf-04965842 2018-02-15 22:27:29.176+00 https://www.pharmasalmanac.com/articles/envigo-appoints-lynn-lewis-as-senior-vice-president-of-global-sales 2018-02-15 22:08:41.742+00 https://www.pharmasalmanac.com/articles/roche-receives-fda-clearance-for-factor-ii-and-factor-v-test-on-the-cobas-4800-system 2018-02-15 22:05:16.915+00 https://www.pharmasalmanac.com/articles/lilly-announces-positive-top-line-phase-3-results-for-taltz-ixekizumab-in-ankylosing-spondylitis-radiographic-axial-spondyloarthritis 2018-02-14 23:52:30.037+00 https://www.pharmasalmanac.com/articles/lonza-expands-cell-culture-portfolio-with-quasi-vivo-system 2018-02-14 23:42:56.76+00 https://www.pharmasalmanac.com/articles/sun-pharma-announces-twelve-tildrakizumab-abstracts-to-be-presented-at-american-academy-of-dermatology-2018-annual-meeting 2018-02-14 23:36:05.886+00 https://www.pharmasalmanac.com/articles/sirenas-enters-into-multi-target-collaboration-with-bristol-myers-squibb 2018-02-14 23:23:19.863+00 https://www.pharmasalmanac.com/articles/fueled-by-growth-alcami-unveils-new-sales-office-in-cambridge-ma 2018-02-14 19:30:19.861+00 https://www.pharmasalmanac.com/articles/lanxess-successfully-completes-acquisition-of-solvays-phosphorus-additive-business 2018-02-14 12:58:11.664+00 https://www.pharmasalmanac.com/articles/behind-the-scenes-of-international-pharmaceutical-business-success-a-conversation-with-horst-wallrabe 2018-02-14 02:03:59.19+00 https://www.pharmasalmanac.com/articles/the-path-toward-generics-2017s-record-breaking-year 2018-02-13 20:02:44.674+00 https://www.pharmasalmanac.com/articles/label-update-approved-for-novartis-cosentyx 2018-02-13 19:59:59.991+00 https://www.pharmasalmanac.com/articles/china-invests-heavily-in-western-biotech 2018-02-13 19:57:40.545+00 https://www.pharmasalmanac.com/articles/allergen-acquires-elastagen 2018-02-13 19:54:04.546+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-congratulates-tychan-for-dosing-first-patient-of-a-zika-antibody-after-record-9-months-of-development 2018-02-09 23:57:51.691+00 https://www.pharmasalmanac.com/articles/denali-therapeutics-and-lonza-pharma-biotech-announce-exclusive-partnership-to-develop-and-produce-biologic-medicines 2018-02-09 23:52:35.871+00 https://www.pharmasalmanac.com/articles/tyzivumab-is-ready-for-trials 2018-02-09 15:18:38.205+00 https://www.pharmasalmanac.com/articles/amgen-to-open-biomanufacturing-plant-in-the-us 2018-02-09 15:15:34.326+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-launches-axiom-microbiome-array-for-research 2018-02-09 12:30:10.163+00 https://www.pharmasalmanac.com/articles/royal-biologics-launches-amnio-maxx-a-stem-cell-product-derived-from-human-amniotic-placental-tissue 2018-02-08 20:15:48.548+00 https://www.pharmasalmanac.com/articles/encorafenib-and-binimetinib-combination-treatment-demonstrates-33.6-month-median-overall-survival-os-in-patients-with-braf-mutant-melanoma- 2018-02-08 19:58:28.236+00 https://www.pharmasalmanac.com/articles/takeda-announces-publication-of-study-utilizing-state-of-the-art-modeling-to-better-understand-optimal-treatment-positioning-for-patients-with-ulcerative-colitis 2018-02-08 19:47:51.308+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-wins-citeab-2018-award-for-its-antibody-validation-initiative 2018-02-08 19:24:14.02+00 https://www.pharmasalmanac.com/articles/abbvie-and-mbc-biolabs-team-up-to-support-life-science-startups-in-the-san-francisco-bay-area 2018-02-08 18:36:23.9+00 https://www.pharmasalmanac.com/articles/grifols-hyperrab-rabies-immune-globulin-human-300-iu/ml-receives-fda-approval-to-treat-patients-exposed-to-rabies-virus-infection 2018-02-08 18:33:04.937+00 https://www.pharmasalmanac.com/articles/celanese-completes-omni-acquisition 2018-02-08 15:58:23.121+00 https://www.pharmasalmanac.com/articles/polpharma-group-gets-digital 2018-02-08 15:49:56.161+00 https://www.pharmasalmanac.com/articles/improving-packaging-processes-to-meet-regulatory-and-patient-needs 2018-02-07 22:10:42.93+00 https://www.pharmasalmanac.com/articles/marken-accelerates-its-reach-and-growth-in-clinical-trial-logistics 2018-02-06 16:19:59.02+00 https://www.pharmasalmanac.com/articles/clinical-logistics-meeting-the-21st-century-cures-challenge 2018-02-05 21:57:19.68+00 https://www.pharmasalmanac.com/articles/syndax-announces-immuno-oncology-clinical-trial-collaboration-with-astrazeneca 2018-02-03 00:10:16.612+00 https://www.pharmasalmanac.com/articles/fda-approves-avycaz-ceftazidime-and-avibactam-for-the-treatment-of-patients-with-hospital-acquired-bacterial-pneumonia- 2018-02-03 00:03:56.722+00 https://www.pharmasalmanac.com/articles/kcas-bioanalytical-and-biomarker-services-welcomes-executive-director-of-bioanalytical-rd-and-lc-ms/ms-services 2018-02-02 23:52:14.52+00 https://www.pharmasalmanac.com/articles/dracen-pharmaceuticals-raises-over-40-million 2018-02-02 18:22:00.826+00 https://www.pharmasalmanac.com/articles/mylan-and-theravance-will-receive-fda-decision-on-copd-drug-by-november 2018-02-02 18:06:41.655+00 https://www.pharmasalmanac.com/articles/leading-companies-taking-action-to-address-healthcare 2018-02-02 16:59:19.572+00 https://www.pharmasalmanac.com/articles/versamaris-jv-formed-by-dsm-and-evonik 2018-02-02 16:28:55.205+00 https://www.pharmasalmanac.com/articles/bioduro-announces-cooperation-agreement-with-porton-pharma-solutions 2018-02-02 13:55:54.008+00 https://www.pharmasalmanac.com/articles/adding-multimedia-stand-up-to-cancer-announces-11m-collaborative-multi-disciplinary-research-program 2018-02-02 12:55:01.995+00 https://www.pharmasalmanac.com/articles/mylan-expands-access-to-hiv/aids-medicines-with-launch-of-first-generic-sustiva-tablets 2018-02-01 23:52:04.354+00 https://www.pharmasalmanac.com/articles/partner-therapeutics-ptx-acquires-leukine-from-sanofi 2018-02-01 23:37:29.88+00 https://www.pharmasalmanac.com/articles/novartis-announces-nejm-publication-of-updated-analysis-from-eliana-trial-showing-longer-term-durable-remissions-with-kymriah-in-children-young-adults-with-r/r-all 2018-02-01 23:28:07.553+00 https://www.pharmasalmanac.com/articles/takedas-zika-vaccine-candidate-receives-u.s.-fda-fast-track-designation 2018-02-01 14:47:40.114+00 https://www.pharmasalmanac.com/articles/copd-patients-excited-about-astrazeneca-trial-results 2018-02-01 14:00:18.75+00 https://www.pharmasalmanac.com/articles/engine-biosciences-raises-10-million-in-seed-financing-to-accelerate-drug-discovery-using-genomics-and-artificial-intelligence 2018-01-31 23:35:29.431+00 https://www.pharmasalmanac.com/articles/cambrex-expands-process-research-and-development-capabilities-across-north-america 2018-01-31 23:29:34.714+00 https://www.pharmasalmanac.com/articles/prime-therapeutics-and-boehringer-ingelheim-enter-into-outcomes-based-contract-for-jardiance 2018-01-31 23:26:29.227+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-announces-paul-fonteyne-to-retire-at-the-end-of-2018 2018-01-31 23:22:46.749+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-congratulates-bioatla-on-fda-clearance-of-ind-application-for-cab-axl-adc 2018-01-31 23:19:28.753+00 https://www.pharmasalmanac.com/articles/stopping-cancer-cell-division-using-targeted-enzyme-control 2018-01-31 21:50:11.239+00 https://www.pharmasalmanac.com/articles/fda-grants-fast-track-status-to-takedas-zika-vaccine-candidate 2018-01-31 21:49:34.196+00 https://www.pharmasalmanac.com/articles/agilent-partners-with-science-exchange 2018-01-31 19:30:48.336+00 https://www.pharmasalmanac.com/articles/scientists-discover-how-gene-mutation-triggers-immune-disease 2018-01-31 19:24:53.989+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-aravive-biologics-to-form-strategic-manufacturing-collaboration-following-successful-ind-filing-for-avb-s6-500 2018-01-31 19:21:04.935+00 https://www.pharmasalmanac.com/articles/specific-protein-plays-key-role-in-the-spread-of-breast-cancer 2018-01-31 12:50:07.972+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-and-mylan-announce-fda-acceptance-of-new-drug-application-for-revefenacin-td-4208-in-adults-with-chronic-obstructive-pulmonary-disease 2018-01-30 20:03:25.821+00 https://www.pharmasalmanac.com/articles/casi-pharmaceuticals-acquires-anda-portfolio-from-sandoz-inc.-sandoz 2018-01-30 19:40:08.6+00 https://www.pharmasalmanac.com/articles/novartis-makes-more-biosimilar-moves 2018-01-30 17:34:26.519+00 https://www.pharmasalmanac.com/articles/ema-committee-gives-positive-recommendation-to-gsks-shingles-vaccine 2018-01-30 17:31:19.273+00 https://www.pharmasalmanac.com/articles/sanofi-will-acquire-ablynx-for-3.9-billion 2018-01-30 17:27:32.834+00 https://www.pharmasalmanac.com/articles/-analytical-testing-contractors-take-on-the-challenge-of-complex-molecules 2018-01-29 22:09:38.089+00 https://www.pharmasalmanac.com/articles/new-real-world-analysis-finds-lower-risk-of-major-bleeding-and-similar-risk-of-stroke-with-standard-dose-of-pradaxa-compared-to-rivaroxaban 2018-01-29 21:47:26.721+00 https://www.pharmasalmanac.com/articles/janssen-to-present-14-abstracts-in-prostate-and-urothelial-cancers-at-asco-gu-2018 2018-01-29 21:27:02.626+00 https://www.pharmasalmanac.com/articles/wearable-medical-devices-market-18.3-cagr-to-2022 2018-01-29 21:18:32.544+00 https://www.pharmasalmanac.com/articles/innovation-in-telemedicine-and-mhealth-solutions-significantly-changing-the-healthcare-industry 2018-01-29 21:17:52.35+00 https://www.pharmasalmanac.com/articles/rexgenero-treats-first-patient-in-its-phase-iii-programme-with-lead-product-rex-001-a-novel-cell-therapy-for-the-treatment-of-critical-limb-ischemia-cli 2018-01-29 21:09:29.011+00 https://www.pharmasalmanac.com/articles/global-stroke-management-market-expected-to-reach-36756-million-by-2023-allied-market-research 2018-01-29 21:07:08.123+00 https://www.pharmasalmanac.com/articles/efficacy-testing-market-worth-501.6-million-usd-by-2022 2018-01-29 20:58:32.649+00 https://www.pharmasalmanac.com/articles/pfizer-joins-gilead-in-car-t-development- 2018-01-26 15:09:02.299+00 https://www.pharmasalmanac.com/articles/fda-and-dod-launch-joint-program-to-accelerate-drug-development 2018-01-26 15:06:43.53+00 https://www.pharmasalmanac.com/articles/cell-therapy-companies-can-now-have-improved-cell-thawing-capabilities 2018-01-26 15:01:12.915+00 https://www.pharmasalmanac.com/articles/upm-pharmaceuticals-appoints-daniel-dixon-as-vice-president-of-quality-control 2018-01-25 18:20:47.493+00 https://www.pharmasalmanac.com/articles/paragon-bioservices-announces-new-commercial-manufacturing-facility-expansion 2018-01-25 18:18:47.895+00 https://www.pharmasalmanac.com/articles/sandoz-biocon-deal-one-more-sign-that-u.s.-biosimilars-have-arrived 2018-01-25 18:14:49.623+00 https://www.pharmasalmanac.com/articles/amgen-and-novartis-reach-an-important-milestone 2018-01-25 15:35:42.215+00 https://www.pharmasalmanac.com/articles/gsk-launches-three-in-one-hiv-pill-in-china 2018-01-25 15:29:03.867+00 https://www.pharmasalmanac.com/articles/celgene-confirms-9-billion-buyout-of-juno-therapeutics 2018-01-25 15:25:35.552+00 https://www.pharmasalmanac.com/articles/contract-research-organization-growth-and-investment 2018-01-24 23:32:54.307+00 https://www.pharmasalmanac.com/articles/x-chem-enters-expanded-global-drug-discovery-and-technology-transfer-collaboration-with-astrazeneca 2018-01-23 21:31:58.854+00 https://www.pharmasalmanac.com/articles/marken-opens-new-location-in-stuttgart-germany 2018-01-23 21:31:07.12+00 https://www.pharmasalmanac.com/articles/fda-to-expand-the-use-of-gilotrif 2018-01-23 17:30:33.759+00 https://www.pharmasalmanac.com/articles/abbvie-to-add-jobs-in-ireland 2018-01-23 17:27:33.673+00 https://www.pharmasalmanac.com/articles/sanofi-buys-bioverativ 2018-01-23 17:21:27.556+00 https://www.pharmasalmanac.com/articles/european-commission-approves-bristol-myers-squibbs-yervoy-ipilimumab-for-treatment-of-pediatric-patients-12-years-and-older-with-unresectable-or-metastatic-melanoma 2018-01-22 23:10:39.489+00 https://www.pharmasalmanac.com/articles/taiho-oncology-and-servier-present-lonsurf-trifluridine-and-tipiracil-metastatic-colorectal-cancer-mcrc-data-at-asco-2018-gastrointestinal-cancers-symposium 2018-01-22 22:55:23.034+00 https://www.pharmasalmanac.com/articles/first-time-data-for-mercks-keytruda-pembrolizumab-in-patients-with-previously-treated-advanced-hepatocellular-carcinoma-hcc-to-be-presented-at-2018-asco-gi-symposium 2018-01-22 22:46:33.645+00 https://www.pharmasalmanac.com/articles/lynparza-olaparib-receives-approval-in-japan-for-the-treatment-of-advanced-ovarian-cancer 2018-01-22 22:40:37.202+00 https://www.pharmasalmanac.com/articles/european-commission-approves-amgen-and-allergans-mvasi-biosimilar-bevacizumab-for-the-treatment-of-certain-types-of-cancer 2018-01-22 22:34:42.451+00 https://www.pharmasalmanac.com/articles/neurometrix-and-glaxosmithkline-consumer-healthcare-announce-strategic-collaboration-to-develop-and-expand-access-to-quell-wearable-pain-relief-technology 2018-01-22 22:26:22.193+00 https://www.pharmasalmanac.com/articles/overall-survival-analysis-from-kyprolis-carfilzomib-phase-3-aspire-trial-published-in-the-journal-of-clinical-oncology 2018-01-22 22:22:40.117+00 https://www.pharmasalmanac.com/articles/colorcon-inc.-transforms-the-sugar-coating-process-with-a-new-opadry-system 2018-01-22 22:08:26.283+00 https://www.pharmasalmanac.com/articles/upm-pharmaceuticals-appoints-chris-curtin-as-chief-operating-officer 2018-01-22 22:07:51.623+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-adds-jean-paul-mangeolle-to-board-of-directors 2018-01-22 12:50:01.539+00 https://www.pharmasalmanac.com/articles/celerion-creates-a-fully-automated-early-development-clinical-trial-data-management-platform 2018-01-19 22:28:44.46+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-more-than-30-orders-for-ion-genestudio-s5-one-week-after-deb 2018-01-19 22:14:02.854+00 https://www.pharmasalmanac.com/articles/lustgarten-foundation-awarded-22-million-for-pancreatic-cancer-research 2018-01-19 22:10:17.968+00 https://www.pharmasalmanac.com/articles/cytovance-biologics-welcomes-edwin-miranda-as-vice-president-of-quality 2018-01-19 22:00:42.595+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-continues-to-grow-through-acquisition 2018-01-19 17:17:53.756+00 https://www.pharmasalmanac.com/articles/harvard-researchers-use-chip-technology-to-investigate-new-anti-inflammatory-drugs 2018-01-19 15:42:21.401+00 https://www.pharmasalmanac.com/articles/abzena-selects-sartorius-stedum-biotech-as-supplier-of-single-use-tech 2018-01-19 15:37:37.014+00 https://www.pharmasalmanac.com/articles/cmc-biologics-becomes-agc-biologics 2018-01-19 15:33:58.739+00 https://www.pharmasalmanac.com/articles/eu-approves-astrazenecas-respiratory-biologic 2018-01-18 20:33:16.173+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-adimab-partner-on-antibodies 2018-01-18 20:27:32.284+00 https://www.pharmasalmanac.com/articles/sebaceous-glands-in-3d 2018-01-18 19:54:53.714+00 https://www.pharmasalmanac.com/articles/sandoz-regulatory-submission-for-proposed-biosimilar-adalimumab-accepted-by-fda 2018-01-17 22:40:50.66+00 https://www.pharmasalmanac.com/articles/marken-opens-new-kit-building-facility-in-shanghai 2018-01-17 22:21:37.404+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approves-lynparza-olaparib-in-germline-brca-mutated-metastatic-breast-cancer 2018-01-17 12:50:09.674+00 https://www.pharmasalmanac.com/articles/q2-tn-innovation-at-the-heart-of-biopharmaceutical-industry-growth-nice-insight-highlights-key-trends-driving-growth-in-the-biopharmaceutical-market 2018-01-17 00:52:03.13+00 https://www.pharmasalmanac.com/articles/olympus-periview-flex-tbna-needle-brings-new-capabilities-to-early-diagnosis-of-lung-disease 2018-01-16 22:03:32.6+00 https://www.pharmasalmanac.com/articles/clinical-decision-support-software-to-be-developed-by-roche-and-ge-healthcare 2018-01-16 19:28:55.397+00 https://www.pharmasalmanac.com/articles/impact-biomedicines-acquired-by-celgene 2018-01-16 19:15:27.049+00 https://www.pharmasalmanac.com/articles/takeda-moves-into-stem-cell-therapies-with-acquisition-of-tigenix 2018-01-16 18:08:29.579+00 https://www.pharmasalmanac.com/articles/abzena-continues-to-expand-globally 2018-01-16 18:00:14.279+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-appoints-dr.-chiang-syin-a-former-fda-officer-as-chief-quality-officer 2018-01-15 23:33:00.531+00 https://www.pharmasalmanac.com/articles/gsk-receives-fda-approval-for-expanded-indication-for-fluarix-quadrivalent 2018-01-15 23:19:05.921+00 https://www.pharmasalmanac.com/articles/first-treatment-for-mers-appears-safe-in-nih-phase-i-clinical-trial 2018-01-15 13:30:00.801+00 https://www.pharmasalmanac.com/articles/pharmafluidics-raises-7.3-million-euro-to-expand-commercialization-of-novel-micro-chip-device-for-biomarker-diagnostics-and-drug-development-applications 2018-01-12 23:27:33.146+00 https://www.pharmasalmanac.com/articles/forty-seven-inc.-to-collaborate-on-a-novel-immuno-oncology-combination-for-leukemia-and-bladder-cancer 2018-01-12 23:22:18.827+00 https://www.pharmasalmanac.com/articles/forty-seven-inc.-to-collaborate-with-merck-kgaa-darmstadt-germany-on-a-novel-immuno-oncology-combination-for-ovarian-cancer 2018-01-12 23:17:54.024+00 https://www.pharmasalmanac.com/articles/helsinn-group-and-mei-pharma-announce-that-pracinostat-has-received-orphan-drug-designation-from-the-european-medicines-agency 2018-01-12 22:24:05.9+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-gains-immunology-contract-research-services 2018-01-12 18:05:06.344+00 https://www.pharmasalmanac.com/articles/sharp-completes-pennsylvania-facility 2018-01-12 18:02:57.303+00 https://www.pharmasalmanac.com/articles/moderna-announces-19-development-candidates-at-jpm 2018-01-12 17:58:36.045+00 https://www.pharmasalmanac.com/articles/medical-research-collaborating-center-selects-medidata-to-meet-global-regulatory-requirements-during-clinical-trials 2018-01-12 17:07:11.949+00 https://www.pharmasalmanac.com/articles/flexible-partnership-inflexible-quality 2018-01-12 16:47:52.322+00 https://www.pharmasalmanac.com/articles/arvinas-protein-degradation-technology-attracts-pfizers-attention 2018-01-11 19:36:49.266+00 https://www.pharmasalmanac.com/articles/ignyta-snapped-up-by-roche 2018-01-11 19:33:03.577+00 https://www.pharmasalmanac.com/articles/fda-still-addressing-drug-shortages-resulting-from-manufacturing-disruptions-in-puerto-rico 2018-01-11 19:28:58.379+00 https://www.pharmasalmanac.com/articles/mallinckrodt-expands-rare-disease-pipeline-with-sucampo-acquisition 2018-01-11 18:52:49.392+00 https://www.pharmasalmanac.com/articles/pulmonx-submits-premarket-approval-pma-application-to-u.s.-fda-for-zephyr-endobronchial-valve-as-treatment-for-emphysema 2018-01-11 15:15:28.054+00 https://www.pharmasalmanac.com/articles/1vision-awarded-home-telehealth-contract-from-the-u.s.-department-of-veterans-affairs 2018-01-11 15:09:08.081+00 https://www.pharmasalmanac.com/articles/bergenbio-meets-first-efficacy-endpoint-in-phase-ii-trial-with-selective-axl-inhibitor-bgb324-bemcentinib-in-nsclc 2018-01-11 14:24:14.794+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-group-and-mayo-clinic-form-joint-venture-to-deliver-clinical-diagnostic-services 2018-01-11 14:01:08.632+00 https://www.pharmasalmanac.com/articles/amorsa-therapeutics-announces-notice-of-allowance-for-u.s.-patent-covering-oral-compositions-of-ketamine-and-related-compounds 2018-01-11 14:00:19.326+00 https://www.pharmasalmanac.com/articles/biohaven-announces-positive-results-from-bioequivalence-study-with-sublingual-bhv-0223-zydis-orally-dissolving-tablet 2018-01-10 22:51:59.707+00 https://www.pharmasalmanac.com/articles/syapse-enters-strategic-collaboration-with-roche-to-advance-precision-medicine-in-oncology 2018-01-10 22:42:49.65+00 https://www.pharmasalmanac.com/articles/global-biolife-a-biomedical-subsidiary-of-singapore-edevelopment-limited-completes-cancer-research-for-new-universal-therapeutic-drug-platform 2018-01-10 21:55:27.582+00 https://www.pharmasalmanac.com/articles/california-legalizes-cannabis-with-canada-looming 2018-01-10 21:53:52.189+00 https://www.pharmasalmanac.com/articles/abzena-takes-on-new-facilities-in-cambridge-uk-and-san-diego 2018-01-10 15:22:55.928+00 https://www.pharmasalmanac.com/articles/seattle-genetics-highlights-leadership-in-expanding-field-of-antibody-drug-conjugates-adcs-at-the-36th-annual-j.p.-morgan-healthcare-conference 2018-01-10 15:07:32.63+00 https://www.pharmasalmanac.com/articles/taxus-cardium-announces-name-change-to-gene-biotherapeutics 2018-01-10 14:01:07.822+00 https://www.pharmasalmanac.com/articles/genomics-firm-attracts-high-tech-investments 2018-01-09 19:16:40.298+00 https://www.pharmasalmanac.com/articles/generex-biotech-and-shenzhen-bioscien-enter-into-licensing-agreement 2018-01-09 19:10:24.212+00 https://www.pharmasalmanac.com/articles/china-fda-publishes-guidance-for-priority-review 2018-01-09 19:09:51.048+00 https://www.pharmasalmanac.com/articles/potenza-therapeutics-unveils-pipeline-of-immuno-oncology-programs 2018-01-09 15:16:50.881+00 https://www.pharmasalmanac.com/articles/former-receptos-executives-launch-gossamer-bio-inc 2018-01-09 15:16:12.735+00 https://www.pharmasalmanac.com/articles/safety-of-intravenous-administration-of-biostars-cultured-stem-cells-was-proven-no-possibility-of-cancer-occurrence-from-multiple-infusions 2018-01-09 14:58:38.38+00 https://www.pharmasalmanac.com/articles/intec-pharma-announces-development-collaboration-with-global-pharmaceutical-company 2018-01-09 14:51:39.521+00 https://www.pharmasalmanac.com/articles/abbvies-upadacitinib-granted-breakthrough-therapy-designation-from-the-u.s.-food-and-drug-administration-for-atopic-dermatitis 2018-01-08 17:44:42.256+00 https://www.pharmasalmanac.com/articles/takeda-and-denali-therapeutics-collaborate-to-develop-and-commercialize-therapies-for-neurodegenerative-diseases 2018-01-05 22:05:57.342+00 https://www.pharmasalmanac.com/articles/new-class-of-exosome-biologics-focuses-on-stroke-treatment 2018-01-05 18:55:20.184+00 https://www.pharmasalmanac.com/articles/defense-department-commits-16-million-to-fight-bacterial-bioweapons 2018-01-05 18:46:41.923+00 https://www.pharmasalmanac.com/articles/deal-with-inovio-launches-apollobios-commercialization-plans-in-china 2018-01-05 18:37:52.123+00 https://www.pharmasalmanac.com/articles/fda-approves-gene-therapy 2018-01-04 18:59:21.897+00 https://www.pharmasalmanac.com/articles/genetically-engineered-horses-could-be-a-reality 2018-01-04 18:10:34.044+00 https://www.pharmasalmanac.com/articles/array-biopharma-forms-new-subsidiary-yarra-therapeutics 2018-01-04 18:06:14.567+00 https://www.pharmasalmanac.com/articles/thermo-fisher-gets-key-customer-for-its-cell-therapy-activation-reagents 2018-01-04 17:52:01.716+00 https://www.pharmasalmanac.com/articles/ni-seeking-quality-deals-consolidation-and-acquisition 2018-01-03 22:04:58.932+00 https://www.pharmasalmanac.com/articles/expansion-therapeutics-raises-55.3-million-in-series-a-financing-to-advance-portfolio-of-novel-rna-targeted-small-molecule-medicines-to-treat-rare-diseases 2018-01-03 19:11:14.115+00 https://www.pharmasalmanac.com/articles/new-fda-mr-conditional-labeling-approvals-further-expand-abbotts-portfolio-of-mri-ready-devices 2018-01-03 19:10:24.859+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering-0-0-0-0-0 2018-01-03 00:01:38.507+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering-0-0-0-0 2018-01-03 00:00:28.772+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering-0-0-0 2018-01-02 23:59:53.682+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering-0-0 2018-01-02 23:58:46.572+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering-0 2018-01-02 23:58:02.687+00 https://www.pharmasalmanac.com/articles/armo-biosciences-files-registration-statement-for-proposed-initial-public-offering 2018-01-02 23:55:10.599+00 https://www.pharmasalmanac.com/articles/building-dna-and-rna-origami-for-drug-delivery 2018-01-02 14:00:07.725+00 https://www.pharmasalmanac.com/articles/continuous-manufacturing-to-be-continued- 2017-12-29 14:40:21.272+00 https://www.pharmasalmanac.com/articles/2016-cro-industry-leader 2017-12-29 14:38:04.626+00 https://www.pharmasalmanac.com/articles/test-q1/2016-cdmo-industry-leader 2017-12-29 14:37:32.249+00 https://www.pharmasalmanac.com/articles/changes-in-the-wind-for-the-cdmo-market 2017-12-28 18:20:17.101+00 https://www.pharmasalmanac.com/articles/pfizer-receives-fda-approval-for-remicade-biosimilar 2017-12-28 14:00:13.922+00 https://www.pharmasalmanac.com/articles/needle-free-injection-technology-advances-to-phase-ii-trial 2017-12-26 18:00:07.338+00 https://www.pharmasalmanac.com/articles/mitochondrial-expert-mitobridge-snapped-up-by-astellas-pharma 2017-12-22 22:14:27.856+00 https://www.pharmasalmanac.com/articles/new-platform-brings-ai-efficiency-to-health-data-processing 2017-12-22 22:00:07.459+00 https://www.pharmasalmanac.com/articles/fda-received-numerous-comments-on-its-draft-guidance-for-evaluating-biosimilarity 2017-12-22 21:56:20.319+00 https://www.pharmasalmanac.com/articles/gileads-new-kite-subsidiary-to-buy-car-t-cell-therapy-company-cell-design-labs 2017-12-22 21:45:50.641+00 https://www.pharmasalmanac.com/articles/new-method-could-provide-super-resolution-for-biological-imaging 2017-12-22 21:41:20.537+00 https://www.pharmasalmanac.com/articles/gilead-makes-100-million-commitment-to-fighting-hiv/aids 2017-12-22 21:02:12.827+00 https://www.pharmasalmanac.com/articles/transporters-targeting-cells-metabolic-gates-win-financing 2017-12-22 20:57:15.522+00 https://www.pharmasalmanac.com/articles/nda-submitted-for-antimalarial-drug 2017-12-22 20:24:24.726+00 https://www.pharmasalmanac.com/articles/cmc-biologics-announces-agreement 2017-12-21 17:24:48.932+00 https://www.pharmasalmanac.com/articles/what-are-the-greatest-challenges-drug-manufacturers-face-when-working-to-meet-the-new-requirements-for-excipient-supply-chain-security 2017-12-21 16:54:24.938+00 https://www.pharmasalmanac.com/articles/the-fda-recently-validated-a-continuous-manufacturing-pharma-process-line-what-do-you-think-this-means-for-the-future 2017-12-21 16:35:00.012+00 https://www.pharmasalmanac.com/articles/tumor-killing-combo-wins-third-u.s.-patent 2017-12-21 16:14:10.232+00 https://www.pharmasalmanac.com/articles/chinese-biopharma-receives-series-a-financing 2017-12-21 15:57:54.225+00 https://www.pharmasalmanac.com/articles/biovectra-and-keryx-expand-strategic-api-supply-relationship 2017-12-21 15:54:57.265+00 https://www.pharmasalmanac.com/articles/worlds-largest-biologics-plant-gets-ema-nod 2017-12-19 17:37:56.974+00 https://www.pharmasalmanac.com/articles/renova-therapeutics-gene-transfer-tech-enters-the-fast-lane 2017-12-19 17:28:21.475+00 https://www.pharmasalmanac.com/articles/memory-t-cells-fit-to-be-cross-trained 2017-12-19 17:25:20.369+00 https://www.pharmasalmanac.com/articles/altering-white-blood-cells-to-kill-cancer 2017-12-19 17:22:47.17+00 https://www.pharmasalmanac.com/articles/fucoidans-found-in-seaweed-exhibit-promising-anticancer-properties 2017-12-15 16:44:01.352+00 https://www.pharmasalmanac.com/articles/novo-nordisk-bags-fda-approval-for-new-diabetes-treatment 2017-12-15 16:40:37.584+00 https://www.pharmasalmanac.com/articles/new-fda-draft-guidance-intended-to-accelerate-development-of-drugs-for-rare-pediatric-diseases 2017-12-15 16:36:12.016+00 https://www.pharmasalmanac.com/articles/charles-river-expands-crispr-offerings-with-second-license 2017-12-15 16:30:33.912+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-granted-exclusive-license-by-ono-pharmaceutical-for-multiple-programs-targeting-immuno-suppressive-factors-in-the-tumor-microenvironment 2017-12-15 15:00:45.676+00 https://www.pharmasalmanac.com/articles/biovectra-and-keryx-biopharmaceuticals-enter-agreement-for-ferric-citrate-production-expansion 2017-12-15 14:54:53.711+00 https://www.pharmasalmanac.com/articles/molex-expands-strategic-investment-platform-with-venture-initiative 2017-12-15 00:31:17.896+00 https://www.pharmasalmanac.com/articles/fda-approves-new-pfizer-biosimilar 2017-12-14 23:09:07.083+00 https://www.pharmasalmanac.com/articles/vedanta-biosciences-granted-four-new-u.s.-patents-expanding-coverage-for-compositions-and-methods-of-use-for-therapeutics 2017-12-14 23:03:12.735+00 https://www.pharmasalmanac.com/articles/parexel-launches-perceptive-cloud-for-the-life-sciences-industry 2017-12-14 19:12:12.597+00 https://www.pharmasalmanac.com/articles/acadia-pharmaceuticals-announces-appointment-of-damien-mcdevitt-ph.d.-as-senior-vice-president-corporate-development 2017-12-14 19:10:09.265+00 https://www.pharmasalmanac.com/articles/phase-iii-study-confirms-abbvie-leukemia-combo-meets-endpoint 2017-12-14 17:37:44.388+00 https://www.pharmasalmanac.com/articles/new-generic-for-kenalog-40-approved 2017-12-14 17:20:05.179+00 https://www.pharmasalmanac.com/articles/first-follow-on-insulin-product-approved 2017-12-14 17:12:08.701+00 https://www.pharmasalmanac.com/articles/aprecia-and-cycle-team-to-develop-3d-printed-orphan-drugs 2017-12-14 17:04:09.548+00 https://www.pharmasalmanac.com/articles/emerging-lyme-disease-tests-found-efficacious 2017-12-12 18:30:42.636+00 https://www.pharmasalmanac.com/articles/results-of-new-gene-therapy-revealed-at-hemophilia-meeting 2017-12-12 18:27:26.51+00 https://www.pharmasalmanac.com/articles/zuma-1-study-of-yescarta-reports-58-complete-remission 2017-12-12 18:24:23.385+00 https://www.pharmasalmanac.com/articles/phase-ii-results-reveal-high-performance-immunotherapy 2017-12-12 18:21:40.776+00 https://www.pharmasalmanac.com/articles/booklet-label-combines-tamper-protection-and-drug-information 2017-12-12 15:40:38.685+00 https://www.pharmasalmanac.com/articles/holiday-program-brings-hope-home-to-lung-cancer-patients 2017-12-08 16:14:54.049+00 https://www.pharmasalmanac.com/articles/men-in-the-uk-will-be-able-to-buy-viagra-over-the-counter-next-may 2017-12-08 15:37:01.091+00 https://www.pharmasalmanac.com/articles/generic-firms-developing-opioids-with-abuse-deterrent-properties-have-new-fda-guidance-to-follow 2017-12-08 15:36:35.319+00 https://www.pharmasalmanac.com/articles/vetter-begins-construction-of-packaging-facility-expansion 2017-12-08 15:20:37.906+00 https://www.pharmasalmanac.com/articles/genentech-and-biothera-to-assess-combination-cancer-therapy 2017-12-08 15:17:37.17+00 https://www.pharmasalmanac.com/articles/u.s.-patient-receives-kites-yescarta-cart-t-therapy 2017-12-07 20:23:37.93+00 https://www.pharmasalmanac.com/articles/first-biosimilar-to-treat-breast-and-stomach-cancers-approved 2017-12-07 20:13:06.841+00 https://www.pharmasalmanac.com/articles/fda-clears-kardiaband-apple-watch-heart-monitoring-app 2017-12-07 19:57:54.598+00 https://www.pharmasalmanac.com/articles/five-critical-considerations-for-pharmaceutical-ma 2017-12-07 18:11:25.76+00 https://www.pharmasalmanac.com/articles/fda-finalizes-emerging-drug-manufacturing-technology-guidance 2017-12-05 22:04:37.392+00 https://www.pharmasalmanac.com/articles/society-for-clinical-research-sites-announces-winning-sponsor-and-cro-of-2017-eagle-award-eli-lilly-and-inc-research/inventiv-health 2017-12-05 21:19:32.754+00 https://www.pharmasalmanac.com/articles/novartis-receives-first-ever-fda-approval-for-a-car-t-cell-therapy-kymriahtm-ctl019 2017-12-05 21:16:21.126+00 https://www.pharmasalmanac.com/articles/fda-grants-priority-review-to-gilotrif-for-uncommon-egfr-mutations-in-advanced-nsclc 2017-12-05 20:57:07.67+00 https://www.pharmasalmanac.com/articles/astrazeneca-launches-strategic-joint-venture-in-china 2017-12-05 19:36:34.168+00 https://www.pharmasalmanac.com/articles/kite-pharma-acquisition-by-gilead-finalized 2017-12-05 17:40:07.559+00 https://www.pharmasalmanac.com/articles/fda-expands-510k-clearance-for-nuvasives-limb-lengthening-platform-to-include-bone-transport 2017-12-05 16:31:24.94+00 https://www.pharmasalmanac.com/articles/connected-clinical-trial-online-platform-launches 2017-12-04 22:31:23.512+00 https://www.pharmasalmanac.com/articles/lab-on-a-chip-technology-advancing-treatments-for-lung-cancer 2017-12-04 21:59:09.837+00 https://www.pharmasalmanac.com/articles/unlocking-the-relationship-between-genetics-and-disease 2017-12-04 17:03:13.378+00 https://www.pharmasalmanac.com/articles/outsourcing-provides-advantages-to-sponsor-companies 2017-12-01 16:00:08.603+00 https://www.pharmasalmanac.com/articles/international-society-for-cellular-therapy-supports-new-fda-policy-framework-for-regenerative-medicine 2017-12-01 15:27:28.538+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientifics-patheon-division-to-manufacture-nasal-formulation-for-evoke-pharma 2017-12-01 15:22:20.611+00 https://www.pharmasalmanac.com/articles/new-collaboration-targets-the-development-of-oligonucleotides 2017-12-01 15:17:20.918+00 https://www.pharmasalmanac.com/articles/amerisource-bergen-expands-in-the-us-with-acquisition-of-h.d.-smith 2017-12-01 15:01:20.223+00 https://www.pharmasalmanac.com/articles/dissolving-boundaries-in-worldwide-clinical-trial-logistics-for-biological-samples-and-new-therapies 2017-11-30 19:57:46.608+00 https://www.pharmasalmanac.com/articles/bio-rad-authorizes-new-250-million-share-repurchase-program 2017-11-30 19:23:30.014+00 https://www.pharmasalmanac.com/articles/pharmaterials-acquired-by-quotient-sciences 2017-11-30 19:06:38.984+00 https://www.pharmasalmanac.com/articles/study-finds-less-teflon-in-environment-leads-to-less-brain-damage 2017-11-30 16:11:42.569+00 https://www.pharmasalmanac.com/articles/single-pill-hiv-1-combination-therapy-approved 2017-11-30 15:56:17.513+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-hitgen-enter-drug-discovery-collaboration 2017-11-30 15:48:22.341+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheims-adalimumab-biosimilar-wins-first-eu-approval 2017-11-28 19:00:53.906+00 https://www.pharmasalmanac.com/articles/advanced-follicular-lymphoma-treatment-approved 2017-11-28 18:54:48.651+00 https://www.pharmasalmanac.com/articles/fresenius-kabi-plans-100-million-north-carolina-expansion 2017-11-28 18:02:19.306+00 https://www.pharmasalmanac.com/articles/excision-biotherapeutics-licenses-uc-berkeley-crispr-systems 2017-11-28 18:00:19.732+00 https://www.pharmasalmanac.com/articles/grand-river-aseptic-manufacturing-announces-majority-investment-by-arlington-capital-partners 2017-11-27 14:37:33.852+00 https://www.pharmasalmanac.com/articles/digital-technology-makes-it-into-medicines 2017-11-27 00:44:56.046+00 https://www.pharmasalmanac.com/articles/more-gene-editing-technology-being-developed-by-novartis 2017-11-27 00:36:38.881+00 https://www.pharmasalmanac.com/articles/alcami-to-produce-clinical-supplies-of-darinaparsin-for-solasia 2017-11-27 00:23:38.433+00 https://www.pharmasalmanac.com/articles/glycan-coated-gold-nanoparticles-are-target-of-nanofacturing-consortium 2017-11-27 00:19:01.973+00 https://www.pharmasalmanac.com/articles/bioengineered-robotic-hand-senses-touch 2017-11-23 19:03:10.068+00 https://www.pharmasalmanac.com/articles/study-reveals-new-medication-options-for-opioid-dependency 2017-11-22 19:49:26.107+00 https://www.pharmasalmanac.com/articles/astrazenecas-anti-asthma-fasenra-wins-fda-approval 2017-11-22 19:38:32.558+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-powers-new-pad-blood-test 2017-11-22 19:33:29.555+00 https://www.pharmasalmanac.com/articles/simplified-versions-of-teixobactin-could-be-commercialized 2017-11-21 18:19:01.583+00 https://www.pharmasalmanac.com/articles/siteone-therapeutics-garners-us-department-of-defense-award 2017-11-21 18:08:56.565+00 https://www.pharmasalmanac.com/articles/collaboration-announced-between-takeda-pharmaceutical-and-portal-instruments 2017-11-21 17:50:29.634+00 https://www.pharmasalmanac.com/articles/almac-expands-analytical-services-with-bioclin-laboratories-acquisition 2017-11-21 16:48:37.612+00 https://www.pharmasalmanac.com/articles/vetters-opens-a-new-office-in-south-korea 2017-11-17 13:04:06.995+00 https://www.pharmasalmanac.com/articles/small-molecule-cancer-combination-therapy-receives-second-patent 2017-11-17 13:02:04.275+00 https://www.pharmasalmanac.com/articles/fujifilm-plans-1-billion-capacity-expansion-in-u.s.-u.k 2017-11-17 13:00:12.054+00 https://www.pharmasalmanac.com/articles/intrauterine-devices-offer-new-benefit 2017-11-16 19:25:42.098+00 https://www.pharmasalmanac.com/articles/new-malaria-therapeutic-receives-fda-orphan-drug-designation 2017-11-16 19:08:18.104+00 https://www.pharmasalmanac.com/articles/novel-compound-developed-that-could-serve-as-a-non-addictive-opiod-alternative 2017-11-16 19:04:25.866+00 https://www.pharmasalmanac.com/articles/first-treatment-for-rare-blood-disorder-approved-by-fda 2017-11-16 19:00:40.847+00 https://www.pharmasalmanac.com/articles/compugen-advances-lead-anti-tigit-monoclonal-antibody-to-manufacturing 2017-11-16 18:56:58.473+00 https://www.pharmasalmanac.com/articles/quintilesims-now-iqvia 2017-11-14 19:39:09.883+00 https://www.pharmasalmanac.com/articles/ultrasound-transducer-from-butterfly-network-receives-fda-approval-for-13-applications 2017-11-14 19:35:04.018+00 https://www.pharmasalmanac.com/articles/dicerna-and-boehringer-ingelheim-ink-deal-to-develop-treatments-for-chronic-liver-diseases 2017-11-14 19:31:06.389+00 https://www.pharmasalmanac.com/articles/mallinckrodt-expands-pipeline-with-ocera-therapeutics-buy 2017-11-10 18:53:15.024+00 https://www.pharmasalmanac.com/articles/abbvie-starts-up-new-mammalian-cell-culture-production-facility-in-singapore 2017-11-10 18:53:06.75+00 https://www.pharmasalmanac.com/articles/eli-lilly-expands-insulin-production-capacity-in-indiana 2017-11-10 18:45:04.456+00 https://www.pharmasalmanac.com/articles/ema-fda-move-forward-with-mutual-recognition-of-inspections 2017-11-10 18:30:45.652+00 https://www.pharmasalmanac.com/articles/alcami-to-manufacture-darinaparsin 2017-11-09 19:39:50.515+00 https://www.pharmasalmanac.com/articles/londons-science-museum-displays-breakthrough-stem-cell-sprayer 2017-11-09 19:27:42.155+00 https://www.pharmasalmanac.com/articles/nih-funds-bacterial-dna-superbug-killer 2017-11-09 19:25:11.7+00 https://www.pharmasalmanac.com/articles/lung-cancer-research-institute-recipients-announced 2017-11-09 19:22:29.744+00 https://www.pharmasalmanac.com/articles/marken-delivering-new-hybrid-service 2017-11-07 22:55:22.008+00 https://www.pharmasalmanac.com/articles/russian-biotechnology-company-biocad-prepares-to-enters-the-european-market 2017-11-07 22:50:59.635+00 https://www.pharmasalmanac.com/articles/fertility-experts-embryos-travel-better-frozen 2017-11-07 16:27:23.75+00 https://www.pharmasalmanac.com/articles/ovarian-cycle-bracelet-detects-pregnancy-in-trials 2017-11-07 16:24:47.091+00 https://www.pharmasalmanac.com/articles/bariatric-surgery-demonstrates-effective-diabetes-control 2017-11-07 16:22:31.447+00 https://www.pharmasalmanac.com/articles/amgen-and-novartis-expand-collaboration-to-prevent-alzheimers 2017-11-07 16:16:52.227+00 https://www.pharmasalmanac.com/articles/crispr-technology-could-enable-new-treatments-for-resistant-fungal-infections 2017-11-03 17:21:42.765+00 https://www.pharmasalmanac.com/articles/immuno-oncology-approach-based-on-electronic-circuitry 2017-11-03 17:21:07.931+00 https://www.pharmasalmanac.com/articles/parexel-and-microsoft-to-develop-new-cloud-technology 2017-11-03 17:18:32.267+00 https://www.pharmasalmanac.com/articles/calquence-astrazenecas-btk-inhibitor-approved-by-fda 2017-11-03 17:13:07.006+00 https://www.pharmasalmanac.com/articles/new-nsaid-topical-gels-penetrate-three-times-faster 2017-11-03 17:11:02.441+00 https://www.pharmasalmanac.com/articles/intelligent-nanoparticles-kill-cancer-cells 2017-11-03 17:10:35.563+00 https://www.pharmasalmanac.com/articles/polyphor-ag-polyphor-launches-the-development-of-an-inhaled-formulation-of-its-antibiotic-murepavadin 2017-11-03 17:05:28.563+00 https://www.pharmasalmanac.com/articles/servier-cdmo-expands-preparative-chromatography-platform-at-normandy-site-to-support-market-need 2017-11-03 16:58:52.561+00 https://www.pharmasalmanac.com/articles/mustang-bio-sends-car-t-cell-therapy-line-to-college 2017-11-02 19:11:30.536+00 https://www.pharmasalmanac.com/articles/fda-european-regulators-align-for-more-efficient-gmp-inspections 2017-11-02 19:07:38.861+00 https://www.pharmasalmanac.com/articles/no-clinically-meaningful-difference-the-upward-trend-of-biosimilars 2017-10-31 19:15:09.938+00 https://www.pharmasalmanac.com/articles/studies-show-delayed-umbilical-cord-clamping-might-be-key-to-life-extension 2017-10-31 18:46:11.901+00 https://www.pharmasalmanac.com/articles/gene-therapy-for-hemophilia-a-granted-breakthrough-therapy-designation 2017-10-31 18:42:27.581+00 https://www.pharmasalmanac.com/articles/new-initiative-to-accelerate-development-of-universal-flu-vaccines-launches 2017-10-31 18:33:36.056+00 https://www.pharmasalmanac.com/articles/novartis-plans-acquisition-of-advanced-accelerator-applications-for-3.9-billion 2017-10-31 18:29:01.962+00 https://www.pharmasalmanac.com/articles/managing-the-complexities-of-outbound-clinical-drug-distribution 2017-10-31 15:06:19.342+00 https://www.pharmasalmanac.com/articles/moving-beyond-monoclonal-antibodies 2017-10-26 21:47:45.145+00 https://www.pharmasalmanac.com/articles/from-digitalization-to-nanoscale-delivery-emerging-technologies-are-driving-the-future-of-pharma 2017-10-26 21:06:19.886+00 https://www.pharmasalmanac.com/articles/adcs-the-future-of-biologic-drugs 2017-10-26 21:04:39.723+00 https://www.pharmasalmanac.com/articles/right-first-time-innovation-approach-drives-continual-investment 2017-10-26 21:03:24.478+00 https://www.pharmasalmanac.com/articles/pharmas-automation-index-on-the-rise 2017-10-26 20:43:13.094+00 https://www.pharmasalmanac.com/articles/developing-targeted-potassium-channel-openers-for-cns-related-therapeutics 2017-10-26 20:42:10.81+00 https://www.pharmasalmanac.com/articles/single-use-operational-excellence-explained-effective-lifecycle-management 2017-10-26 20:34:33.169+00 https://www.pharmasalmanac.com/articles/sanofi-expanding-manufacturing-capacity-for-quadrivalent-influenza-vaccine 2017-10-26 20:15:43.544+00 https://www.pharmasalmanac.com/articles/merger-to-create-large-us-generics-firm 2017-10-26 19:39:01.7+00 https://www.pharmasalmanac.com/articles/forge-therapeutics-and-evotec-expand-their-partnership 2017-10-26 19:29:58.579+00 https://www.pharmasalmanac.com/articles/smart-phone-compatible-cardiac-monitor-launched 2017-10-26 19:17:02.823+00 https://www.pharmasalmanac.com/articles/dont-be-scared-new-insight-into-how-the-brain-learns-fear 2017-10-26 17:53:25.502+00 https://www.pharmasalmanac.com/articles/first-treatment-for-generalized-myasthenia-gravis-approved-in-60-years 2017-10-26 17:32:09.842+00 https://www.pharmasalmanac.com/articles/breakthrough-car-t-immunotherapy-approved 2017-10-26 17:23:06.591+00 https://www.pharmasalmanac.com/articles/study-finds-beta-blockers-interrupt-nerves-sustaining-prostate-tumor-growth 2017-10-24 17:56:14.659+00 https://www.pharmasalmanac.com/articles/biomarin-highlights-advanced-genetic-disease-therapy-pipeline 2017-10-24 16:47:19.567+00 https://www.pharmasalmanac.com/articles/fighting-opioid-abuse-axial-healthcare-rolls-out-new-it-based-care-platform 2017-10-24 16:38:28.515+00 https://www.pharmasalmanac.com/articles/abzena-and-uga-team-up-to-develop-ms-therapeutic 2017-10-24 16:34:41.402+00 https://www.pharmasalmanac.com/articles/ventria-bioscience-aids-global-fight-against-intestinal-infections-that-threaten-up-to-400-million-children-a-year 2017-10-23 15:36:36.033+00 https://www.pharmasalmanac.com/articles/fda-is-tracking-the-impact-of-hurricanes-irma-and-maria-on-drug-production-in-puerto-rico 2017-10-20 16:42:43.537+00 https://www.pharmasalmanac.com/articles/janssen-expands-biomanufacturing-capabilities-in-ireland 2017-10-20 16:26:47.219+00 https://www.pharmasalmanac.com/articles/california-moves-to-increase-transparency-of-prescription-drug-pricing 2017-10-20 16:22:11.503+00 https://www.pharmasalmanac.com/articles/ieee-releases-first-detailed-study-of-blockchain-technology-in-pharma 2017-10-19 20:37:33.077+00 https://www.pharmasalmanac.com/articles/alzheimers-clinical-trial-focused-on-restoring-lost-brain-connections 2017-10-19 20:02:03.329+00 https://www.pharmasalmanac.com/articles/aging-frailty-stem-cell-therapy-advances 2017-10-19 19:27:48.752+00 https://www.pharmasalmanac.com/articles/achieving-successful-treatment-outcomes-through-the-delivery-of-manufacturing-services 2017-10-17 20:44:46.637+00 https://www.pharmasalmanac.com/articles/fda-holds-first-patient-engagement-advisory-committee-meeting 2017-10-17 20:40:52.912+00 https://www.pharmasalmanac.com/articles/subdermal-parkinsons-implant-treatment-in-trials 2017-10-17 20:05:47.736+00 https://www.pharmasalmanac.com/articles/leprosy-vaccine-in-human-trials 2017-10-17 19:16:29.65+00 https://www.pharmasalmanac.com/articles/new-3d-printing-lab-dedicated-to-pharma-opens-in-sweden 2017-10-16 20:14:59.644+00 https://www.pharmasalmanac.com/articles/focusing-on-patient-compliance 2017-10-13 18:03:53.689+00 https://www.pharmasalmanac.com/articles/merck-jj-receive-barda-funding-for-ebola-vaccine-development 2017-10-13 17:24:10.399+00 https://www.pharmasalmanac.com/articles/amgen-and-cytomx-therapeutics-collaborate-on-the-development-of-bispecific-antibodies 2017-10-13 17:19:42.83+00 https://www.pharmasalmanac.com/articles/gene-therapy-stops-neurodegenerative-disease 2017-10-12 16:27:53.039+00 https://www.pharmasalmanac.com/articles/fda-approves-new-implantable-sleep-apnea-treatment 2017-10-12 16:26:22.047+00 https://www.pharmasalmanac.com/articles/bone-marrow-transplant-therapy-gets-monoclonal-antibody-boost 2017-10-12 16:02:34.278+00 https://www.pharmasalmanac.com/articles/trial-for-cancer-treatment-using-microscopic-beads-begins 2017-10-12 15:45:24.973+00 https://www.pharmasalmanac.com/articles/q2-alcami-rigorous-integration-in-a-scalable-development-and-manufacturing-enterprise-to-support-continued-growth-of-biopharmaceuticals 2017-10-12 14:54:01.922+00 https://www.pharmasalmanac.com/articles/study-demonstrates-benefit-of-wests-id-adapter-for-improving-intradermal-administration-of-polio-vaccine 2017-10-11 22:39:01.471+00 https://www.pharmasalmanac.com/articles/russian-pharma-market-offers-great-potential-for-local-manufacturers 2017-10-11 20:36:50.673+00 https://www.pharmasalmanac.com/articles/new-insulin-formulation-improves-mealtime-glycemic-control 2017-10-10 19:08:01.349+00 https://www.pharmasalmanac.com/articles/gsks-flonase-goes-to-market-with-smart-shelf-solution 2017-10-10 18:39:32.472+00 https://www.pharmasalmanac.com/articles/biotechs-collaborate-to-develop-multifunctional-cancer-immunotherapies 2017-10-10 18:33:34.139+00 https://www.pharmasalmanac.com/articles/energizing-client-portfolios-with-patient-friendly-dosage-forms 2017-10-07 17:33:53.219+00 https://www.pharmasalmanac.com/articles/new-plant-will-supply-large-numbers-of-genetically-modified-mosquitos 2017-10-06 16:03:09.846+00 https://www.pharmasalmanac.com/articles/eli-lilly-gets-early-approval-for-breast-cancer-drug 2017-10-06 15:58:21.686+00 https://www.pharmasalmanac.com/articles/amgen-to-co-develop-biosimilars-for-chinese-market-with-simcere-pharmaceutical-group 2017-10-06 15:56:38.977+00 https://www.pharmasalmanac.com/articles/fda-attracts-big-tech-companies-in-effort-to-develop-digital-health-apps 2017-10-06 15:50:12.049+00 https://www.pharmasalmanac.com/articles/pre-filled-syringe-technology-benefits-patients-healthcare-providers-and-drug-makers 2017-10-05 16:35:24.46+00 https://www.pharmasalmanac.com/articles/printing-human-organs-one-step-closer-to-reality 2017-10-03 21:58:17.652+00 https://www.pharmasalmanac.com/articles/nih-funds-novel-small-molecule-approach-to-interrupt-alzheimers-dementia 2017-10-03 21:29:10.186+00 https://www.pharmasalmanac.com/articles/brammer-bio-leverages-advanced-bioprocessing-technologies-to-accelerate-capacity 2017-10-03 19:31:26.048+00 https://www.pharmasalmanac.com/articles/fda-approves-grifols-prolastin-c-liquid 2017-10-03 18:19:54.419+00 https://www.pharmasalmanac.com/articles/facility-expansion-at-abzena 2017-10-02 22:14:02.174+00 https://www.pharmasalmanac.com/articles/recipharm-and-roche-enter-strategic-manufacturing-pact 2017-09-29 15:05:32.685+00 https://www.pharmasalmanac.com/articles/potential-breakthrough-hiv/aids-intervention-developed 2017-09-29 14:52:26.654+00 https://www.pharmasalmanac.com/articles/dna-binding-protein-may-increase-ovarian-cancer-survival 2017-09-29 14:51:50.881+00 https://www.pharmasalmanac.com/articles/modeling-mechanisms-for-crossing-the-blood-brain-barrier 2017-09-29 14:16:00.214+00 https://www.pharmasalmanac.com/articles/catalent-acquires-cook-pharmica 2017-09-26 19:35:12.436+00 https://www.pharmasalmanac.com/articles/alliance-aims-to-develop-novel-mass-spectrometry-sample-handling-technology 2017-09-26 17:04:13.15+00 https://www.pharmasalmanac.com/articles/fda-approves-first-biosimilar-treatment-for-multiple-cancers 2017-09-26 16:57:45.287+00 https://www.pharmasalmanac.com/articles/ajinomoto-althea-set-to-open-new-capacity-in-san-diego 2017-09-26 16:53:26.431+00 https://www.pharmasalmanac.com/articles/gsk-shingles-vaccine-recommended-for-approval-by-fda-panel 2017-09-21 19:18:49.433+00 https://www.pharmasalmanac.com/articles/new-cdmo/cro-collaboration-announced 2017-09-21 18:50:05.991+00 https://www.pharmasalmanac.com/articles/chinese-biopharmaceutical-company-acquires-a-canada-based-cdmo 2017-09-21 18:49:18.664+00 https://www.pharmasalmanac.com/articles/new-organ-on-a-chip-designed-to-model-influenza-virus-infections 2017-09-21 18:05:50.308+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-announces-release-of-joint-white-paper-with-domino-on-ink-leachability-in-pharmaceutical-serialization 2017-09-20 21:01:04.092+00 https://www.pharmasalmanac.com/articles/mitigating-shortages-of-injectable-drugs-in-the-united-states 2017-09-20 20:47:40.145+00 https://www.pharmasalmanac.com/articles/ohara-technologies-inc.-evonik-colorcon-and-techceuticals-llc-to-provide-solid-dose-pharmaceuticals-technologies-training-at-federal-equipment-company 2017-09-20 20:34:29.522+00 https://www.pharmasalmanac.com/articles/upm-designing-effective-drug-formulations-keys-to-successful-proof-of-concept-services 2017-09-19 18:58:34.259+00 https://www.pharmasalmanac.com/articles/findings-suggest-low-cal-sweeteners-pose-no-increased-diabetes-risk 2017-09-19 18:30:15.257+00 https://www.pharmasalmanac.com/articles/fda-green-lights-mobile-app-to-help-treat-drug-abuse 2017-09-19 16:56:55.803+00 https://www.pharmasalmanac.com/articles/big-data-alliance-aims-to-advance-cancer-treatments 2017-09-19 16:50:46.62+00 https://www.pharmasalmanac.com/articles/gsk-and-innoviva-present-positive-results-from-pioneering-asthma-study 2017-09-19 16:46:59.804+00 https://www.pharmasalmanac.com/articles/veeva-vault-etmf-helps-cancer-research-uk-improve-clinical-trial-efficiency-and-compliance 2017-09-18 22:17:33.591+00 https://www.pharmasalmanac.com/articles/milliporesigma-expands-celonics-upstream-capabilities-with-mobius-single-use-bioreactors 2017-09-18 22:15:29.881+00 https://www.pharmasalmanac.com/articles/managing-the-complexity-of-global-clinical-logistics-for-next-generation-personalized-medicines 2017-09-15 21:15:10.196+00 https://www.pharmasalmanac.com/articles/combining-content-and-research-in-a-single-website-platform 2017-09-15 21:12:46.411+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-in-review 2017-09-15 21:09:45.612+00 https://www.pharmasalmanac.com/articles/baxter-expands-generic-injectables-portfolio-with-claris-injectables-acquisition 2017-09-15 18:53:33.606+00 https://www.pharmasalmanac.com/articles/pfizer-gets-second-adc-approval-in-2017 2017-09-15 18:17:22.564+00 https://www.pharmasalmanac.com/articles/pharma-contract-services-consolidation-wave-continues 2017-09-15 18:14:04.797+00 https://www.pharmasalmanac.com/articles/evolving-role-of-the-process-architect 2017-09-15 18:13:03.322+00 https://www.pharmasalmanac.com/articles/stronger-than-ever 2017-09-15 18:10:00.477+00 https://www.pharmasalmanac.com/articles/fighting-prescription-drug-abuse-with-demonstrated-abuse-deterrent-formulations 2017-09-15 18:04:02.832+00 https://www.pharmasalmanac.com/articles/upm-pushes-forward-with-serialization-efforts 2017-09-15 18:02:57.255+00 https://www.pharmasalmanac.com/articles/the-cdmo-and-the-international-supply-chain 2017-09-15 17:59:07.307+00 https://www.pharmasalmanac.com/articles/building-strategic-sponsor-cro-partnerships 2017-09-15 13:00:49.397+00 https://www.pharmasalmanac.com/articles/perfusion-appears-to-be-gaining-traction-in-biopharma-manufacturing 2017-09-14 20:31:27.715+00 https://www.pharmasalmanac.com/articles/becoming-bioavailable 2017-09-14 20:29:20.503+00 https://www.pharmasalmanac.com/articles/mergers-acquisitions-combining-market-segments 2017-09-14 19:53:23.412+00 https://www.pharmasalmanac.com/articles/oral-solid-dose-manufacturing-efficiency-is-driving-new-attention-to-plant-design 2017-09-14 18:20:41.864+00 https://www.pharmasalmanac.com/articles/marken-launches-new-marketing-campaign 2017-09-13 18:33:59.164+00 https://www.pharmasalmanac.com/articles/astrazenecas-tagrisso-osimertinib-shows-potential-as-a-new-standard-of-care-in-1st-line-egfr-mutated-non-small-cell-lung-cancer-at-esmo-2017-congress 2017-09-13 17:05:16.09+00 https://www.pharmasalmanac.com/articles/post-approval-studies-confirm-therapeutic-value-of-oral-anticoagulants 2017-09-13 16:52:00.308+00 https://www.pharmasalmanac.com/articles/axion-biosystems-introduces-the-maestro-pro-and-maestro-edge-platforms 2017-09-12 19:12:27.196+00 https://www.pharmasalmanac.com/articles/results-from-the-injourney-trial-investigating-ofev-with-add-on-pirfenidone-provide-new-insights-into-this-combination-treatment-for-ipf 2017-09-12 19:00:11.634+00 https://www.pharmasalmanac.com/articles/upm-pharmaceuticals-successfully-serializes-its-first-pharmaceutical-product 2017-09-12 18:56:18.838+00 https://www.pharmasalmanac.com/articles/pci-announces-further-investment-in-specialized-labeling-capabilities 2017-09-12 18:55:18.698+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-achieves-good-growth-in-the-first-half-of-2017 2017-09-12 18:09:47.527+00 https://www.pharmasalmanac.com/articles/new-entamoeba-histolytica-monoclonal-antibodies 2017-09-12 18:02:58.069+00 https://www.pharmasalmanac.com/articles/women-gain-new-control-over-mammogram-discomfort 2017-09-12 16:43:02.882+00 https://www.pharmasalmanac.com/articles/cladribine-demonstrates-disease-control-with-shorter-course-treatment 2017-09-12 16:38:45.794+00 https://www.pharmasalmanac.com/articles/carlyle-group-gtcr-complete-amri-acquisition 2017-09-12 16:37:59.787+00 https://www.pharmasalmanac.com/articles/analysis-confirms-majority-of-americans-are-misusing-their-prescriptions 2017-09-12 16:37:17.758+00 https://www.pharmasalmanac.com/articles/us-now-has-an-approved-treatment-for-chagas-disease 2017-09-08 17:07:06.998+00 https://www.pharmasalmanac.com/articles/another-biosimilar-gets-fda-nod 2017-09-08 16:59:01.215+00 https://www.pharmasalmanac.com/articles/collaborations-within-fda-intended-to-improve-facility-inspections-and-facilitate-drug-approvals 2017-09-08 16:54:02.99+00 https://www.pharmasalmanac.com/articles/protein-sciences-officially-part-of-sanofi 2017-09-08 16:51:31.449+00 https://www.pharmasalmanac.com/articles/attracting-investors-and-shortening-development-times 2017-09-07 20:46:51.5+00 https://www.pharmasalmanac.com/articles/10x-genomics-appoints-mathai-mammen-m.d.-ph.d.-to-its-board-of-directors 2017-09-07 20:41:22.635+00 https://www.pharmasalmanac.com/articles/bonti-announces-start-of-lantern-1-phase-2-clinical-study-evaluating-eb-001-in-reducing-musculoskeletal-pain 2017-09-07 20:23:00.78+00 https://www.pharmasalmanac.com/articles/ibio-institute-announces-honorees-of-11th-annual-icon-awards 2017-09-07 20:04:17.642+00 https://www.pharmasalmanac.com/articles/dr.-reddys-laboratories-announces-the-out-licensing-of-dfd-06-to-encore-dermatology 2017-09-07 20:03:26.213+00 https://www.pharmasalmanac.com/articles/providing-a-complete-modular-solution 2017-09-07 16:48:13.978+00 https://www.pharmasalmanac.com/articles/magnetic-bead-technology-activates-novartis-car-t-therapy 2017-09-05 17:10:30.297+00 https://www.pharmasalmanac.com/articles/novel-genetic-test-helps-confirm-opioid-addiction-risk 2017-09-05 17:10:15.192+00 https://www.pharmasalmanac.com/articles/samsung-to-develop-novel-drugs 2017-09-01 22:05:53.41+00 https://www.pharmasalmanac.com/articles/lilly-tackling-autoimmune-diseases-using-antigen-technology-from-topas-therapeutics 2017-09-01 18:59:11.95+00 https://www.pharmasalmanac.com/articles/pharma-manufacturers-now-have-fda-draft-guidance-on-securing-the-drug-supply-chain 2017-09-01 18:54:20.084+00 https://www.pharmasalmanac.com/articles/aptuit-acquisition-completed-by-evotec 2017-09-01 18:14:40.523+00 https://www.pharmasalmanac.com/articles/pharmapack-much-more-than-packages 2017-08-30 16:46:45.847+00 https://www.pharmasalmanac.com/articles/pharmapack-a-glass-half-full 2017-08-30 16:46:13.529+00 https://www.pharmasalmanac.com/articles/serialization-and-standardization-the-challenge 2017-08-30 16:45:46.795+00 https://www.pharmasalmanac.com/articles/pharmapack-2017-innovations-in-medical-devices 2017-08-30 16:44:47.314+00 https://www.pharmasalmanac.com/articles/pharma-packaging-time-to-get-smart 2017-08-30 16:20:41.939+00 https://www.pharmasalmanac.com/articles/fda-ema-complete-mutual-recognition-journey 2017-08-30 16:18:07.315+00 https://www.pharmasalmanac.com/articles/sanofi-lonza-invest-in-large-scale-biologics-partnership 2017-08-30 16:17:10.645+00 https://www.pharmasalmanac.com/articles/european-medical-and-pharma-patent-filings-fell-in-2016 2017-08-30 16:14:42.994+00 https://www.pharmasalmanac.com/articles/fine-industries-sold-to-lianhetech 2017-08-30 16:13:03.018+00 https://www.pharmasalmanac.com/articles/aptuit-in-bacteria-resistance-collaboration 2017-08-30 16:11:46.795+00 https://www.pharmasalmanac.com/articles/charles-river-and-chiesi-to-extend-six-year-partnership 2017-08-30 16:11:06.309+00 https://www.pharmasalmanac.com/articles/fda-warns-two-more-companies 2017-08-30 16:10:22.313+00 https://www.pharmasalmanac.com/articles/optel-vision-launches-preconfigured-serialization-products 2017-08-30 16:09:43.897+00 https://www.pharmasalmanac.com/articles/pfizer-centreone-expands-on-two-fronts 2017-08-30 16:08:35.169+00 https://www.pharmasalmanac.com/articles/piramal-completes-acquisition-of-drug-portfolio-from-mallinckrodt 2017-08-30 16:07:57.817+00 https://www.pharmasalmanac.com/articles/siegfried-sees-rise-in-sales-after-acquisitions 2017-08-30 16:07:14.092+00 https://www.pharmasalmanac.com/articles/fda-approves-breakthrough-cancer-therapy 2017-08-30 16:05:35.302+00 https://www.pharmasalmanac.com/articles/vetters-roth-appointed-to-fraunhofer-advisory-board 2017-08-30 16:04:55.729+00 https://www.pharmasalmanac.com/articles/charles-river-announces-ncg-mouse-model 2017-08-30 16:02:49.833+00 https://www.pharmasalmanac.com/articles/relay-therapeutics-tags-sanjiv-patel-for-ceo-position 2017-08-30 16:02:04.472+00 https://www.pharmasalmanac.com/articles/merck-and-bristol-myers-squibb-extend-partnerships-with-incyte 2017-08-30 16:00:49.814+00 https://www.pharmasalmanac.com/articles/bioprocessing-technologies-dominate-interphex-exhibitor-awards 2017-08-30 16:00:05.757+00 https://www.pharmasalmanac.com/articles/sartorius-acquires-umetrics 2017-08-30 15:59:08.475+00 https://www.pharmasalmanac.com/articles/germfree-bio-introduces-mobile-gmp-cleanroom-platform 2017-08-30 15:58:23.733+00 https://www.pharmasalmanac.com/articles/patheon-leads-in-new-drug-approvals 2017-08-30 15:56:36.181+00 https://www.pharmasalmanac.com/articles/catalent-completes-controlled-temperature-capacity 2017-08-30 15:53:45.348+00 https://www.pharmasalmanac.com/articles/hold-23andme-personal-genome-service-gets-fda-nod 2017-08-30 15:51:55.491+00 https://www.pharmasalmanac.com/articles/bain-capital-cinven-and-stada-make-a-deal 2017-08-30 15:50:18.227+00 https://www.pharmasalmanac.com/articles/rentschler-sharpens-its-competitive-edge 2017-08-30 15:49:17.836+00 https://www.pharmasalmanac.com/articles/topical-drug-formulations-strong-growth-based-on-new-understandings 2017-08-30 15:48:35.912+00 https://www.pharmasalmanac.com/articles/fusion-antibodies-mab-discovery-team-to-speed-antibody-development 2017-08-30 15:47:36.157+00 https://www.pharmasalmanac.com/articles/hold-mestoblasts-stem-cell-therapy-for-heart-failure-reaches-phase-iii 2017-08-30 15:46:15.699+00 https://www.pharmasalmanac.com/articles/famar-expands-into-north-america 2017-08-30 15:44:58.422+00 https://www.pharmasalmanac.com/articles/cobra-biologics-invests-in-gene-therapy 2017-08-30 15:43:49.728+00 https://www.pharmasalmanac.com/articles/the-diagnostic-promise-screening-with-crispr-to-detect-the-zika-virus-and-more 2017-08-30 15:42:50.289+00 https://www.pharmasalmanac.com/articles/bioprocessing-capacity-is-in-high-demand 2017-08-30 15:40:58.045+00 https://www.pharmasalmanac.com/articles/women-in-leadership-forum 2017-08-30 15:40:13.353+00 https://www.pharmasalmanac.com/articles/personalized-car-t-cell-therapy-receives-breakthrough-therapy-designation 2017-08-30 15:39:04.11+00 https://www.pharmasalmanac.com/articles/trulance-gets-veteran-to-pilot-ibs-therapy-launch 2017-08-30 15:36:26.385+00 https://www.pharmasalmanac.com/articles/first-on-label-abuse-deterrent-opioid-approved 2017-08-30 15:35:49.186+00 https://www.pharmasalmanac.com/articles/biosimilar-era-begins-to-blossom 2017-08-30 15:34:40.777+00 https://www.pharmasalmanac.com/articles/medical-cannabis-continues-to-cultivate-innovation 2017-08-30 15:33:07.254+00 https://www.pharmasalmanac.com/articles/sawai-pharmaceutical-acquires-upsher-smith-generics-business 2017-08-30 15:30:11.56+00 https://www.pharmasalmanac.com/articles/takeda-acquisition-followed-by-a-speedy-approval 2017-08-30 15:28:42.055+00 https://www.pharmasalmanac.com/articles/recipharm-delivers-first-serialized-drug-products-in-saudi-arabia 2017-08-30 15:27:36.824+00 https://www.pharmasalmanac.com/articles/demand-for-ovarian-cancer-drugs-forecast-to-increase 2017-08-30 15:26:39.859+00 https://www.pharmasalmanac.com/articles/epa-pollution-expert-dr.-jeffery-morris-added-to-informex-2017-speakers 2017-08-30 15:25:13.426+00 https://www.pharmasalmanac.com/articles/bio-applauds-ustrs-2017-special-301-report-on-global-challenges-to-ip 2017-08-30 15:22:55.884+00 https://www.pharmasalmanac.com/articles/fresenius-kabi-expand-its-generics-and-biosimilars-businesses 2017-08-30 15:20:52.775+00 https://www.pharmasalmanac.com/articles/millipore-sigma-sponsoring-labcentral 2017-08-30 15:19:54.8+00 https://www.pharmasalmanac.com/articles/allergan-zeltiq-aesthetics-acquisition-finalized 2017-08-30 15:19:06.166+00 https://www.pharmasalmanac.com/articles/theres-new-hope-for-keeping-aging-muscles-healthy 2017-08-30 15:17:48.977+00 https://www.pharmasalmanac.com/articles/patheon-adds-sterile-fill/finish-capability-to-greenville-nc-site 2017-08-30 15:16:58.88+00 https://www.pharmasalmanac.com/articles/astrazeneca-pieris-pharmaceuticals-join-forces-to-combat-respiratory-diseases 2017-08-30 15:16:09.999+00 https://www.pharmasalmanac.com/articles/inside-the-immune-system 2017-08-30 15:13:42.615+00 https://www.pharmasalmanac.com/articles/first-new-als-treatment-in-decades-approved-by-fda 2017-08-30 15:12:37.933+00 https://www.pharmasalmanac.com/articles/patheon-acquired-by-thermo-fisher-scientific 2017-08-30 15:11:52.732+00 https://www.pharmasalmanac.com/articles/new-licensing-agreement-could-lead-to-improved-brain-cancer-treatment 2017-08-30 15:10:59.502+00 https://www.pharmasalmanac.com/articles/modeling-patient-specific-kidney-diseases-by-combining-engineered-stem-cells-and-chip-technology 2017-08-30 15:10:26.715+00 https://www.pharmasalmanac.com/articles/pfizer-collaborates-with-gene-editing-company-sangamo-therapeutics-on-hemophilia-a-treatment 2017-08-30 15:09:41.391+00 https://www.pharmasalmanac.com/articles/ambry-genetics-acquired-by-konica-minolta 2017-08-29 21:18:47.466+00 https://www.pharmasalmanac.com/articles/vitamin-c-prostate-cancers-new-foe 2017-08-29 19:40:55.951+00 https://www.pharmasalmanac.com/articles/gilead-sciences-to-fly-kite-pharma-for-11.9-billion 2017-08-29 19:40:44.71+00 https://www.pharmasalmanac.com/articles/multiple-sclerosis-study-first-to-collect-data-from-patient-smartphones 2017-08-29 19:37:37.363+00 https://www.pharmasalmanac.com/articles/collaboration-seeks-novel-pancreatitis-therapies 2017-08-29 19:28:55.55+00 https://www.pharmasalmanac.com/articles/adopting-for-flexibility-overseas-and-at-home 2017-08-25 16:23:17.561+00 https://www.pharmasalmanac.com/articles/tuberculosis-drugs-under-development-in-new-collaboration 2017-08-25 15:50:22.973+00 https://www.pharmasalmanac.com/articles/researchers-at-the-university-of-colorado-develop-new-combination-hepatitis-c-treatment 2017-08-25 15:49:42.945+00 https://www.pharmasalmanac.com/articles/new-fda-draft-guidance-on-manufacturing-changes-for-biologics-issued 2017-08-25 15:45:58.733+00 https://www.pharmasalmanac.com/articles/perrigo-sells-api-business-to-sk-capital 2017-08-25 15:42:24.525+00 https://www.pharmasalmanac.com/articles/bringing-bioscience-to-space 2017-08-25 14:26:29.932+00 https://www.pharmasalmanac.com/articles/inside-out-targeting-proteins-on-cancer-cells 2017-08-25 14:02:49.482+00 https://www.pharmasalmanac.com/articles/harmonizing-development-internationally 2017-08-23 22:20:34.215+00 https://www.pharmasalmanac.com/articles/speeding-development-and-reducing-costs-with-analytical-quality-by-design 2017-08-22 19:51:01.414+00 https://www.pharmasalmanac.com/articles/walgreens-introduces-center-for-health-wellbeing-research-website 2017-08-22 18:47:52.012+00 https://www.pharmasalmanac.com/articles/researchers-equipped-with-new-zika-virus-diagnostic-development-tool 2017-08-22 18:35:38.382+00 https://www.pharmasalmanac.com/articles/wuxi-licenses-ligand-clinical-stage-antibody 2017-08-22 18:26:26.616+00 https://www.pharmasalmanac.com/articles/fda-accepts-vbi-vaccines-ind-to-treat-glioblastoma-multiforme 2017-08-22 18:14:05.199+00 https://www.pharmasalmanac.com/articles/the-fda-reauthorization-act-passes-the-us-senate 2017-08-22 18:08:35.622+00 https://www.pharmasalmanac.com/articles/fda-makes-waves-with-generic-approvals 2017-08-17 22:00:46.143+00 https://www.pharmasalmanac.com/articles/quadruple-myeloma-combination-treatment-study-begins 2017-08-17 21:18:33.616+00 https://www.pharmasalmanac.com/articles/an-existing-diabetes-drug-could-help-patients-with-parkinsons-disease 2017-08-17 20:13:04.947+00 https://www.pharmasalmanac.com/articles/study-projects-an-18-billion-neuroprosthetics-market-by-2028 2017-08-17 15:58:06.107+00 https://www.pharmasalmanac.com/articles/emphasis-on-aggressive-cancer-cells 2017-08-16 17:00:07.14+00 https://www.pharmasalmanac.com/articles/academic-industry-partnership-receives-funds-to-develop-ebola-vaccine 2017-08-15 17:09:44.888+00 https://www.pharmasalmanac.com/articles/genetic-analysis-of-solid-tumors-provides-insight-on-how-they-spread 2017-08-15 15:57:35.974+00 https://www.pharmasalmanac.com/articles/labcorp-makes-another-acquisition 2017-08-15 15:51:43.849+00 https://www.pharmasalmanac.com/articles/designing-a-better-single-use-facility 2017-08-14 18:53:56.787+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-acquiring-ifm-therapeutics-innate-immune-system-stimulators 2017-08-11 19:53:08.782+00 https://www.pharmasalmanac.com/articles/kite-submits-investigational-new-drug-application-for-kite-585 2017-08-11 19:28:25.238+00 https://www.pharmasalmanac.com/articles/cambrex-invests-in-new-highly-potent-api-manufacturing-capacity 2017-08-11 19:22:34.322+00 https://www.pharmasalmanac.com/articles/flow-chemistry-pathway-for-continuous-api-manufacturing 2017-08-11 16:45:07.909+00 https://www.pharmasalmanac.com/articles/focusing-on-clinical-and-research-services 2017-08-09 18:56:28.363+00 https://www.pharmasalmanac.com/articles/a-right-first-time-approach 2017-08-09 18:49:04.586+00 https://www.pharmasalmanac.com/articles/benchtop-scale-with-the-bione 2017-08-09 14:12:27.818+00 https://www.pharmasalmanac.com/articles/a-culture-of-innovation-in-southeast-england 2017-08-09 14:10:12.655+00 https://www.pharmasalmanac.com/articles/an-expanded-depth-of-field-3d-microscopes-for-biotech 2017-08-09 13:58:09.641+00 https://www.pharmasalmanac.com/articles/selectively-building-muscle-with-sar 2017-08-09 13:41:24.932+00 https://www.pharmasalmanac.com/articles/novel-pneumonia-fighter-enters-pivotal-trial 2017-08-08 22:33:38.533+00 https://www.pharmasalmanac.com/articles/collaboration-targets-vaccine-technologies-to-wipe-out-hiv-1-and-hep-b 2017-08-08 22:31:29.994+00 https://www.pharmasalmanac.com/articles/personalized-genetic-screening-launches-in-the-uk 2017-08-08 22:28:47.784+00 https://www.pharmasalmanac.com/articles/the-chemistry-inside-innovation 2017-08-08 21:24:27.938+00 https://www.pharmasalmanac.com/articles/celgenes-first-ever-oral-leukemia-treatment-gets-fda-nod 2017-08-08 18:33:03.208+00 https://www.pharmasalmanac.com/articles/aptuit-acquisition-positions-evotec-for-growth-expansion 2017-08-08 15:31:19.521+00 https://www.pharmasalmanac.com/articles/new-drug-approved-to-prevent-hereditary-angioedema-attacks-now-available-in-the-us 2017-08-04 17:49:47.329+00 https://www.pharmasalmanac.com/articles/harvard-researchers-develop-a-new-adhesive-that-adheres-even-to-wet-wounds 2017-08-04 17:41:58.194+00 https://www.pharmasalmanac.com/articles/wuxi-passes-pre-license-inspection-for-mab-based-hiv-treatment-production 2017-08-04 17:37:16.879+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-expands-biologics-manufacturing-capacity-in-california 2017-08-04 17:30:46.698+00 https://www.pharmasalmanac.com/articles/joint-program-explores-devices-to-treat-gastrointestinal-disease 2017-08-01 17:03:18.011+00 https://www.pharmasalmanac.com/articles/michael-j.-fox-foundation-and-casis-partner-to-grow-parkinsons-protein-in-space 2017-08-01 16:45:27.857+00 https://www.pharmasalmanac.com/articles/lonza-pharmbiotech-constructing-manufacturing-complex-in-switzerland 2017-08-01 16:35:46.08+00 https://www.pharmasalmanac.com/articles/horizon-discovery-acquires-ge-crispr-unit-for-85-million 2017-08-01 16:31:27.601+00 https://www.pharmasalmanac.com/articles/novel-therapy-targets-obesity-linked-disease 2017-08-01 16:06:26.355+00 https://www.pharmasalmanac.com/articles/potential-alzheimers-drug-targets-identified 2017-08-01 16:05:44.849+00 https://www.pharmasalmanac.com/articles/new-method-for-detecting-the-zika-virus-developed 2017-08-01 16:05:06.058+00 https://www.pharmasalmanac.com/articles/chinese-genetics-company-completes-successful-ipo 2017-07-28 13:57:11.142+00 https://www.pharmasalmanac.com/articles/jefferson-health-ge-healthcare-collaborate-on-healthcare-delivery 2017-07-25 17:24:16.585+00 https://www.pharmasalmanac.com/articles/emergent-biosolutions-expands-its-drug-portfolio-through-two-acquisitions 2017-07-25 17:16:53.598+00 https://www.pharmasalmanac.com/articles/telix-and-obi-license-abzena-cancer-fighters 2017-07-25 16:17:22.089+00 https://www.pharmasalmanac.com/articles/vosevi-hepatitis-c-treatment-approved-by-the-fda 2017-07-25 16:12:50.36+00 https://www.pharmasalmanac.com/articles/protein-sciences-snapped-up-by-sanofi 2017-07-21 17:33:07.676+00 https://www.pharmasalmanac.com/articles/can-cells-replace-computers 2017-07-21 16:20:23.374+00 https://www.pharmasalmanac.com/articles/fda-recommends-approval-of-mylans-trastuzumab-biosimilar 2017-07-21 15:46:35.026+00 https://www.pharmasalmanac.com/articles/johnson-johnson-gets-fda-nod-for-new-treatment-for-plaque-psoriasis 2017-07-21 15:31:15.133+00 https://www.pharmasalmanac.com/articles/the-future-of-uniquely-delivered-drugs-and-adcs 2017-07-21 15:19:13.112+00 https://www.pharmasalmanac.com/articles/competition-yields-benefits-for-pharma-companies-outsourcing-api-manufacturing 2017-07-19 15:44:23.387+00 https://www.pharmasalmanac.com/articles/q4-2015-bolstering-capabilities-for-parenteral-drug-development-and-manufacturing 2017-07-19 15:25:56.71+00 https://www.pharmasalmanac.com/articles/pfizers-mylotarg-demonstrates-favorable-profile 2017-07-18 19:52:30.967+00 https://www.pharmasalmanac.com/articles/regenerating-knee-cartilage-with-stem-cells 2017-07-18 19:48:59.417+00 https://www.pharmasalmanac.com/articles/science-exchange-raises-28-million-in-series-c-funding 2017-07-18 19:48:34.62+00 https://www.pharmasalmanac.com/articles/single-use-bioreactor-capacity-reaches-4000l 2017-07-17 13:22:54.455+00 https://www.pharmasalmanac.com/articles/celgene-makes-moves-in-china 2017-07-13 18:26:57.155+00 https://www.pharmasalmanac.com/articles/fda-received-ind-from-shire-for-a-new-gene-therapy-to-treat-hemophilia-a 2017-07-13 18:06:29.304+00 https://www.pharmasalmanac.com/articles/lillys-breast-cancer-treatment-granted-priority-review 2017-07-13 16:13:50.666+00 https://www.pharmasalmanac.com/articles/new-class-of-antibiotics-looks-promising 2017-07-13 16:02:50.948+00 https://www.pharmasalmanac.com/articles/new-diagnostics-agent-designed-to-identify-circulating-tumor-cells 2017-07-11 21:50:59.644+00 https://www.pharmasalmanac.com/articles/new-sickle-cell-treatment-approved 2017-07-11 18:14:28.829+00 https://www.pharmasalmanac.com/articles/agilent-acquires-cobalt-a-raman-innovator 2017-07-11 18:11:52.246+00 https://www.pharmasalmanac.com/articles/amgens-vectibix-approved-for-ras-metastatic-colorectal-cancer 2017-07-11 18:08:14.321+00 https://www.pharmasalmanac.com/articles/unjamming-the-orphan-drug-backlog 2017-07-11 15:50:07.867+00 https://www.pharmasalmanac.com/articles/moving-quality-to-the-forefront-brings-measurable-results 2017-07-11 15:28:00.044+00 https://www.pharmasalmanac.com/articles/research-collaboration-will-focus-on-the-development-of-new-car-t-cell-treatments 2017-07-10 13:14:36.868+00 https://www.pharmasalmanac.com/articles/new-partnership-to-tackle-challenging-infectious-diseases 2017-07-07 20:34:05.177+00 https://www.pharmasalmanac.com/articles/patheon-invests-45-million-to-fuel-growth 2017-07-07 20:32:25.683+00 https://www.pharmasalmanac.com/articles/roundtable-question-3 2017-07-07 14:58:38.815+00 https://www.pharmasalmanac.com/articles/cmc-achieving-continuous-downstream-bioprocessing 2017-07-03 17:09:06.257+00 https://www.pharmasalmanac.com/articles/pfizer-breaks-new-ground-in-missouri 2017-07-03 16:10:21.912+00 https://www.pharmasalmanac.com/articles/fda-moves-to-improve-patient-access 2017-07-03 15:43:48.566+00 https://www.pharmasalmanac.com/articles/breckenridge-wins-anda-for-azacitidine 2017-07-03 15:43:24.468+00 https://www.pharmasalmanac.com/articles/ema-approves-continuous-manufacture-of-prezista 2017-07-03 15:42:55.717+00 https://www.pharmasalmanac.com/articles/new-partnership-targets-colorectal-cancer-with-combination-therapy-including-avelumab 2017-07-03 14:14:11.135+00 https://www.pharmasalmanac.com/articles/new-report-predicts-singapore-pharma-market-worth-more-than-1-billion-by-2019 2017-06-29 20:16:08.841+00 https://www.pharmasalmanac.com/articles/connecting-the-dots-for-clients 2017-06-29 19:43:49.83+00 https://www.pharmasalmanac.com/articles/biopharmaceutical-manufacturing-goes-mainstream 2017-06-29 19:36:33.224+00 https://www.pharmasalmanac.com/articles/new-technology-allows-imaging-of-complex-molecular-processes 2017-06-29 18:54:07.896+00 https://www.pharmasalmanac.com/articles/fda-approves-two-drugs-for-the-treatment-of-adhd 2017-06-29 18:44:51.405+00 https://www.pharmasalmanac.com/articles/fdas-gottlieb-weighs-in-on-the-drug-quality-and-security-act-dqsa 2017-06-27 21:03:29.847+00 https://www.pharmasalmanac.com/articles/recombinant-flu-vaccine-outperforms-egg-based-alternatives 2017-06-27 20:21:37.401+00 https://www.pharmasalmanac.com/articles/q2-ash-stevens-process-safety-evaluations-crucial-to-successful-cdmo-operations 2017-06-23 18:33:43.198+00 https://www.pharmasalmanac.com/articles/upsher-smith-laboratories-generics-business-now-part-of-sawai-pharmaceutical 2017-06-23 17:48:05.355+00 https://www.pharmasalmanac.com/articles/trends-in-excipient-demand 2017-06-23 17:24:44.877+00 https://www.pharmasalmanac.com/articles/number-of-new-collaborations-announced-by-johnson-johnson-innovation 2017-06-23 15:37:07.648+00 https://www.pharmasalmanac.com/articles/biosimilar-manufacturers-get-favorable-decision-from-us-supreme-court 2017-06-23 15:36:04.729+00 https://www.pharmasalmanac.com/articles/harvard-university-researchers-develop-ultrasound/nanoparticle-method-for-targeted-delivery-of-chemotherapeutics 2017-06-23 15:35:34.3+00 https://www.pharmasalmanac.com/articles/the-new-wave-in-cancer-screening-liquid-biopsy-testing 2017-06-23 15:34:18.166+00 https://www.pharmasalmanac.com/articles/biologics-driving-force-in-pharma 2017-06-20 20:17:18.465+00 https://www.pharmasalmanac.com/articles/checkmate-pharmaceuticals-receives-series-b-funding-for-cmp-001 2017-06-20 16:38:04.141+00 https://www.pharmasalmanac.com/articles/sanofi-will-increase-investments-in-biologics 2017-06-20 16:36:43.776+00 https://www.pharmasalmanac.com/articles/fda-fast-track-designation-granted-for-pfizer-and-eli-lillys-innovative-pain-treatment 2017-06-20 16:35:54.078+00 https://www.pharmasalmanac.com/articles/3d-patch-reduces-ischemia-in-mouse-models 2017-06-20 16:30:47.39+00 https://www.pharmasalmanac.com/articles/the-impact-of-wearable-health-monitoring-tools-on-contract-research-organizations-cros 2017-06-20 16:02:17.055+00 https://www.pharmasalmanac.com/articles/whats-new-in-bio-analysis 2017-06-20 14:47:31.809+00 https://www.pharmasalmanac.com/articles/takeda-begins-expansion-of-its-manufacturing-footprint-in-ireland 2017-06-16 19:22:59.143+00 https://www.pharmasalmanac.com/articles/roche-cmv-viral-load-test-platform-gets-fda-nod 2017-06-15 20:20:53.432+00 https://www.pharmasalmanac.com/articles/boston-and-san-francisco-are-the-top-biotech-clusters 2017-06-13 22:03:27.974+00 https://www.pharmasalmanac.com/articles/cros-move-to-fill-the-gap 2017-06-13 22:01:25.596+00 https://www.pharmasalmanac.com/articles/pfizer-gets-fda-advisory-committee-nod-for-biosimilar 2017-06-08 19:37:33.616+00 https://www.pharmasalmanac.com/articles/cardio-candidate-to-be-manufactured-continuously 2017-06-08 16:40:35.913+00 https://www.pharmasalmanac.com/articles/merck-signs-global-license-agreement-for-potential-treatment-for-alzheimers-disease 2017-06-08 16:38:23.549+00 https://www.pharmasalmanac.com/articles/new-data-may-lead-to-the-development-of-drugs-to-prevent-heart-problems-in-diabetics 2017-06-08 16:35:17.726+00 https://www.pharmasalmanac.com/articles/pharma-revs-up-cancer-fighting-car-t-cell-therapy 2017-06-08 16:01:23.949+00 https://www.pharmasalmanac.com/articles/behind-the-rfp-project-optimization-and-technology-integration 2017-06-08 14:14:40.097+00 https://www.pharmasalmanac.com/articles/fit-biopharmaceutical-facilities-a-predictive-maintenance-approach 2017-06-07 18:13:56.069+00 https://www.pharmasalmanac.com/articles/making-real-time-process-analytical-technology-in-biomanufacturing-a-reality 2017-06-07 16:52:22.416+00 https://www.pharmasalmanac.com/articles/serialization-the-first-steps-in-sales-unit-traceability-and-data-management 2017-06-07 14:49:24.502+00 https://www.pharmasalmanac.com/articles/supporting-the-tech-transfer-continuum-for-cell-gene-therapies 2017-06-07 14:37:40.636+00 https://www.pharmasalmanac.com/articles/propagating-a-full-spectrum-of-services-for-adc-development-and-manufacture 2017-06-07 13:59:21.909+00 https://www.pharmasalmanac.com/articles/building-a-one-stop-shop-cdmo-for-biopharmaceuticals 2017-06-06 22:12:38.934+00 https://www.pharmasalmanac.com/articles/growing-through-consolidation 2017-06-06 21:59:04.051+00 https://www.pharmasalmanac.com/articles/four-keys-to-successful-biopharmaceutical-outsourcing-technical-expertise-quality-reliability-and-timeliness 2017-06-05 21:47:53.775+00 https://www.pharmasalmanac.com/articles/the-search-for-alternative-delivery-methods-continues 2017-06-05 20:30:18.451+00 https://www.pharmasalmanac.com/articles/clinical-trials-find-a-device-for-growth 2017-06-05 20:29:41.491+00 https://www.pharmasalmanac.com/articles/small-molecule-injectable-manufacturing-challenges-and-complexities 2017-06-05 20:07:23.848+00 https://www.pharmasalmanac.com/articles/particle-engineering-for-improved-bioavailability-in-oral-solid-dose-medications 2017-06-05 20:06:38.066+00 https://www.pharmasalmanac.com/articles/the-peoples-choice-premeasured-single-dosage-forms 2017-06-05 19:51:25.042+00 https://www.pharmasalmanac.com/articles/how-is-growth-in-the-biosimilars-market-impacting-the-development-of-new-biologics-manufacturing-equipment-technologies 2017-06-05 18:31:06.486+00 https://www.pharmasalmanac.com/articles/fit-biopharmaceutical-facilities-a-predictive-maintenance-approach-0 2017-06-05 18:29:03.587+00 https://www.pharmasalmanac.com/articles/the-road-to-biologics-continued-success 2017-06-05 18:24:22.734+00 https://www.pharmasalmanac.com/articles/making-strides-biologics-push-forward 2017-06-05 18:20:35.128+00 https://www.pharmasalmanac.com/articles/if-you-could-have-one-piece-of-biologic-manufacturing-equipment-improved-what-would-it-be-and-why 2017-06-05 18:14:48.942+00 https://www.pharmasalmanac.com/articles/from-blobs-to-hearts-understanding-the-3d-bioprinting-revolution 2017-06-05 18:14:11.218+00 https://www.pharmasalmanac.com/articles/implications-of-serialization-for-the-u.s.-pharma-industry 2017-06-05 17:26:25.197+00 https://www.pharmasalmanac.com/articles/bringing-the-supply-chain-together-to-tackle-development-challenges 2017-06-05 16:16:38.013+00 https://www.pharmasalmanac.com/articles/has-downstream-processing-technology-caught-up-with-the-significantly-higher-titers-coming-out-of-the-current-upstream-process-if-no-what-issues-remain-0 2017-06-05 16:15:18.142+00 https://www.pharmasalmanac.com/articles/advancing-clinical-trial-efficiency-with-electronic-informed-consent 2017-06-05 14:03:52.234+00 https://www.pharmasalmanac.com/articles/facilitating-tech-transfer-for-parenteral-products 2017-05-31 21:30:54.423+00 https://www.pharmasalmanac.com/articles/hiv-vaccine-demonstrates-remarkable-rates 2017-05-31 20:09:28.38+00 https://www.pharmasalmanac.com/articles/top-biotech-companies-still-at-home-in-ireland 2017-05-31 20:08:49.738+00 https://www.pharmasalmanac.com/articles/bioverativ-to-acquire-true-north 2017-05-31 19:10:55.491+00 https://www.pharmasalmanac.com/articles/the-link-between-cancer-and-the-flu-virus 2017-05-31 19:09:58.503+00 https://www.pharmasalmanac.com/articles/priority-review-given-to-kites-axicabtagene-ciloleucel 2017-05-31 19:09:07.13+00 https://www.pharmasalmanac.com/articles/bristol-meyers-squibb-array-biopharma-enter-strategic-collaboration 2017-05-31 19:08:46.376+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-expands-its-contract-manufacturing-footprint-in-china 2017-05-25 21:27:34.434+00 https://www.pharmasalmanac.com/articles/milliporesigma-increases-the-efficiency-of-gene-editing 2017-05-25 21:26:42.693+00 https://www.pharmasalmanac.com/articles/biovectra-inc.-to-increase-capacity 2017-05-25 21:17:09.514+00 https://www.pharmasalmanac.com/articles/keeping-track-of-antibiotic-resistance-just-got-easier 2017-05-25 21:12:04.887+00 https://www.pharmasalmanac.com/articles/common-biomarker-guides-new-cancer-therapy 2017-05-25 21:10:54.259+00 https://www.pharmasalmanac.com/articles/spending-on-excipients-grows-diversifies 2017-05-25 14:29:19.786+00 https://www.pharmasalmanac.com/articles/trends-in-the-topical-delivery-of-dermatology-medications 2017-05-25 14:07:15.699+00 https://www.pharmasalmanac.com/articles/the-cost-of-pain 2017-05-23 21:59:49.39+00 https://www.pharmasalmanac.com/articles/fresh-ra-treatment-from-sanofi/regeneron-approved 2017-05-23 21:57:11.136+00 https://www.pharmasalmanac.com/articles/astellas-completes-acquisition-of-ogeda 2017-05-23 21:31:30.94+00 https://www.pharmasalmanac.com/articles/facilities-for-the-future 2017-05-23 21:28:25.334+00 https://www.pharmasalmanac.com/articles/new-ventures-in-the-microbiome 2017-05-23 20:36:19.417+00 https://www.pharmasalmanac.com/articles/pharmas-back-to-nature-trend 2017-05-23 20:34:39.449+00 https://www.pharmasalmanac.com/articles/cfda-calls-for-clinical-trial-reform 2017-05-23 20:26:46.207+00 https://www.pharmasalmanac.com/articles/johnson-johnson-looks-forward-to-ten-blockbuster-drugs-by-2021 2017-05-23 20:25:47.134+00 https://www.pharmasalmanac.com/articles/hovione-dry-powder-inhalation-formulation-balancing-performance-and-manufacturability 2017-05-22 18:58:33.907+00 https://www.pharmasalmanac.com/articles/x-ray-and-inspection-solutions-for-quality-control 2017-05-16 15:21:03.916+00 https://www.pharmasalmanac.com/articles/a-fill-line-is-more-than-just-a-fill-line-incorporating-whats-hidden-in-facilities 2017-05-12 22:41:40.47+00 https://www.pharmasalmanac.com/articles/manufacturing-precision-machines 2017-05-11 21:48:50.104+00 https://www.pharmasalmanac.com/articles/pharmas-great-automation-migration 2017-05-11 20:15:18.576+00 https://www.pharmasalmanac.com/articles/creating-a-unique-cleanroom-faster 2017-05-09 22:54:01.882+00 https://www.pharmasalmanac.com/articles/the-move-towards-modularity 2017-05-09 21:07:04.827+00 https://www.pharmasalmanac.com/articles/quantum-leaps-in-continuous-processing-and-tablet-imprinting 2017-05-09 21:06:05.021+00 https://www.pharmasalmanac.com/articles/expanding-into-clinical-trials 2017-05-09 21:04:35.199+00 https://www.pharmasalmanac.com/articles/local-vs.-global-manufacturing-1 2017-05-09 20:37:51.618+00 https://www.pharmasalmanac.com/articles/increasing-productivity-and-profitability 2017-05-09 13:40:07.39+00 https://www.pharmasalmanac.com/articles/big-data-a-big-challenge 2017-05-08 13:52:50.613+00 https://www.pharmasalmanac.com/articles/moving-the-industry-forward 2017-05-05 21:48:51.431+00 https://www.pharmasalmanac.com/articles/latest-developments-in-cellular-and-gene-therapies 2017-05-05 20:53:02.205+00 https://www.pharmasalmanac.com/articles/the-mission-of-commissioning-agents-inc 2017-05-05 20:39:33.921+00 https://www.pharmasalmanac.com/articles/q2-roundtable-biosimilar-roundtable-are-we-on-the-edge-of-a-new-era-of-biologics-what-will-the-biosimilars-landscape-look-like-in-the-next-10-years 2017-05-04 22:22:40.114+00 https://www.pharmasalmanac.com/articles/batch-to-continuous-changing-customer-mindset 2017-05-03 21:54:11.105+00 https://www.pharmasalmanac.com/articles/engineering-machines-for-solid-dosage-forms-and-the-global-market 2017-05-03 19:56:14.887+00 https://www.pharmasalmanac.com/articles/innovation-and-formulation 2017-05-03 19:12:53.608+00 https://www.pharmasalmanac.com/articles/trends-in-pharma-lyophilization-evolution-and-aggressive-molecules 2017-05-03 19:12:07.273+00 https://www.pharmasalmanac.com/articles/acoustics-for-separation-and-filtration-of-applications 2017-05-03 19:08:16.541+00 https://www.pharmasalmanac.com/articles/better-data-in-bioprocessing 2017-05-03 18:19:17.321+00 https://www.pharmasalmanac.com/articles/formulation-challenges-drive-interest-in-cdmos 2017-04-30 21:23:32.746+00 https://www.pharmasalmanac.com/articles/q1-hovione-continuous-processing-meeting-the-need-for-new-manufacturing-strategies 2017-04-28 16:32:02.52+00 https://www.pharmasalmanac.com/articles/combinational-immunotherapies-the-bright-future-of-cancer-treatment 2017-04-27 21:52:45.224+00 https://www.pharmasalmanac.com/articles/coping-with-the-data-avalanche 2017-04-22 17:43:54.909+00 https://www.pharmasalmanac.com/articles/integrating-innovation-fostering-the-new-growth-in-pharma 2017-04-21 21:23:49.248+00 https://www.pharmasalmanac.com/articles/servier-cultivating-a-proactive-quality-culture 2017-04-21 20:46:54.912+00 https://www.pharmasalmanac.com/articles/q4-2015-merge-digital-automation-in-clinical-trials-the-promise-and-potential 2017-04-21 20:22:25.618+00 https://www.pharmasalmanac.com/articles/q1-cmc-advancing-biologics-development-and-manufacturing 2017-04-21 20:20:18.691+00 https://www.pharmasalmanac.com/articles/q2-cmc-bio-scale-down-models-an-indispensable-tool-to-biopharmaceutical-process-development 2017-04-21 20:19:46.336+00 https://www.pharmasalmanac.com/articles/qa-with-guido-driesen-capsugels-transformation 2017-04-21 20:17:28.067+00 https://www.pharmasalmanac.com/articles/q4-2015-tn-special-focus-achieving-strong-customer-perception-the-customer-experience 2017-04-21 20:17:03.726+00 https://www.pharmasalmanac.com/articles/alcami-supply-chain-management-and-the-importance-of-security-of-supply 2017-04-21 20:14:36.562+00 https://www.pharmasalmanac.com/articles/q1-alcami-strengthening-cdmos-to-meet-industry-needs-for-2016-and-beyond 2017-04-21 20:13:17.581+00 https://www.pharmasalmanac.com/articles/ash-stevens-meeting-unmet-patient-needs-with-small-volume-apis 2017-04-21 19:34:18.611+00 https://www.pharmasalmanac.com/articles/q1-ash-stevens-growing-demand-for-small-molecule-cdmo-services 2017-04-21 19:22:13.689+00 https://www.pharmasalmanac.com/articles/keys-to-cultural-integration 2017-04-21 19:14:38.645+00 https://www.pharmasalmanac.com/articles/supporting-the-pharma-industry-small-business-growth-engine 2017-04-21 19:12:54.166+00 https://www.pharmasalmanac.com/articles/meeting-customer-needs 2017-04-21 18:02:11.023+00 https://www.pharmasalmanac.com/articles/managing-equipment-assets-across-multiple-sites 2017-04-20 16:25:15.381+00 https://www.pharmasalmanac.com/articles/designing-facilities 2017-04-20 16:24:33.35+00 https://www.pharmasalmanac.com/articles/oral-solid-dose-train-the-trainer-for-production-personnel 2017-04-20 16:23:04.282+00 https://www.pharmasalmanac.com/articles/direct-to-patient-logistics-and-technology 2017-04-20 16:19:51.303+00 https://www.pharmasalmanac.com/articles/spreading-the-word-in-the-pharma-world-0-1 2017-04-20 16:18:54.747+00 https://www.pharmasalmanac.com/articles/continuous-processing 2017-04-20 16:18:16.064+00 https://www.pharmasalmanac.com/articles/growth-anticipated-for-intermediates 2017-04-18 17:53:57.575+00 https://www.pharmasalmanac.com/articles/co-processed-excipients-help-formulate-better-osds 2017-04-14 20:28:23.525+00 https://www.pharmasalmanac.com/articles/anticipating-future-guidelines-by-utilizing-the-latest-technologies-in-particle-characterization 2017-04-14 15:01:48.118+00 https://www.pharmasalmanac.com/articles/idle-no-longer-strategizing-around-used-equipment 2017-04-13 17:00:27.807+00 https://www.pharmasalmanac.com/articles/making-it-simple 2017-04-12 18:04:28.485+00 https://www.pharmasalmanac.com/articles/microjet-reactor-mjr-for-apis 2017-04-12 18:00:26.19+00 https://www.pharmasalmanac.com/articles/quality-is-everything 2017-04-12 17:55:41.102+00 https://www.pharmasalmanac.com/articles/grand-river-has-come-a-long-way 2017-04-12 17:52:00.964+00 https://www.pharmasalmanac.com/articles/dan-peizer-reveals-catalants-newest-acquisition 2017-04-12 17:46:47.291+00 https://www.pharmasalmanac.com/articles/experience-and-expertise-facilitate-controlled-substance-manufacturing 2017-04-10 18:47:48.01+00 https://www.pharmasalmanac.com/articles/candid-with-the-ceo 2017-04-07 22:31:57.867+00 https://www.pharmasalmanac.com/articles/partnering-for-formulation-development 2017-04-06 22:25:29.981+00 https://www.pharmasalmanac.com/articles/the-capsule-manufacturing-market 2017-04-06 22:25:08.841+00 https://www.pharmasalmanac.com/articles/innovation-is-key 2017-04-06 22:24:43.016+00 https://www.pharmasalmanac.com/articles/the-latest-developments-at-triskelion 2017-04-06 22:24:07.617+00 https://www.pharmasalmanac.com/articles/keeping-it-clean 2017-04-06 22:23:09.889+00 https://www.pharmasalmanac.com/articles/innovative-drug-delivery-technology 2017-04-06 22:22:38.442+00 https://www.pharmasalmanac.com/articles/choosing-the-right-pathway 2017-04-06 22:21:03.307+00 https://www.pharmasalmanac.com/articles/hiring-top-talent-in-pharma 2017-04-06 22:18:52.075+00 https://www.pharmasalmanac.com/articles/whats-trending-for-thermo-fisher 2017-04-06 22:18:14.963+00 https://www.pharmasalmanac.com/articles/making-solvias-solid 2017-04-06 22:17:38.867+00 https://www.pharmasalmanac.com/articles/novel-technologies-in-tablet-manufacturing 2017-04-06 22:16:19.878+00 https://www.pharmasalmanac.com/articles/disease-in-a-dish-creating-human-tissues-in-vitro 2017-04-06 22:15:49.627+00 https://www.pharmasalmanac.com/articles/enhancement-and-availability 2017-04-06 22:15:18.477+00 https://www.pharmasalmanac.com/articles/filling-a-market-need 2017-04-06 22:14:54.189+00 https://www.pharmasalmanac.com/articles/freund-vector-cant-go-wrong-with-granurex 2017-04-06 22:14:22.841+00 https://www.pharmasalmanac.com/articles/a-new-type-of-medicine-biotherapeutics-usher-in-a-new-era 2017-04-06 22:13:54.246+00 https://www.pharmasalmanac.com/articles/an-inside-look-strategy-at-sgs 2017-04-06 22:10:52.567+00 https://www.pharmasalmanac.com/articles/breakthrough-drug-delivery-technology 2017-04-06 22:09:25.978+00 https://www.pharmasalmanac.com/articles/expanding-capabilities 2017-04-06 22:08:31.332+00 https://www.pharmasalmanac.com/articles/whats-new-in-granulation 2017-04-06 22:07:51.475+00 https://www.pharmasalmanac.com/articles/spreading-the-word-in-the-pharma-world 2017-04-06 22:06:55.591+00 https://www.pharmasalmanac.com/articles/avista-pharma-solutions-completes-4-million-expansion 2017-04-05 19:56:54.753+00 https://www.pharmasalmanac.com/articles/understanding-solid-state-properties-for-formulation-success 2017-04-05 19:55:02.501+00 https://www.pharmasalmanac.com/articles/investors-may-look-smaller 2017-04-04 19:24:16.885+00 https://www.pharmasalmanac.com/articles/keeping-the-chain-going 2017-04-04 19:23:52.939+00 https://www.pharmasalmanac.com/articles/equipment-must-integrate 2017-04-04 19:23:19.361+00 https://www.pharmasalmanac.com/articles/spending-on-contract-research-services-slowing-down 2017-04-04 19:21:59.534+00 https://www.pharmasalmanac.com/articles/industry-benchmark-introduction 2017-04-04 19:11:05.946+00 https://www.pharmasalmanac.com/articles/cracking-soils-microbiome-biopesticides-and-plant-biostimulants 2017-04-04 16:38:35.493+00 https://www.pharmasalmanac.com/articles/solvias-continues-on-growth-path 2017-03-30 22:11:05.46+00 https://www.pharmasalmanac.com/articles/spray-drying-enhances-solubility-and-bioavailability 2017-03-30 20:40:19.481+00 https://www.pharmasalmanac.com/articles/cost-forecasting-for-clinical-trial-management 2017-03-30 19:52:47.732+00 https://www.pharmasalmanac.com/articles/q2-nice-consulting-mergers-and-acquisitions-protecting-the-core-and-maximizing-value 2017-03-30 17:20:17.094+00 https://www.pharmasalmanac.com/articles/ways-to-lower-costs-of-clinical-trials-and-how-cros-help 2017-03-30 16:19:18.938+00 https://www.pharmasalmanac.com/articles/the-importance-of-flexibility-competitive-solutions-in-an-era-of-innovation 2017-03-30 16:19:18.935+00 https://www.pharmasalmanac.com/articles/ni-two-promising-small-molecule-orphan-drugs-in-clinical-trials 2017-03-30 16:19:18.921+00 https://www.pharmasalmanac.com/articles/cai-speed-to-market-process-and-capacity-on-demand 2017-03-30 16:18:33.227+00 https://www.pharmasalmanac.com/articles/expanding-trial-data-demands-new-analytical-methods 2017-03-30 16:18:33.224+00 https://www.pharmasalmanac.com/articles/strong-growth-for-cro-market-tox-testing-poses-challenges 2017-03-30 16:18:11.347+00 https://www.pharmasalmanac.com/articles/new-post-the-search-for-practical-and-economical-catalysts 2017-03-30 16:16:29.078+00 https://www.pharmasalmanac.com/articles/operational-excellence-in-outsourced-fill-finish-services 2017-03-30 16:16:10.158+00 https://www.pharmasalmanac.com/articles/ppd-offers-apprenticeships-to-military-veterans 2017-03-30 16:12:45.047+00 https://www.pharmasalmanac.com/articles/fda-approves-bavencio-for-rare-skin-cancer 2017-03-30 16:12:13.44+00 https://www.pharmasalmanac.com/articles/eli-lilly-to-spend-850-million-on-u.s.-manufacturing 2017-03-30 13:55:07.724+00 https://www.pharmasalmanac.com/articles/verona-turns-to-quintilesims-for-drug-development 2017-03-30 13:54:24.383+00 https://www.pharmasalmanac.com/articles/stay-tuned-pharmas-almanac-tv-goes-live 2017-03-29 19:08:37.681+00 https://www.pharmasalmanac.com/articles/q2-hovione-quality-culture-wins-over-compliance 2017-03-27 22:00:23.124+00 https://www.pharmasalmanac.com/articles/cell-line-development-for-therapeutic-recombinant-proteins 2017-03-24 17:41:55.632+00 https://www.pharmasalmanac.com/articles/analytical-testing-outsourcing-trends-update 2017-03-18 04:48:19.259+00 https://www.pharmasalmanac.com/articles/environmental-monitoring-an-evolving-process-for-todays-evolving-production 2017-03-17 15:21:03.659+00 https://www.pharmasalmanac.com/articles/supplier-integrity-and-polymer-performance-remain-important-for-innovating-single-use-manufacturing 2017-03-17 14:25:10.117+00 https://www.pharmasalmanac.com/articles/new-post-/-whats-new-at-aaps-equipment 2017-03-16 14:18:28.083+00 https://www.pharmasalmanac.com/articles/to-be-published-tunable-microgels-to-advance-cell-therapy 2017-03-16 14:18:27.274+00 https://www.pharmasalmanac.com/articles/please-post-lonza-rings-the-changes-with-capsugel-buy 2017-03-16 14:18:27.094+00 https://www.pharmasalmanac.com/articles/cambrex-and-axyntis-moving-towards-cdmos 2017-03-16 14:18:26.908+00 https://www.pharmasalmanac.com/articles/new-post-pcas-patheon-adds-new-sites 2017-03-16 14:18:26.723+00 https://www.pharmasalmanac.com/articles/medical-device-security-through-materials 2017-03-16 14:18:26.483+00 https://www.pharmasalmanac.com/articles/an-industry-portal-for-data-knowledge-thought-leadership-and-opinion 2017-03-16 14:18:25.977+00 https://www.pharmasalmanac.com/articles/what-new-technology-introduced-within-the-last-year-have-you-found-to-have-the-most-impact-on-your-business 2017-03-14 17:02:06.261+00 https://www.pharmasalmanac.com/articles/parenteral-strategy-advancing-patient-centric-parenteral-drug-strategies 2017-03-13 20:55:20.173+00 https://www.pharmasalmanac.com/articles/virtual-panel-pharmaceutical-packaging-differentiation-equates-to-brand-loyalty 2017-03-13 20:43:20.653+00 https://www.pharmasalmanac.com/articles/move-toward-cell-based-manufacturing-signals-opening-in-vaccine-market 2017-03-13 18:46:45.767+00 https://www.pharmasalmanac.com/articles/ni-lifecycle-management-strategies-can-uncover-hidden-value 2017-03-10 23:13:30.627+00 https://www.pharmasalmanac.com/articles/human-factors-engineering-and-the-variability-of-the-human-condition 2017-03-10 18:07:13.591+00 https://www.pharmasalmanac.com/articles/manufacturers-and-cmos-streamline-bioprocessing-with-single-use-devices-a-nice-insights-biomanufacturing-outsourcing-report 2017-03-10 15:21:31.199+00 https://www.pharmasalmanac.com/articles/single-use-now-key-technology-in-biopharmaceutical-manufacturing 2017-03-10 15:19:54.019+00 https://www.pharmasalmanac.com/articles/sponsors-not-the-only-party-to-benefit-from-clinical-trials-in-emerging-markets 2017-03-10 15:17:20.108+00 https://www.pharmasalmanac.com/articles/identifying-segmentation-within-the-pharmaceutical-outsourcing-market 2017-03-10 15:16:19.591+00 https://www.pharmasalmanac.com/articles/cro-outsourcing-trends-for-2015-the-move-to-the-cloud-the-web-and-mobile-technology-continues 2017-03-10 15:15:39.313+00 https://www.pharmasalmanac.com/articles/nice-insight-survey-focus-on-automated-laboratory-systems 2017-03-10 15:15:07.264+00 https://www.pharmasalmanac.com/articles/expect-pharmaceutical-contract-manufacturing-to-continue-apace-in-2016 2017-03-10 15:13:37.016+00 https://www.pharmasalmanac.com/articles/new-post-what-are-the-latest-guidelines-for-excipients 2017-03-10 15:12:18.184+00 https://www.pharmasalmanac.com/articles/will-biosimilars-make-a-difference-for-the-cmo/cdmo-market 2017-03-10 15:04:44.146+00 https://www.pharmasalmanac.com/articles/the-data-generation 2017-03-09 16:20:09.166+00 https://www.pharmasalmanac.com/articles/the-data-generation-0 2017-03-09 01:38:29.894+00 https://www.pharmasalmanac.com/articles/nice-symposium-oral-solid-dose-thank-you-to-our-2017-sponsors 2017-03-09 01:22:34.291+00 https://www.pharmasalmanac.com/articles/expanding-the-commercial-options-for-preparation-of-amorphous-solid-dispersions 2017-03-08 22:36:08.31+00 https://www.pharmasalmanac.com/articles/achieving-security-of-supply-with-effective-particle-engineering 2017-03-08 22:35:32.687+00 https://www.pharmasalmanac.com/articles/pharmas-reputation-gap-consumer-business-innovation 2017-03-08 22:18:42.645+00 https://www.pharmasalmanac.com/articles/next-generation-osd-manufacturing-strategy 2017-03-08 22:06:57.666+00 https://www.pharmasalmanac.com/articles/an-oee-approach-to-solid-dose-equipment-purchasing-and-implementation 2017-03-08 21:38:35.32+00 https://www.pharmasalmanac.com/articles/nice-insight-overview-a-look-at-recent-pharma-industry-innovations 2017-03-06 21:27:49.387+00 https://www.pharmasalmanac.com/articles/q2-brammer-achieving-large-scale-cell-and-gene-therapy-manufacturing 2017-03-06 21:01:29.483+00 https://www.pharmasalmanac.com/articles/advanced-technologies-cited-as-essential-for-clinical-trial-challenges 2017-03-02 23:13:23.998+00 https://www.pharmasalmanac.com/articles/q1-fed-equip-gaining-optimal-roi-for-surplus-laboratory-and-manufacturing-assets 2017-02-16 17:08:21.074+00 https://www.pharmasalmanac.com/articles/innovation-moves-up-in-rank-and-technologies-move-into-the-outsourcing-paradigm 2017-02-15 18:10:11.57+00 https://www.pharmasalmanac.com/articles/roundtable-question-2 2017-02-07 20:43:14.223+00 https://www.pharmasalmanac.com/articles/in-close-supplier-partner-relationships-what-pitfalls-do-you-try-to-avoid-how-close-is-too-close 2017-02-07 20:40:26.027+00 https://www.pharmasalmanac.com/articles/what-have-you-found-to-be-the-greatest-benefit-from-close-collaboration-partnership-models 2017-02-07 20:37:48.971+00 https://www.pharmasalmanac.com/articles/what-are-you-doing-to-become-a-premier-outsourcing-partner-in-the-context-of-fdas-recent-shift-to-a-focus-on-quality-culture-rather-than-just-metrics 2017-02-07 19:56:54.229+00 https://www.pharmasalmanac.com/articles/what-is-your-perception-of-the-state-of-serialization-in-your-sector-of-the-pharma-industry 2017-02-06 21:44:31.21+00 https://www.pharmasalmanac.com/articles/q1-tn-another-exciting-year-for-clinical-research-outsourcing 2017-01-31 23:31:37.301+00 https://www.pharmasalmanac.com/articles/q1-tn-strong-cmo/cdmo-market-outlook-for-2016-but-beware-moderating-factors 2017-01-31 23:30:28.077+00 https://www.pharmasalmanac.com/articles/the-pharmaceuticals-app-market-is-comparatively-weak-and-inherently-limited-but-considerable-potential-exists 2017-01-20 15:37:26.543+00 https://www.pharmasalmanac.com/articles/to-be-publishedimage-needed-the-rise-of-biosimilars 2017-01-05 16:07:21.095+00 https://www.pharmasalmanac.com/articles/to-be-published-viral-clearance-risk-mitigation-in-biopharmaceutical-manufacturing 2017-01-03 18:41:11.179+00 https://www.pharmasalmanac.com/articles/investment-in-biopharma-facilities-continues 2016-12-22 15:40:39.425+00 https://www.pharmasalmanac.com/articles/2016-pharmaceutical-equipment-buying-trends 2016-12-22 15:39:37.385+00 https://www.pharmasalmanac.com/articles/effective-quality-assurance-capabilities-essential-for-cdmo/cro-success 2016-12-22 14:25:27.305+00 https://www.pharmasalmanac.com/articles/new-post-pharma-equipment-budget-expansion-fueling-quest-for-operational-excellence 2016-12-21 22:04:13.784+00 https://www.pharmasalmanac.com/articles/optimising-excipients-to-improve-bioavailability 2016-12-21 22:00:03.61+00 https://www.pharmasalmanac.com/articles/targeted-highly-potent-therapies-big-growth-driver-for-the-cdmo-market-le-here 2016-12-21 21:58:42.069+00 https://www.pharmasalmanac.com/articles/cros-grow-it-chops-to-gain-competitive-edge 2016-12-21 21:48:04.046+00 https://www.pharmasalmanac.com/articles/new-post-aaps-expedited-pathways 2016-12-21 21:33:04.58+00 https://www.pharmasalmanac.com/articles/nice-insight-announces-publication-of-its-q2-cro/cmo-quarterly-intelligence-report 2016-12-21 20:46:37.34+00 https://www.pharmasalmanac.com/articles/sponsor-company-size-influences-contract-service-provision 2016-12-21 20:42:36.872+00 https://www.pharmasalmanac.com/articles/controlling-glycosylation-for-improved-product-quality 2016-12-21 19:54:41.818+00 https://www.pharmasalmanac.com/articles/why-innovative-drug-delivery-packaging-solutions-are-needed-for-todays-patients 2016-12-16 22:42:08.39+00 https://www.pharmasalmanac.com/articles/customer-drivers-influencing-supplier-differentiation 2016-12-16 22:03:26.326+00 https://www.pharmasalmanac.com/articles/trends-in-outsourcing-whats-going-on-in-big-pharma 2016-12-16 21:58:47.864+00 https://www.pharmasalmanac.com/articles/new-post-advances-in-delivering-protein-and-peptide-therapeutics 2016-12-15 18:49:18.903+00 https://www.pharmasalmanac.com/articles/q4-2015-tn-be-innovative-maneuvering-the-global-pharmaceutical-market 2016-12-09 22:50:18.2+00 https://www.pharmasalmanac.com/articles/new-post-incorporating-qbd-into-lyophilization-manufacturing 2016-12-07 16:12:39.917+00 https://www.pharmasalmanac.com/articles/new-post-whats-new-at-aaps-materials 2016-12-05 16:19:01.129+00 https://www.pharmasalmanac.com/articles/new-post-beginning-your-digital-transformation 2016-12-04 22:15:47.966+00 https://www.pharmasalmanac.com/articles/increasing-the-chances-of-finding-the-best-possible-cro/cmo-fit 2016-12-01 20:59:36.512+00 https://www.pharmasalmanac.com/articles/outsourcing-trends-for-2012-top-services-by-customer-segment-and-the-prevalence-of-contracting-to-emerging-markets 2016-12-01 20:59:10.469+00 https://www.pharmasalmanac.com/articles/biocatalysis-versus-chemocatalysis 2016-12-01 20:58:02.228+00 https://www.pharmasalmanac.com/articles/challenges-facing-pharmaceutical-excipients 2016-12-01 20:54:44.718+00 https://www.pharmasalmanac.com/articles/the-buzz-around-oncology-update-on-biologics-approvals 2016-12-01 20:53:11.56+00 https://www.pharmasalmanac.com/articles/a-look-at-2015-outsourcing-trends-and-what-to-expect-in-2016 2016-12-01 20:52:44.042+00 https://www.pharmasalmanac.com/articles/suiting-a-strategy-to-fit-biotech-behaviours 2016-12-01 20:51:42.023+00 https://www.pharmasalmanac.com/articles/outsourcing-increasing-to-cros-and-cmos-known-for-quality-and-cost-effectiveness 2016-12-01 20:51:19.73+00 https://www.pharmasalmanac.com/articles/cro-or-cmo-which-is-best-for-your-preformulation-needs 2016-12-01 20:50:55.166+00 https://www.pharmasalmanac.com/articles/leads-ways-of-selecting-cmos-and-cros 2016-12-01 20:50:28.296+00 https://www.pharmasalmanac.com/articles/trends-impacting-pharma-equipment 2016-12-01 20:50:02.069+00 https://www.pharmasalmanac.com/articles/improving-global-supply-chain-security-in-the-pharmaceutical-industry 2016-12-01 20:49:36.603+00 https://www.pharmasalmanac.com/articles/speaking-the-same-language-the-gap-between-the-sales-pitch-and-supplier-selection-criteria-and-how-it-applies-in-the-excipients-market 2016-12-01 20:49:07.208+00 https://www.pharmasalmanac.com/articles/biopharmaceutical-outsourcing-to-cros-in-emerging-markets-surges-for-2015 2016-12-01 20:46:47.051+00 https://www.pharmasalmanac.com/articles/bioreactor-preferences-from-an-outsourcing-perspective-part-i 2016-12-01 20:46:19.692+00 https://www.pharmasalmanac.com/articles/industry-data-developing-targeted-marketing-strategies 2016-12-01 20:45:48.959+00 https://www.pharmasalmanac.com/articles/the-cdmo-model-and-outsourcing-development 2016-12-01 20:45:27.221+00 https://www.pharmasalmanac.com/articles/increased-demand-for-vaccines-will-continue-to-benefit-cmos 2016-12-01 20:38:22.881+00 https://www.pharmasalmanac.com/articles/new-post-pharmaceutical-contract-manufacturing-market-remains-strong-but-could-face-headwinds 2016-12-01 15:56:52.534+00 https://www.pharmasalmanac.com/articles/logistics-providers-strive-to-fulfill-biopharma-needs-specialty-companies-offer-advantages-but-get-a-bad-rap-on-price 2016-11-30 20:28:27.643+00 https://www.pharmasalmanac.com/articles/is-discounting-services-good-for-drug-development 2016-11-30 20:25:43.967+00 https://www.pharmasalmanac.com/articles/strategic-supply-marketing-agreements-as-complementary-alternative-to-classic-contract-manufacturing 2016-11-30 20:25:22.832+00 https://www.pharmasalmanac.com/articles/the-continued-evolution-of-the-sponsor-cro-relationship 2016-11-30 20:25:00.433+00 https://www.pharmasalmanac.com/articles/outsourcing-trends-in-small-molecule-api-manufacturing 2016-11-30 20:24:18.953+00 https://www.pharmasalmanac.com/articles/an-update-on-the-buzz-around-oncology 2016-11-30 20:23:57.628+00 https://www.pharmasalmanac.com/articles/outsourcing-biomanufacturing-continues-to-grow-in-frequency 2016-11-30 20:23:38.95+00 https://www.pharmasalmanac.com/articles/following-the-lead-from-big-pharma-or-biotech-may-not-identify-the-right-supplier-for-emerging-niche-or-start-up-companies 2016-11-30 20:23:17.672+00 https://www.pharmasalmanac.com/articles/as-outsourcing-relationships-evolve-vaccine-production-will-continue-to-shift-to-cmos 2016-11-30 20:22:05.066+00 https://www.pharmasalmanac.com/articles/can-cros-help-reduce-the-expense-of-clinical-trials 2016-11-30 20:20:06.925+00 https://www.pharmasalmanac.com/articles/new-technologies-in-fill-finish-may-bring-brand-loyalty-along-with-improved-patient-safety 2016-11-30 20:19:42.389+00 https://www.pharmasalmanac.com/articles/building-strategic-partnerships-with-cros-opportunities-exist-for-businesses-of-all-sizes-on-both-ends-of-the-deal 2016-11-30 20:19:18.669+00 https://www.pharmasalmanac.com/articles/trends-in-outsourcing-solid-dose-manufacturing-in-2014 2016-11-30 20:11:05.144+00 https://www.pharmasalmanac.com/articles/biologics-development-continues-to-rise-at-traditional-pharma-companies-what-does-it-mean-for-outsourcing 2016-11-30 20:10:29.32+00 https://www.pharmasalmanac.com/articles/with-outsourcing-on-the-rise-why-isnt-strategic-partnering-getting-easier 2016-11-30 20:09:57.561+00 https://www.pharmasalmanac.com/articles/outsourcing-to-cros-and-cmos-in-emerging-markets-in-2014 2016-11-30 20:09:25.309+00 https://www.pharmasalmanac.com/articles/api-manufacturing-strategic-partnering-preferences-with-cmos-vary-among-small-molecule-high-potency-and-biologic-api 2016-11-30 20:08:51.598+00 https://www.pharmasalmanac.com/articles/using-2013-trends-by-buyer-group-to-plan-your-outsourcing-initiatives 2016-11-30 20:08:22.148+00 https://www.pharmasalmanac.com/articles/outsourcing-biomanufacturing 2016-11-30 20:07:25.276+00 https://www.pharmasalmanac.com/articles/the-top-cros-by-therapeutic-indication-share-strong-regulatory-and-productivity-performance 2016-11-30 19:55:05.086+00 https://www.pharmasalmanac.com/articles/cros-and-cmos-continuing-drug-delivery-innovation 2016-11-30 19:54:44.45+00 https://www.pharmasalmanac.com/articles/outsourcing-and-the-oral-solid-dose-will-challenges-lead-to-new-patterns-of-outsourcing 2016-11-30 19:54:23.589+00 https://www.pharmasalmanac.com/articles/outsourcing-clinical-research-trends-by-customer-group 2016-11-30 19:50:54.322+00 https://www.pharmasalmanac.com/articles/do-companies-that-offer-regulatory-support-services-score-higher-on-regulatory-compliance 2016-11-30 19:44:18.831+00 https://www.pharmasalmanac.com/articles/the-evolving-dynamic-of-the-sponsor-cro-relationship 2016-11-30 19:43:49.852+00 https://www.pharmasalmanac.com/articles/essential-qualities-vary-by-buyer-category-and-business-size-when-it-comes-to-outsourcing-relationships 2016-11-30 19:42:55.463+00 https://www.pharmasalmanac.com/articles/how-relevant-are-483s-in-terms-of-compliance-perception 2016-11-30 19:40:06.945+00 https://www.pharmasalmanac.com/articles/strategic-partnering-for-innovation 2016-11-30 19:31:12.664+00 https://www.pharmasalmanac.com/articles/evolution-in-the-research-used-for-the-cmo-awards 2016-11-30 19:19:16.228+00 https://www.pharmasalmanac.com/articles/will-a-focus-on-innovation-pay-off-for-custom-synthesis-providers 2016-11-30 19:18:50.184+00 https://www.pharmasalmanac.com/articles/whats-the-buzz-around-oncology 2016-11-30 19:18:27.873+00 https://www.pharmasalmanac.com/articles/is-a-cmo-with-a-global-supply-chain-always-the-best-option 2016-11-30 19:18:05.344+00 https://www.pharmasalmanac.com/articles/data-management-and-information-technology-do-the-benefits-outweigh-the-risks 2016-11-30 19:17:44.85+00 https://www.pharmasalmanac.com/articles/advancing-sponsor/cro-collaborations-to-improve-preclinical-throughput 2016-11-30 19:17:21.931+00 https://www.pharmasalmanac.com/articles/outsourcing-clinical-research-established-vs.-emerging-markets 2016-11-30 19:17:00.127+00 https://www.pharmasalmanac.com/articles/key-drivers-for-outsourcing-partner-selection 2016-11-30 19:16:24.842+00 https://www.pharmasalmanac.com/articles/optimizing-the-partner-selection-process-for-drug-developers 2016-11-30 19:16:04.84+00 https://www.pharmasalmanac.com/articles/best-practices-for-targeted-marketing-communications 2016-11-30 19:15:46.36+00 https://www.pharmasalmanac.com/articles/overcoming-barriers-to-forming-successful-relationships-with-cmos-in-emerging-markets 2016-11-30 19:15:07.323+00 https://www.pharmasalmanac.com/articles/why-sponsors-should-regularly-re-evaluate-their-preferred-vendor-list-of-contract-research-and-contract-manufacturing-organizations 2016-11-30 19:14:45.784+00 https://www.pharmasalmanac.com/articles/who-should-be-doing-your-pharmaceutical-analytical-testing-a-cro-or-cmo 2016-11-30 19:13:51.42+00 https://www.pharmasalmanac.com/articles/tools-that-improve-outsourcing-selection 2016-11-30 19:13:31.936+00 https://www.pharmasalmanac.com/articles/what-cros-and-cmos-can-learn-from-q3-outsourcing-data-and-2011-trends 2016-11-30 19:13:07.798+00 https://www.pharmasalmanac.com/articles/sterile-manufacturing-opportunities 2016-11-30 19:10:49.532+00 https://www.pharmasalmanac.com/articles/where-do-strategic-business-opportunities-lie-for-mid-tier-cros 2016-11-30 18:57:07.611+00 https://www.pharmasalmanac.com/articles/benefit-from-clinical-trials-in-emerging-markets-while-limiting-risk-exposure 2016-11-30 18:56:32.758+00 https://www.pharmasalmanac.com/articles/connecting-cmos-and-cros-and-big-pharma 2016-11-30 18:56:06.46+00 https://www.pharmasalmanac.com/articles/strong-regulatory-compliance-and-reliability-indicative-of-solid-partnership-choices 2016-11-30 18:54:51.231+00 https://www.pharmasalmanac.com/articles/outsourcing-insights 2016-11-30 18:54:19.403+00 https://www.pharmasalmanac.com/articles/bringing-order-to-the-outsourced-manufacturing-space 2016-11-30 18:53:45.814+00 https://www.pharmasalmanac.com/articles/look-for-more-outsourcing-of-research-activities-in-2016 2016-11-30 18:53:18.989+00 https://www.pharmasalmanac.com/articles/nice-insight-outsourcing-trends-in-2016 2016-11-30 18:47:28.189+00 https://www.pharmasalmanac.com/articles/introduction-pharmas-almanac-a-foundation-of-innovation 2016-11-29 20:36:50.115+00 https://www.pharmasalmanac.com/articles/new-post-pharmas-role-in-pediatric-medication-adherence 2016-11-29 15:56:29.779+00 https://www.pharmasalmanac.com/articles/better-design-better-outcomes-better-economics 2016-11-28 16:01:17.874+00 https://www.pharmasalmanac.com/articles/the-right-preformulation/formulation-outsourcing-partner-can-alleviate-challenges-to-reducing-costs 2016-11-22 23:08:11.07+00 https://www.pharmasalmanac.com/articles/rx-360-an-industry-group-like-no-other 2016-11-21 16:14:23.387+00 https://www.pharmasalmanac.com/articles/perspectives-on-product-pricing-strategy-and-practice 2016-11-21 16:13:10.993+00 https://www.pharmasalmanac.com/articles/fed-equip-equipment-redeployments-strategic-role 2016-11-21 15:54:24.681+00 https://www.pharmasalmanac.com/articles/biovectra-finding-the-ideal-partner-for-your-next-biotherapeutic 2016-11-21 15:46:27.859+00 https://www.pharmasalmanac.com/articles/a-new-industry-think-tank-forum-for-leaders-of-outsourced-services-and-customers 2016-11-21 15:31:44.431+00 https://www.pharmasalmanac.com/articles/shaping-the-conversation-bringing-voice-value 2016-11-21 15:30:29.59+00 https://www.pharmasalmanac.com/articles/q4-2015-gsk-risk-minimization-through-careful-cdmo-selection 2016-11-18 22:47:59.262+00 https://www.pharmasalmanac.com/articles/ni-this-just-in 2016-11-18 22:42:54.739+00 https://www.pharmasalmanac.com/articles/q4-2015-hovione-in-depth-process-and-product-expertise-this-is-key-to-cdmo-support-of-orphan-drug-and-breakthrough-therapy-development-commercialization 2016-11-18 22:31:30.307+00 https://www.pharmasalmanac.com/articles/q4-2015-ash-stevens-what-does-it-mean-to-be-a-full-service-cdmo 2016-11-18 22:30:22.879+00 https://www.pharmasalmanac.com/articles/q4-2015-fed-equip-innovative-strategies-to-meet-todays-changing-equipment-needs 2016-11-18 22:22:48.13+00 https://www.pharmasalmanac.com/articles/q4-2015-choosing-the-optimal-drug-delivery-system-to-meet-patient-needs 2016-11-18 22:14:38.273+00 https://www.pharmasalmanac.com/articles/q4-2015-am.-aerogel-ensuring-the-integrity-of-temperature-sensitive-drugs-along-the-cold-chain-what-you-can-do-to-mitigate-risk 2016-11-18 22:10:10.616+00 https://www.pharmasalmanac.com/articles/q4-2015-cultural-competence-in-pharma-multicultural-marketing-is-no-longer-innovation-its-competitive-advantage 2016-11-18 22:05:56.759+00 https://www.pharmasalmanac.com/articles/trusted-partnerships-key-to-leveraging-full-benefits-of-surplus-pharmaceutical-equipment-market 2016-11-18 22:04:30.637+00 https://www.pharmasalmanac.com/articles/how-a-cmo-can-help-with-investigational-new-drug-applications 2016-11-18 21:54:05.93+00 https://www.pharmasalmanac.com/articles/q2-roundtable-antibody-drug-conjugate-roundtable-do-we-understand-the-capital-investment-in-our-staff 2016-11-18 21:27:33.246+00 https://www.pharmasalmanac.com/articles/alcami-connected-at-every-level 2016-11-18 21:13:33.941+00 https://www.pharmasalmanac.com/articles/q2-bioduro-integrating-drug-discovery-and-development-to-improve-efficiency-and-candidate-success 2016-11-18 21:09:01.833+00 https://www.pharmasalmanac.com/articles/q2-ni-nice-insight-pharmaceutical-equipment-2016-annual-study 2016-11-18 20:26:14.981+00 https://www.pharmasalmanac.com/articles/q2-grifols-a-holistic-interpretation-of-commitment-to-quality 2016-11-18 20:20:43.074+00 https://www.pharmasalmanac.com/articles/q2-codexis-accelerating-drug-development-and-manufacturing-with-engineered-enzymes 2016-11-18 20:00:51.679+00 https://www.pharmasalmanac.com/articles/q2-unither-dose-and-form-matter-future-of-care-demands-optimal-drug-delivery 2016-11-18 19:56:02.086+00 https://www.pharmasalmanac.com/articles/q2-gsk-enabling-right-first-time-tech-transfer-with-effective-scale-down-modeling 2016-11-18 19:53:31.908+00 https://www.pharmasalmanac.com/articles/q2-tn-research-database-recommendations 2016-11-18 19:49:10.762+00 https://www.pharmasalmanac.com/articles/tn-from-qualified-to-ideal-the-importance-of-partnership 2016-11-18 19:41:15.466+00 https://www.pharmasalmanac.com/articles/q1-grifols-patient-safety-and-parenteral-delivery-systems 2016-11-18 19:25:29.041+00 https://www.pharmasalmanac.com/articles/q1-nice-consulting-customer-experience-key-to-growth-in-the-outsourced-services-industry 2016-11-18 19:19:52.231+00 https://www.pharmasalmanac.com/articles/q1-unither-the-importance-of-convenient-dosing-formulations-for-elderly-patients 2016-11-18 19:18:24.819+00 https://www.pharmasalmanac.com/articles/q1-tn-equipment-trends-transforming-pharmaceutical-manufacturing 2016-11-18 19:14:05.84+00 https://www.pharmasalmanac.com/articles/q1-gsk-putting-the-d-in-cdmo-with-advanced-process-development 2016-11-18 19:05:30.691+00 https://www.pharmasalmanac.com/articles/q1-tn-opportunities-abound-for-contract-services-in-2016 2016-11-18 19:02:04.342+00 https://www.pharmasalmanac.com/articles/strategic-outsourcing-often-means-combining-functional-and-full-service-cros 2016-11-17 17:26:33.013+00 https://www.pharmasalmanac.com/articles/process-optimization-innovations-role 2016-11-14 22:29:01.608+00 https://www.pharmasalmanac.com/articles/using-industry-spending-data-to-develop-strategic-marketing 2016-11-14 22:24:28.242+00 https://www.pharmasalmanac.com/articles/contract-services-spending-whos-spending-what-and-where 2016-11-14 22:23:59.195+00 https://www.pharmasalmanac.com/articles/a-diversified-portfolio-of-contract-providers-might-improve-results 2016-11-14 22:22:00.481+00 https://www.pharmasalmanac.com/articles/what-can-2013-outsourcing-trends-lead-us-to-expect-in-2014 2016-11-14 22:21:32.53+00 https://www.pharmasalmanac.com/articles/biologics-account-for-an-increasing-share-of-outsourcing-spending 2016-11-14 18:34:44.565+00 https://www.pharmasalmanac.com/articles/spotlight-on-cleanroom-technology 2016-11-14 18:33:42.547+00 https://www.pharmasalmanac.com/articles/trends-in-outsourcing-the-benefit-of-engaging-a-cmo-for-injectable-product-development-through-to-fill-finish 2016-11-14 18:32:53.922+00 https://www.pharmasalmanac.com/articles/building-strategic-partnerships-with-cmos 2016-11-14 18:32:19.325+00 https://www.pharmasalmanac.com/articles/selecting-an-outsourcing-partner-for-vaccine-production 2016-11-14 18:31:10.007+00 https://www.pharmasalmanac.com/articles/ensuring-profitability-through-strategic-decision-making 2016-11-14 18:30:46.602+00 https://www.pharmasalmanac.com/articles/what-does-2015-hold-for-the-indian-cmo-industry 2016-11-14 18:29:50.029+00 https://www.pharmasalmanac.com/articles/emerging-pharma-and-emerging-biotech-value-different-traits-in-cros 2016-11-14 18:25:10.494+00 https://www.pharmasalmanac.com/articles/a-recap-on-2014-outsourcing-trends-and-what-to-expect-in-2015 2016-11-14 18:20:05.188+00 https://www.pharmasalmanac.com/articles/2014-trends-in-strategic-outsourcing-changes-in-the-qualities-that-drive-outsourcing-partner-selection 2016-11-14 18:17:37.864+00 https://www.pharmasalmanac.com/articles/biotherapeutics-outpace-conventional-therapies 2016-11-14 18:14:41.412+00 https://www.pharmasalmanac.com/articles/capacity-issues-and-the-question-to-insource-or-outsource 2016-11-14 18:10:44.05+00 https://www.pharmasalmanac.com/articles/outsourcing-to-emerging-markets-the-effect-of-the-european-economic-crisis 2016-11-14 18:07:50.706+00 https://www.pharmasalmanac.com/articles/pharmas-renaissance-continues 2016-11-10 00:31:06.548+00 https://www.pharmasalmanac.com/articles/2016-cro-industry-leader-0 2016-11-10 00:22:30.372+00 https://www.pharmasalmanac.com/articles/test-q1/2016-cdmo-industry-leader-0 2016-11-10 00:05:05.142+00 https://www.pharmasalmanac.com/articles/pharma-equipment-industry-leader 2016-11-09 20:38:30.242+00